PYRIDINECARBOXAMIDES, USEFUL-PLANT-PROTECTING COMPOSITION COMPRISING THEM AND PROCESSES FOR THEIR PREPARATION AND THEIR USE

04-10-2012 дата публикации
Номер:
US20120252670A1
Принадлежит: Individual
Контакты:
Номер заявки: 94-37-1352
Дата заявки: 14-06-2012

INCORPORATION BY REFERENCE

[0001]

The present application is a continuation of U.S. patent application Ser. No. 12/111,419 filed Apr. 29, 2008, which claims benefit under 35 U.S.C. 119(a) of European patent application 07400013.4, filed on Apr. 30, 2007.

[0002]

Any foregoing applications, including U.S. patent application Ser. No. 12/111,419 and European patent application EP 07400013.4, and all documents cited therein or during their prosecution (“application cited documents”) and all documents cited or referenced in the application cited documents, and all documents cited or referenced herein (“herein cited documents”), and all documents cited or referenced in herein cited documents, together with any manufacturer's instructions, descriptions, product specifications, and product sheets for any products mentioned herein or in any document incorporated by reference herein, are hereby incorporated herein by reference, and may be employed in the practice of the invention.

DESCRIPTION

[0003]

The present invention relates to useful-plant-protecting compounds and compositions comprising specific compounds as safeners for reducing phytotoxic actions of agrochemicals, in particular of herbicides. The invention relates in particular to pyridone derivatives as safeners and to processes for their preparation.

[0004]

When controlling unwanted organisms in crops of plants which are useful for agriculture or forestry by using pesticides, the useful plants are frequently also damaged to a greater or lesser extent, by the pesticides employed. This unwanted phytotoxic effect is encountered in particular with the use of a considerable number of herbicides in crops of useful plants such as, for example, corn, rice or cereals- and there primarily in the post-emergence application. In some instances, the useful plants can be protected against the phytotoxic properties of the pesticides by employing safeners or antidotes, without diminishing or substantially impairing the pesticidal activity against the harmful organisms. In some cases, even an improved pesticidal action against harmful organisms such as weeds was observed.

[0005]

The compounds hitherto known as safeners belong to a large number of different chemical structure classes, their suitability as safeners generally also depending on the chemical structures of the pesticides and on the crops of useful plants.

[0006]

Known for a long time have been the safener actions of compounds from the group of the phenoxy- or heteroaryloxyalkanecarboxylic acids, provided these compounds are applied in combination with herbicides. Examples of such compounds are MCPA and similar compounds which are at the same time herbicidally active against harmful plants, or cloquintocet-mexyl.

[0007]

Known are furthermore safeners from the group of the derivatives of N-phenyl-substituted heteroaromatic carboxylic esters having a plurality of heteroatoms in the heterocycle. Examples of such safeners are the safeners mefenpyr-diethyl and isoxadifen-ethyl, which are used in commercial products.

[0008]

WO 2004/084631 (us 2004-0224844) discloses the use of hydroxyl-substituted aromatic carboxylic acid derivatives. WO 2005/015994 (US 2005-037922) describes specific derivatives of salicylic acid as safeners. These compounds are suitable in particular for use as safeners in crops of corn and soybeans.

[0009]

Furthermore, WO 2005/112630 (US 2005-256000) discloses 1,2-dihydroquinoxalin-2-one derivatives as safeners.

[0010]

Active compounds from the chemical class of the pyridones with pesticidal properties are known from the literature. Various biological actions are described; thus, for example, WO 2001/014339 (US 2002-177578) describes the fungicidal action of certain substituted pyridonecarboxamides, WO 2005/042492 (US 2007-196406) and WO 2005/042493 (US 2007-037858) describe inter alia the fungicidal action of heterocyclylcarboxanilides. EP-A-544151 (U.S. Pat. No. 5,344,813) describes the action of hydroxyl-substituted pyridonecarboxamides as herbicides.

[0011]

Also known are representatives having pharmacological properties. Thus, WO 2001/055115 (U.S. Pat. No. 6,794,397) describes nicotinanilides as inductors of apoptosis, and US 2004/0116479 describes dialkylnicotinamides as inhibitors of angiogenesis.

[0012]

Furthermore, EP-A-522392 (U.S. Pat. No. 5,235,060) describes 6-trifluoromethyl-substituted pyridonecarboxamides as precursors for the synthesis of herbicidally active sulfonylureas. Helv. Chirp. Acta 71 (1988) 596-601 and GB 2305174 mention 1,2-dihydro-2-oxo-6-trifluoromethylpyridine-3-carboxamide, 6-chloro(difluoro)methyl-1,2-dihydro-2-oxopyridine-3-carboxamide and 6-difluoromethyl-1,2-dihydro-2-oxopyridine-3-carboxamide as intermediates in the synthesis of pyranopyridines. WO 2007/041052 mentions 1,2-dihydro-2-oxo-6-trifluoromethylpyridine-3-carboxamide as an intermediate in the synthesis of pharmacologically active spiropiperidines.

[0013]

The use of such compounds as safeners in combination with certain pesticides has hitherto not been disclosed.

[0014]

WO 2006/007981 (US 2007-265164) describes a method for identifying compounds which induce the defense of plants against pathogens, where the increase of the expression of plant-endogenous genes is considered to be an indication for the induction.

[0015]

Here, 1,2-dihydro-2-oxo-6-trifluoromethylpyridine-3-carboxamide is mentioned as part of a group of six compounds which may be referred to as safeners. A safener action confirmed by biological tests on plants has hitherto not been disclosed for this compound, and is also not sufficiently disclosed by WO 2006/007981.

[0016]

In particular the expression values obtained according to WO 2006/007981 for the compound, which in some cases are at a considerably lower level than those for commercially available safeners also mentioned, lead it to be expected in the best case that, as safeners, they are considerably less suitable, if at all.

[0017]

When safeners were used to protect useful plants against damage by pesticides, it was found that the known safeners may in many cases have disadvantages. These include:

    • the safener reduces the efficacy of the pesticides, in particular that of herbicides, against the harmful plants,
    • the useful-plant-protecting properties are insufficient,
    • in combination with a certain herbicide, the spectrum of the useful plants in which the safener/herbicide is to be employed is not sufficiently wide,
    • a certain safener can only be combined with a small number of herbicides,
    • by using safeners, the application rate to be applied and the amount of formulation is increased, which may cause problems during the application.

[0023]

For the reasons mentioned, there is a need to provide alternative compounds having safener action.

[0024]

The invention provides the use of compounds of the formula (I) or salts thereof

[0000]

[0025]

in which

  • R1is a (C1-C6)-haloalkyl radical, preferably a radical of the formula CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CFHCF3, CF(CF3)2, CH(CF3)2, CF2CF2CF3, or C(CH3)2F and
  • R2is hydrogen or halogen and
  • R3is hydrogen, (C1-C16)-alkyl, (C2-C16-alkenyl or (C2-C16)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted,
    • or (C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted,
    • and
  • R4is (C1-C16)-alkyl, (C2-C16)-alkenyl or (C2-C16)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted
    • or (C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted,
    • or
  • R3is (C1-C4)-alkoxy, (C2-C4)-alkenyloxy, (C2-C6)-alkynyloxy or (C2-C4)-haloalkoxy and
  • R4is hydrogen or (C1-C4)-alkyl or
  • R3and R4together with the directly attached nitrogen atom are a four- to eight-membered heterocyclic ring which, in addition to the nitrogen atom, may also comprise further hetero ring atoms, preferably up to two further hetero ring atoms selected from the group consisting of N, O and S, and which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, cyano, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, or
  • R3and R4together with the directly attached nitrogen atom are the group —N═CR5—NR6R7, in which
    • R5is hydrogen or (C1-C6)-alkyl, with hydrogen being preferred, and
    • R6, R7independently of one another are hydrogen or (C1-C4)-alkyl, preferably (C1-C2)-alkyl, or R6and R7together with the directly attached nitrogen atom form a five- to seven-membered, preferably saturated heterocyclic ring, such as, for example, piperidinyl, pyrrolidinyl or morpholinyl,
    • or
  • R1is a (C1-C6)-haloalkyl radical, preferably a radical of the formula CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CFHCF3, CF(CF3)2, CH(CF3)2, CF2CF2CF3or C(CH3)2F, more preferably a radical of the formula CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CF2CF2CF3or C(CH3)2F, in particular CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CF2CF2CF3or C(CH3)2F, even more preferably CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl or CF2CF2CF3,
  • R2is halogen,
  • R3is hydrogen and
  • R4is hydrogen
    • or
  • R1is a radical of the formula CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CFHCF3, CF(CF3)2, CH(CF3)2, CF2CF2CF3or C(CH3)2F, more preferably CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CF2CF2CF3or C(CH3)2F, even more preferably CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl or CF2CF2CF3,
  • R2is hydrogen,
  • R3is hydrogen and
  • R4is hydrogen,
    as a useful-plant-protecting agent for reducing or preventing harmful actions of agrochemicals, preferably pesticides, in particular herbicides, on the useful plants.

[0054]

Hereinbelow, the compounds of the formula (I) and their salts are in some cases also referred to as “compounds (I)” according to the invention or used according to the invention.

[0055]

The compounds of the formula (I) also include tautomers which can be formed by hydrogen shifts and whose structure is formally not embraced by the formula (I). These tautomers are nevertheless included in the definition of the compounds of the formula (I) according to the invention. The definition of the compounds of the formula (I) includes in particular the tautomeric structures of the formula (Ia) (2-hydroxypyridine-3-carboxamides) or salts thereof

[0000]

[0056]

in which

[0057]

R1, R2, R3and R4are as defined in formula (I).

[0058]

Some compounds of the formula (I) according to the invention or salts thereof are novel and also form part of the subject matter of the invention.

[0059]

It is noted that in this disclosure and particularly in the claims and/or paragraphs, terms such as “comprises”, “comprised”, “comprising” and the like can have the meaning attributed to it in U.S. patent law, e.g., they can mean “includes”, “included”, “including”, and the like; and that terms such as “consisting essentially of” and “consists essentially of” have the meaning ascribed to them in U.S. patent law, e.g., they allow for elements not explicitly recited, but exclude elements that are found in the prior art or that affect a basic or novel characteristic of the invention.

[0060]

It is further noted that the invention does not intend to encompass within the scope of the invention any previously disclosed product, process of making the product or method of using the product, which meets the written description and enablement requirements of the USPTO (35 U.S.C. 112, first paragraph) or the EPO (Article 83 of the EPC), such that applicant(s) reserve the right and hereby disclose a disclaimer of any previously described product, method of making the product or process of using the product.

[0061]

The invention also provides useful-plant-protecting compositions comprising compounds of the formula (I) or salts thereof and formulation auxiliaries. The invention also provides useful-plant-protecting compositions comprising compounds of the formula (I) or salts thereof in combination with further agrochemicals, preferably pesticides, in particular herbicides, and, if appropriate, formulation auxiliaries.

[0062]

Some compounds of the formula (I) are already described as intermediates for preparing active compounds, see the abovementioned GB-A-2305174 (comp. (I) in which R1=CF3, CF2Cl or CF2H and R3═R4═H). EP-A-522392, which has already been mentioned, described in a general manner inter alia compounds (I) as intermediates for preparing sulfonylureas. The safener actions of the compounds have not been described.

[0063]

The invention also provides compounds of the formula (I) or salts thereof

[0000]

[0064]

in which

  • R1is a (C1-C6)-haloalkyl radical, preferably a radical of the formula CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CFHCF3, CF(CF3)2, CH(CF3)2, CF2CF2CF3or C(CH3)2F, in particular a radical of the formula CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CF2CF2CF3or C(CH3)2F, more preferably CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl or CF2CF2CF3and
  • R2is hydrogen or halogen and
  • R3is hydrogen, (C1-C16)-alkyl, (C2-C16)-alkenyl or (C2-C16)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl, or (C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted,
    • and
  • R4is (C1-C16)-alkyl, (C2-C26)-alkenyl or (C2-C16)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl,
    • or (C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted,
    • or
  • R3is (C1-C4)-alkoxy, (C2-C4)-alkenyloxy, (C2-C6)-alkynyloxy or (C2-C4)-haloalkoxy and
  • R4is hydrogen or (C1-C4)-alkyl or
  • R3and R4together with the directly attached nitrogen atom are a four- to eight-membered heterocyclic ring which, in addition to the nitrogen atom, may also comprise further hetero ring atoms, preferably up to two further hetero ring atoms selected from the group consisting of N, O and S, and which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, cyano, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, or
  • R3and R4together with the directly attached nitrogen atom are the group —N═CR5—NR6R7in which
    • R5is hydrogen or (C1-C6)-alkyl, with hydrogen being preferred, and
    • R6, R7independently of one another are hydrogen or (C1-C4)-alkyl, preferably (C1-C2)-alkyl, or R6and R7together with the directly attached nitrogen atom form a five- to seven-membered, preferably saturated heterocyclic ring, such as, for example, piperidinyl, pyrrolidinyl or morpholinyl,
    • or
  • R1is a (C1-C6)-haloalkyl radical, preferably a radical of the formula CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CFHCF3, CF(CF3)2, CH(CF3)2, CF2CF2CF3or C(CH3)2F, more preferably CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CF2CF2CF3or C(CH3)2F, in particular CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CF2CF2CF3or C(CH3)2F, even more preferably CF2Cl, CF2CF3, CF2CF2Cl or CF2CF2CF3,
  • R2is halogen,
  • R3is hydrogen and
  • R4is hydrogen
    • or
  • R1is a radical of the formula CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CFHCF3, CF(CF3)2, CH(CF3)2, CF2CF2CF3or C(CH3)2F, preferably CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CF2CF2CF3or C(CH3)2F, in particular CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3or CF2CF2CF3ieven more preferably CF2CF3, CF2CF2H, CF2CF2Cl or CF2CF2CF3,
  • R2is hydrogen,
  • R3is hydrogen and
  • R4is hydrogen.

[0092]

Preferably excluded are compounds of the formula (I) and salts thereof in which

  • R1is (C1-C3)-alkyl which is substituted by one to three fluorine atoms,
  • R2is hydrogen,
  • R3is (C1-C2)-alkyl and
  • R4is (C1-C2)-alkyl.

[0097]

The lastmentioned preferably excluded compounds are described in a general manner in the abovementioned EP-A-0522392 as intermediates for preparing sulfonylureas.

[0098]

Depending on the nature and the attachment of the substituents, the compounds of the formula (I) may be present as stereoisomers. All possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, Z- and E-isomers, are embraced by the formula (I).

[0099]

If, for example, one or more alkenyl groups are present, it is possible for diastereomers (Z- and E-isomers) to occur. If, for example, one or more asymmetric carbon atoms are present, it is possible for enantiomers and diastereomers to occur. Stereoisomers can be obtained by customary separation methods, for example by chromatographic separation procedures, from the mixtures obtained in the preparation. It is also possible to selectively prepare stereoisomers by employing stereoselective reactions using optically active starting materials and/or auxiliaries. Thus, the invention also relates to all stereoisomers embraced by the formula (I) but not shown in their specific stereoform and mixtures thereof.

[0100]

The possibilities of combining the various substituents of the formula (I) are to be understood in such a way that the general principles of the synthesis of chemical compounds are to be observed, i.e. the formula (I) does not embrace compounds which the skilled worker knows to be chemically impossible.

[0101]

The terms used above and further below are familiar to the person skilled in the art and have in particular the meanings illustrated below:

[0102]

The term “(C1-C4)-alkyl” is a short notation for open-chain alkyl having 1 to 4 carbon atoms corresponding to the stated range of carbon atoms, i.e. it includes the radicals methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl and tert-butyl. Correspondingly, general alkyl radicals having a wider stated range of carbon atoms, for example “(C1-C6)-alkyl”, also include straight-chain or branched alkyl radicals having a larger number of carbon atoms, i.e. in the example also the alkyl radicals having 5 and 6 carbon atoms.

[0103]

Unless specifically indicated, the lower carbon skeletons, for example those having 1 to 6 carbon atoms or, in the case of unsaturated groups, having 2 to 6 carbon atoms, are preferred for the hydrocarbon radicals such as alkyl, alkenyl and alkynyl radicals, including in composite radicals. Alkyl radicals, including in the composite meanings, such as alkoxy, haloalkyl, etc., are, for example, methyl, ethyl, n- or isopropyl, n-, iso, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, isohexyl and 1,3-dimethylbutyl, heptyls, such as n-heptyl, 1-methylhexyl and 1,4-dimethylpentyl; alkenyl and alkynyl radicals have the meanings of the possible unsaturated radicals which correspond to the alkyl radicals; alkenyl is, for example, vinyl, allyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 2-butenyl, pentenyl, 2-methylpentenyl or hexenyl, preferably allyl, 1-methylprop-2-en-1-yl, 2-methylprop-2-en-1-yl, but-2-en-1-yl, but-3-en-1-yl, 1-methylbut-3-en-1-yl or 1-methylbut-2-en-1-yl. (C2-C6)-alkynyl is, for example, ethynyl, propargyl, 1-methyl-2-propynyl, 2-methyl-2-propynyl, 2-butynyl, 2-pentynyl or 2-hexynyl, preferably propargyl, but-2-yn-1-yl, but-3-yn-1-yl or 1-methylbut-3-yn-1-yl.

[0104]

Alkylidene, including, for example, in the form (C1-C10)-alkylidene, is the radical of a straight-chain or branched alkane which is attached via a double bond, where the position of the point of attachment has not yet been fixed. The only possible positions in the case of a branched alkane are, of course, positions in which two hydrogen atoms may be replaced by the double bond; radicals are, for example, ═CH2, ═CH—CH3, ═C(CH3)—CH3, ═C(CH3)—C2H5or ═C(C2H5)—C2H5.

[0105]

Cycloalkyl is a carbocyclic saturated ring system having preferably 3-8 carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. Substituted cycloalkyl embraces cyclic systems having substituents, substituents having a double bond at the cycloalkyl radical, for example an alkylidene group, such as methylidene, also being included. Substituted cycloalkyl also embraces polycyclic aliphatic systems, such as, for example, bicyclo[1.1.0]butan-1-yl, bicyclo[1.1.0]butan-2-yl, bicyclo[2.1.0]-pentan-1-yl, bicyclo[2.1.0]pentan-2-yl, bicyclo[2.1.0]pentan-5-yl, adamantan-1-yl and adamantan-2-yl.

[0106]

Cycloalkenyl is a carbocyclic, non-aromatic, partially unsaturated ring system having preferably 4-8 carbon atoms, for example 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1,3-cyclohexadienyl or 1,4-cyclohexadienyl. The explanations given for substituted cycloalkyl apply correspondingly to substituted cycloalkenyl.

[0107]

The term “halogen” denotes, for example, fluorine, chlorine, bromine or iodine. Haloalkyl, haloalkenyl and haloalkynyl are alkyl, alkenyl and alkynyl, respectively, which are partially or fully substituted by identical or different halogen atoms, preferably from the group consisting of fluorine, chlorine and bromine, in particular from the group consisting of fluorine and chlorine, for example monohaloalkyl, such as CH2CH2Cl, CH2CH2F, CH2ClCH3, CH2FCH3, CH2Cl, CH2F; perhaloalkyl such as CCl3or CF3or CF3CF2; polyhaloalkyl, such as CHF2, CH2F, CH2FCHCl, CHCl2, CF2CF2H, CH2CF3, CH2ClCH3, CH2FCH3; haloalkoxy is, for example, OCF3, OCHF2, OCH2F, CF3CF2O, OCH2CF3and OCH2CH2Cl; this applies correspondingly to haloalkenyl and other halogen-substituted radicals.

[0108]

If a skeleton is substituted “by one or more radicals” from a list of radicals (=group) or a generically defined group of radicals, this includes in each case the simultaneous substitution by a plurality of identical and/or structurally different radicals.

[0109]

Substituted radicals, such as a substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, phenyl, benzyl, heterocyclyl and heteroaryl radical, are, for example, substituted radicals derived from an unsubstituted skeleton, the substituents being, for example, one or more, preferably 1, 2 or 3, radicals from the group consisting of halogen, alkoxy, alkylthio, hydroxyl, amino, nitro, carboxyl, cyano, azido, alkoxycarbonyl, alkylcarbonyl, formyl, carbamoyl, mono- and dialkylaminocarbonyl, substituted amino, such as acylamino, mono- and dialkylamino, trialkylsilyl and optionally substituted cycloalkyl, optionally substituted phenyl, optionally substituted heterocyclyl, where each of the lastmentioned cyclic groups may also be attached via heteroatoms or divalent functional groups as in the alkyl radicals mentioned, and alkylsulfinyl, alkylsulfonyl and, in the case of cyclic radicals (=“cyclic skeleton”), also alkyl, haloalkyl, alkylthioalkyl, alkoxyalkyl, optionally substituted mono- and dialkylaminoalkyl and hydroxyalkyl; the term “substituted radicals”, such as substituted alkyl, etc., includes as substituents, in addition to the saturated hydrocarbon-containing radicals mentioned, the corresponding unsaturated aliphatic and aromatic radicals, such as optionally substituted alkenyl, alkynyl, alkenyloxy, alkynyloxy, phenyl, phenoxy etc. In the case of substituted cyclic radicals having aliphatic moieties in the ring, this also embraces cyclic systems having substituents which are attached to the ring via a double bond, for example substituted by an alkylidene group, such as methylidene or ethylidene, or an oxo group, imino group or substituted imino group.

[0110]

The substituents mentioned by way of example (“first substituent level”) can, if they contain hydrocarbon-containing moieties, be, if appropriate, substituted further in the moieties (“second substituent level”), for example by one of the substituents as defined for the first substituent level. Corresponding further substituent levels are possible. The term “substituted radical” preferably embraces only one or two substituent levels.

[0111]

Preferred substituents for the substituent levels are, for example, amino, hydroxyl, halogen, nitro, cyano, mercapto, carboxyl, carboxamide, SF5, aminosulfonyl, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, monoalkylamino, dialkylamino, N-alkanoylamino, alkoxy, alkenyloxy, alkynyloxy, cycloalkoxy, cycloalkenyloxy, alkoxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkanoyl, alkenylcarbonyl, alkynylcarbonyl, arylcarbonyl, alkylthio, cycloalkylthio, alkenylthio, cycloalkenylthio, alkynylthio, alkylsulfinyl, alkylsulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl, N-alkylaminocarbonyl, N,N-dialkyl-aminocarbonyl, N-alkanoylaminocarbonyl, N-alkanoyl-N-alkylaminocarbonyl, aryl, aryloxy, benzyl, benzyloxy, benzylthio, arylthio, arylamino, benzylamino, heterocyclyl and trialkylsilyl.

[0112]

In the case of radicals having carbon atoms, preference is given to those having 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, in particular 1 or 2 carbon atoms. Preference is generally given to substituents selected from the group consisting of halogen, for example fluorine and chlorine, (C1-C4)-alkyl, preferably methyl or ethyl, (C1-C4)-haloalkyl, preferably trifluoromethyl, (C1-C4)-alkoxy, preferably methoxy or ethoxy, (C1-C4)-haloalkoxy, nitro and cyano. Here, particular preference is given to the substituents methyl, methoxy, fluorine and chlorine.

[0113]

Substituted amino, such as mono- or disubstituted amino, denotes a radical from the group of the substituted amino radicals which are N-substituted, for example, by one or two identical or different radicals selected from the group consisting of alkyl, alkoxy, acyl and aryl; preferably mono- and dialkylamino, mono- and diarylamino, acylamino, N-alkyl-N-acylamino, N-alkyl-N-acylamino and saturated N-heterocycles; here, preference is given to alkyl radicals having 1 to 4 carbon atoms; aryl is preferably phenyl or substituted phenyl; for acyl, the definition given further down applies, preference is given to (C1-C4)-alkanoyl. This applies correspondingly to substituted hydroxylamino or hydrazino.

[0114]

Substituted amino also includes quarternary ammonium compounds (salts) with four organic substituents at the nitrogen atom.

[0115]

Optionally substituted phenyl is preferably phenyl which is unsubstituted or mono- or polysubstituted, preferably up to trisubstituted, by identical or different radicals from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy and nitro, for example o-, m- and p-tolyl, dimethylphenyls, 2-, 3- and 4-chlorophenyl, 2-, 3- and 4-fluorophenyl, 2-, 3- and 4-trifluoromethyl- and -trichloromethylphenyl, 2,4-, 3,5-, 2,5- and 2,3-dichlorophenyl, o-, m- and p-methoxyphenyl.

[0116]

Optionally substituted cycloalkyl is preferably cycloalkyl which is unsubstituted or mono- or polysubstituted, preferably up to trisubstituted, by identical or different radicals from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkyl and (C1-C4)-haloalkoxy, in particular by one or two (C1-C4)-alkyl radicals.

[0117]

Optionally substituted heterocyclyl is preferably heterocyclyl which is unsubstituted or mono- or polysubstituted, preferably up to trisubstituted, by identical or different radicals from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, nitro and oxo, in particular mono- or polysubstituted by radicals from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkyl and oxo, very particularly substituted by one or two (C1-C4)-alkyl radicals.

[0118]

Acyl denotes a radical of an organic acid which, formally, is formed by removing a hydroxyl group from the acid function, it also being possible for the organic radical in the acid to be attached to the acid function via a heteroatom. Examples of acyl are the radical —CO—R of a carboxylic acid HO—CO—R and radicals of acids derived therefrom, such as thiocarboxylic acid, unsubstituted or N-substituted iminocarboxylic acids or the radical of carbonic acid monoesters, N-substituted carbamic acid, sulfonic acids, sulfinic acids, N-substituted sulfonamido acids, phosphonic acids, phosphinic acids.

[0119]

Acyl denotes, for example, formyl, alkylcarbonyl such as [(C1-C4)-alkyl]carbonyl, phenylcarbonyl, alkyloxycarbonyl, phenyloxycarbonyl, benzyloxycarbonyl, alkylsulfonyl, alkylsulfinyl, N-alkyl-1-iminoalkyl, N-alkyl- and N,N-dialkylcarbamoyl and other radicals of organic acids. Here, the radicals may in each case be substituted further in the alkyl or phenyl moiety, for example in the alkyl moiety by one or more radicals selected from the group consisting of halogen, alkoxy, phenyl and phenoxy; examples of substituents in the phenyl moiety are the substituents which have already been mentioned further above in a general manner for substituted phenyl.

[0120]

Acyl denotes preferably an acyl radical in the narrower sense, i.e. a radical of an organic acid where the acid group is attached directly to the carbon atom of an organic radical, for example alkanoyl, such as formyl and acetyl, aroyl, such as phenylcarbonyl, and other radicals of saturated or unsaturated organic acids.

[0121]

“Aroyl” denotes an aryl radical as defined above which is attached via a carbonyl group, for example the benzoyl group.

[0122]

If a general radical is defined as “hydrogen”, this means a hydrogen atom.

[0123]

The “yl-position” of a radical denotes its point of attachment.

[0124]

In accordance with the general definitions:

[0125]

“(C1-C6)-alkyl” is a methyl, ethyl, propyl, isopropyl, 1-butyl, 2-butyl, 2-methylpropyl or tert-butyl radical;

[0126]

“(C1-C10)-alkyl” thus includes the alkyl radicals mentioned above, and also isomeric pentyl radicals, such as n-pentyl, 1,1-dimethylpropyl or 2-methylbutyl, isomeric hexyl, heptyl, octyl, nonyl or decyl radicals.

[0127]

Accordingly, “(C2-C4)-alkenyl” denotes, for example, the vinyl, allyl, 2-methyl-2-propen-1-yl-, 2- or 3-buten-1-yl group,

[0000]

accordingly, “(C3-C10)-alkenyl” denotes, for example, the allyl, 2-methyl-2-propen-1-yl, 2- or 3-buten-1-yl, pentenyl, 2-methylpentenyl, hexenyl, heptenyl, octenyl, nonenyl or decenyl group.

[0128]

“(C2-C4)-Alkynyl” denotes, for example, the ethynyl, propargyl or 2-butyn-1-yl group,

[0129]

“(C3-C10)-alkynyl” denotes, for example, the propargyl, 2-butyn-1-yl, 2-pentyn-1-yl, 2-methylpentyn-3-yl, hexynyl, heptynyl, octynyl, nonynyl or the decynyl group.

[0130]

If the carbon chain of an alkyl radical is interrupted by more than one oxygen atom, this means that two oxygen atoms must not be directly adjacent.

[0131]

“(C3-C6)-Cycloalkyl” denotes the cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl radical,

[0132]

“(C3-C10)-cycloalkyl” denotes monocycle alkyl radicals, such as the cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or cyclodecyl radical, denotes bicyclic alkyl radicals, such as the norbornyl or bicyclo[2.2.2]octyl radical, or denotes fused systems, such as the decahydronaphthyl radical.

[0133]

“(C4-C10)-Cycloalkenyl” denotes monocycle cycloalkylene radicals, such as the cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl or cyclodecenyl radical, denotes bicyclic alkyl radicals, such as the norbornenyl or bicyclo[2.2.2]octenyl radical, or denotes fused systems, such as the tetra-, hexa- or octahydronaphthyl radical.

[0134]

“(C1-C4)-Alkoxy” and “(C1-C10)-alkoxy” are alkoxy groups whose hydrocarbon radicals have the meanings given under the terms “(C1-C4)-alkyl” and “(C1-C10)-alkyl”.

[0135]

In particular for reasons of better crop-plant- or useful-plant-protecting action (safener action), better selectivity and/or better preparability, the use according to the invention of compounds of the formula (I) mentioned or salts thereof is of particular interest in which individual radicals have one of the preferred meanings already mentioned or mentioned below, and in particular those which contain a combination of one or more of the preferred meanings already mentioned or mentioned below.

[0136]

Preferably, if embraced by the above mentioned general definition of formula (I),

  • R1is a (C1-C4)-haloalkyl radical, more preferably CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, C(CH3)2F or CF2CF2CF3, more preferably CF3, CF2Cl, CF2H, CF2CF2CF3or CF2CF3, more preferably CF3, CF2Cl, CF2CF2CF3or CF2CF3, in particular CF3, CF2Cl or CF2CF3.

[0138]

Preferably,

  • R2is hydrogen or halogen. Here, halogen is preferably fluorine, chlorine, bromine or iodine, in particular chlorine, bromine or iodine, very particularly chlorine or bromine.

[0140]

Preferably,

  • R3is hydrogen, (C1-C10)-alkyl, (C2-C10)-alkenyl or (C2-C10)-alkynyl,
    • where each of the 3 last mentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl,
    • (C3-C6)-cycloalkyl, which is unsubstituted or substituted by one or more radicals from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl, preferably unsubstituted or substituted by (C1-C4)-alkyl,
    • phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, and
    • heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo, preferably unsubstituted or substituted by one or more radicals from the group consisting of (C1-C4)-alkyl (C1-C4)-haloalkyl and (C1-C4)-alkoxy,
    • or (C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl,
    • (C3-C6)-cycloalkyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl, preferably unsubstituted or substituted by (C1-C4)-alkyl,
    • phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, and
    • heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo, preferably unsubstituted or substituted by one or more radicals from the group consisting of (C1-C4)-alkyl, (C1-C4)-haloalkyl and (C1-C4)-alkoxy,
    • more preferably hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and (C1-C4)-alkoxycarbonyl,
    • more preferably hydrogen or (C1-C4)-alkyl, in particular hydrogen,
      and
  • R4is (C1-C10)-alkyl, (C2-C10)-alkenyl or (C2-C10)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl,
    • (C3-C6)-cycloalkyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl, preferably unsubstituted or substituted by (C1-C4)-alkyl,
    • phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, and
    • heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo, preferably unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkyl (C1-C4)-haloalkyl and (C1-C4)-alkoxy,
    • or (C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl,
    • (C3-C6)-cycloalkyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl, preferably unsubstituted or substituted by (C1-C4)-alkyl,
    • phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, and
    • heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo, preferably unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkyl, (C1-C4)-haloalkyl and (C1-C4)-alkoxy.

[0163]

Here, heterocyclyl is preferably a heterocyclic 3- to 9-membered, in particular 5- or 6-membered, ring having 1 to 3 hetero ring atoms from the group consisting of N, O and S.

[0164]

More preferably,

  • R3is hydrogen, (C1-C10)-alkyl, (C2-C10)-alkenyl or (C2-C10)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl,
    • (C3-C6)-cycloalkyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl, preferably unsubstituted or substituted by (C1-C4)-alkyl,
    • phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, and
    • heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo,
    • or (C3-C6)-cycloalkyl or (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 2 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkyl,
    • more preferably hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and (C1-C4)-alkoxycarbonyl,
    • more preferably hydrogen or (C1-C4)-alkyl, in particular hydrogen,
      and
  • R4is as already defined above for R4or preferably (C1-C10)-alkyl, (C2-C10)-alkenyl or (C2-C10)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl,
    • (C3-C6)-cycloalkyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl, preferably unsubstituted by (C1-C4)-alkyl,
    • phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, and
    • heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo,
    • or (C3-C6)-cycloalkyl or (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 2 lastmentioned radicals is unsubstituted or substituted by one or more radicals from the group consisting of (C1-C4)-alkyl.

[0181]

More preferably.

  • R3is hydrogen, (C1-C10)-alkyl, (C2-C10)-alkenyl or (C2-C10)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and [(C1-C4)-alkoxy]-carbonyl,
    • preferably hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and (C1-C4)-alkoxycarbonyl,
    • more preferably hydrogen or (C1-C4)-alkyl, in particular hydrogen,
      and
  • R4is as already defined above for R4or preferably
    • (C1-C10)-alkyl, (C2-C10)-alkenyl or (C2-C10)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and [(C1-C4)-alkoxy]-carbonyl,
    • preferably (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and (C1-C4)-alkoxycarbonyl.

[0190]

Particular preference is given to the use according to the invention of compounds of the formula (I) or salts thereof in which

  • R1is CF3, CF2Cl, CF2H, CF2CF2CF3or CF2CF3, preferably CF3, CF2Cl, CF2CF2CF3or CF2CF3, in particular CF3, CF2Cl or CF2CF3and
  • R2is hydrogen or halogen, preferably hydrogen, and
  • R3is hydrogen, (C1-C10)-alkyl, (C1-C10)-alkenyl or (C2-C10)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and (C1-C4)-alkoxycarbonyl,
    • preferably hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and (C1-C4)-alkoxycarbonyl,
    • in particular hydrogen or (C1-C4)-alkyl, and
  • R4is (C1-C10)-alkyl, (C3-C10)-alkenyl or (C3-C10)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl,
    • (C3-C6)-cycloalkyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl, preferably unsubstituted or substituted by (C1-C4)-alkyl,
    • phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio, and
    • heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo,
    • or (C3-C6)-cycloalkyl or (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring,
    • where each of the 2 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkyl,
    • preferably (C1-C10)-alkyl, (C2-C10)-alkenyl or (C2-C10)-alkynyl,
    • where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and (CrC4)-alkoxycarbonyl,
    • more preferably (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and (C1-C4)-alkoxycarbonyl,
      or
  • R3and R4together with the directly attached nitrogen atom are a four- to eight-membered heterocyclic ring, preferably a 5- or 6-membered heterocyclic ring, which, in addition to the nitrogen atom, may also contain further hetero ring atoms, preferably up to two further hetero ring atoms from the group consisting of N, O and S, and which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, cyano, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio,
    or
  • R3and R4together with the directly attached nitrogen atom are the group —N═CR5—NR6R7, in which
    • R5is hydrogen or (C1-C4)-alkyl, with hydrogen being preferred, and
    • R6, R7independently of one another are hydrogen or (C1-C4)-alkyl, preferably (C1-C2)-alkyl, or R5and R7together with the directly attached nitrogen atom form a five- or six-membered, preferably saturated heterocyclic ring, such as, for example, piperidinyl, pyrrolidinyl or morpholinyl.

[0211]

Particular preference is also given to the use according to the invention of compounds of the formula (I) or salts thereof in which

  • R1is a (C1-C6)-haloalkyl radical, preferably from the group consisting of CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CF2CF2CF3and C(CH3)2F, more preferably CF3, CF2Cl, CF2H, CF2CF2CF3or CF2CF3, even more preferably CF3, CF2Cl, CF2CF2CF3or CF2CF3, in particular CF3, CF2CF3or CF2Cl, and
  • R2is halogen and
  • R3is hydrogen and
  • R4is hydrogen.

[0216]

Likewise particularly preferred is the use according to the invention of compounds of the formula (I) or salts thereof in which

  • R1is CF2Cl, CF2H, CF2CF3, CF2CF2H or CF2CF2Cl, more preferably CF2Cl or CF2H or CF2CF3, more preferably CF2Cl or CF2CF3, in particular CF2Cl,
  • R2is hydrogen and
  • R3is hydrogen or (C1-C4)-alkyl and
  • R4is hydrogen.

[0221]

Particular preference is also given to the use according to the invention of compounds of the formula (I) or salts thereof in which the general radicals correspond to the radicals mentioned for R1, R2, R3and R4, respectively, in the examples given in the tables, or embrace them.

[0222]

Particular preference is also given to the use according to the invention of novel compounds of the formula (I) or salts thereof in which R1, R2, R3and R4furthermore preferably have the meanings mentioned for the preferred uses.

[0223]

The compounds of the general formula (I) can be prepared, for example, by

  • (a) reacting a carboxylic acid of the general formula (II)

[0000]

    • in which R1and R2are as defined for the compound of the formula (I) to be prepared, with an amine of the formula (III) or a salt thereof,

[0000]

    • in which R3and R4are as defined for the compound of the formula (I) to be prepared, if appropriate in the presence of a carboxylic acid-activating reagent, for example N,N-carbonyldiimidazole (CDI), or a dehydrating agent, for example dicyclohexylcarbodiimide (DCC), to give the compound of the formula (I) or
  • (b) reacting a carboxylic ester of the general formula (IV)

[0000]

    • in which R1and R2are as defined for the compound of the formula (I) to be prepared and “Alkyl” is an alkyl radical, for example methyl or ethyl, with an amine of the formula (III) or a salt thereof,

[0000]

    • in which R3and R4are as defined for the compound of the formula (I) to be prepared, to give the compound of the formula (I) or
  • (c) reacting a carbonyl halide or a carboxylic anhydride of the general formula (V),

[0000]

    • in which R1and R2are as defined for the compound of the formula (I) to be prepared and Hal is a halogen atom, for example chlorine, or an acyloxy radical, with an amine of the formula (III) or a salt thereof,

[0000]

    • in which R3and R4are as defined for the compound of the formula (I) to be prepared, to give the compound of the formula (I),
  • (d), if R3and R4in the compound of the formula (I) to be prepared are each hydrogen, reacting a compound of the formula (VI),

[0000]

    • in which R1is as defined for the compound of the formula (I) to be prepared, and “Alkyl” is an alkyl radical, for example methyl or ethyl,
    • with malonamide to give the compound of the formula (I).

[0236]

The amide formations according to variant (a) can be carried out, for example, in an inert organic solvent in a temperature range between 0° C. and 150° C., preferably between 0° C. and 50° C. Suitable organic solvents are, for example, polar prone or aprotic solvents, such as ethers, for example diethyl ether, tetrahydrofuran and dioxane, or nitrites, such as acetonitrile, or amides, such as dimethylformamide.

[0237]

The amide formations according to variant (b) can be carried out, for example, in an inert organic solvent in a temperature range between 0° C. and 150° C., preferably between 50° C. and 100° C. Suitable organic solvents are, for example, polar protic or aprotic solvents, such as ethers, for example tetrahydrofuran and dioxane, or nitriles, such as acetonitrile, or amides, such as dimethylformamide. However, preference is given to the amide formation according to variant (b) at elevated temperatures by reacting the undiluted reactants.

[0238]

The amide formations according to variant (c) can be carried out, for example, in the presence of an acid binder in an inert organic solvent in a temperature range between 0° C. and 150° C., preferably between 50° C. and 100° C. Suitable organic solvents are, for example, polar protic or aprotic solvents, such as ethers, for example diethyl ether, tetrahydrofuran and dioxane, or nitriles, such as acetonitrile, or amides, such as dimethylformamide. Acid binders are, for example, alkali metal or alkaline earth metal carbonates, such as, for example, sodium carbonate, potassium carbonate or calcium carbonate, alkali metal or alkaline earth metal hydroxides, such as sodium hydroxide, potassium hydroxide or calcium hydroxide, or alkali metal hydrides or amides, such as sodium hydride or potassium hydride or sodium amide or potassium amide, or else organic bases, such as triethylamine, pyridine, dimethylaminopyridine, DBU (1,8-diazabicyclo[5.4.0]-undec-7-ene), DBN (1,5-diazabicyclo[4.3.0]non-5-ene) and 1,4-diaza-bicyclo[2.2.2]octane.

[0239]

The amide formations according to variant (d) can be carried out analogously to the processes described in EP 522392 and Helv. Chim. Acta 71 (1988) 596-601 and GB 2305174. In general, the malonamide can be converted in an organic anhydrous polar prone or aprotic solvent, for example in an alcohol, with a strong base, such as an alkali metal, alkali metal hydride or alkali metal alkoxide, into a reactive salt, and then be reacted with the compound of the formula (VI). The reaction with the compound (VI) can generally be carried out in a temperature range between 0° C. and the boiling point of the solvent (depending on the solvent up to about 150° C.).

[0240]

The compounds of the general formulae (II), (III), (IV) and (V) are either commercially available or can be prepared by or analogously to methods known to the person skilled in the art (for example Helv. Chim. Acta 71 (1988) 596; EP 502740 (U.S. Pat. No. 5,393,734); EP 522392).

[0241]

Thus, for example, the compounds of the formula (IVa)

[0000]

[0000]

can be obtained by reacting alkoxyvinyl ethers of the formula (VI) with alkyl malonamides of the formula (VII).

[0000]

[0242]

The starting materials of the formula (VI) are either commercially available or can be prepared by known methods (for example Synthesis 2000, 738-742; J. Fluor. Chem., 107, 2001, 285-300; Organometallics 15, 1996, 5374-5379).

[0243]

The compounds of the formula (IV) in which R2is a halogen atom can be prepared by customary halogenations from the compounds of the formula (IVa).

[0244]

Suitable for use as halogenating agents for pyridine are, for example, chlorine (J. Org. Chem. 23, 1958, 1614), bromine (Synth. Commun. 19, 1989, 553-560; U.S. Pat. No. 2,532,055), iodine (Tetrahedron Lett. 45, 2004, 6633-6636), sodium hypochlorite (J. Org. Chem. 49, 1984, 4784-4786; J. Med. Chem. 36, 1993, 2676-2688, U.S. Pat. No. 4,960,896), sodium hypobromite (J. Med. Chem. 32, 1989, 2178-2199), thionyl chloride (Organic Letters, 6, 2004, 3-5), N-chlorosuccinimide (J. Med. Chem. 46, 2003, 702-715), N-bromosuccinimide (Chem. Pharm. Bull. 48, 2000, 1847-1853), N-iodosuccinimide (J. Med. Chem. 36, 1993, 2676-2788).

[0245]

Furthermore, the compounds of the formula (IV) can be prepared from the compounds of the formula (IVa) by successive nitration (for example J. Med. Chem. 36, 1993, 2676-2688; J. Heterocycl. Chem. 33, 1996, 287-294), reduction (for example J. Med. Chem. 33, 1990, 1859-1865), diazotation and subsequent reaction of the diazonium salts in a Sandmeyer or Schiemann reaction.

[0246]

The compounds of the formula (I) in which R3and R4together with the directly attached nitrogen atom are the group —N═CR5—NR6R7can be prepared by reacting a compound of the formula (I) in which R3and R4are hydrogen with compounds of the formula (VIII) in which R5, R6and R7are as defined above

[0000]

[0000]

according to known methods (see, for example Synthesis 1980, 119-121; J. Med. Chem., 33, 1990, 2052-2059).

[0247]

The invention also provides a method for protecting crop plants or useful plants against phytotoxic actions of agrochemicals, such as pesticides or, in particular, herbicides which cause damage to crop plants or useful plants, which method comprises using compounds of the formula (I) or salts thereof as safeners, preferably by applying an effective amount of the compounds of the formula (I) or salts thereof to the plants, to parts of plants or their seeds (or seed).

[0248]

The compounds (I) (=safeners), together with active compounds (pesticides), are suitable for use in the selective control of harmful organisms in a number of plant crops, for example in crops of economic importance, such as cereals (wheat, barley, triticale, rye, rice, corn, millet), sugar beet, sugar cane, oilseed rape, cotton, sunflower, peas, beans and soybeans. Of particular interest is the use in monocotyledonous crops, such as cereals (wheat, barley, rye, triticale, sorghum), including corn and rice, and monocotyledonous vegetable crops, but also in dicotyledonous crops, such as, for example, soybean, oilseed rape, cotton, grape vines, vegetable plants, fruit plants and omamental plants. The herbicide/safener combinations with the safeners (I) are also suitable for controlling harmful plants in beds and plots of useful plants and omamental plants, such as, for example, lawn plots with useful or omamental lawn, especially lolium, meadow grass or Bermuda grass.

[0249]

Also of interest from among the useful plants and crop plants in which the herbicide/safener combinations with safeners (I) may be used are mutant crops which are completely or partially tolerant to certain pesticides or completely or partially tolerant transgenic crops, for example corn crops which are resistant to glufosinate or glyphosate, or soybean crops which are resistant to herbicidal imidazolinones. However, the particular advantage of the safeners used in this novel way is their efficient action in crops which normally are insufficiently tolerant to the pesticides being applied.

[0250]

For the joint use with pesticides, the compounds of the formula (I) according to the invention can be applied simultaneously with the active compounds or in any order, and they are then capable of reducing or completely eliminating harmful side effects of these active compounds in crop plants, without negatively affecting or substantially reducing the activity of these active compounds against unwanted harmful organisms. Here, even damage caused by using a plurality of pesticides, for example a plurality of herbicides or herbicides in combination with insecticides or fungicides, can be reduced substantially or eliminated completely. In this manner, it is possible to extend the field of use of conventional pesticides considerably.

[0251]

If the compositions according to the invention comprise pesticides, these compositions are, after appropriate dilution, applied either directly to the area under cultivation, to the already germinated harmful and/or useful plants or to the already emerged harmful and/or useful plants. If the compositions according to the invention do not comprise any pesticide, these compositions can be employed by the tank mix method—i.e. the user mixes and dilutes the separately available products (=the pesticide and the agent protecting the useful plants) immediately prior to application to the area to be treated—or prior to the application of a pesticide, or after the application of a pesticide, or for the pretreatment of seed, i.e., for example, for dressing the seed of the useful plants. Preferably, safener and pesticide are applied within a short time of one another, in particular when the safener is applied to the plants after the herbicide.

[0252]

The advantageous actions of the compounds (I) according to the invention are observed when they are used together with the pesticides by the pre-emergence method or the post-emergence method, for example in the case of simultaneous application as a tank mix or a coformulation or in the case of a separate application, in parallel or in succession (split application). It is also possible to repeat the application a number of times. In some cases, it may be expedient to combine a pre-emergence application with a post-emergence application. In most cases, one option is a post-emergence application to the useful plant or crop plant together with a simultaneous or later application of the pesticide. Also possible is the use of the compounds (I) according to the invention for seed dressing, for (dip) treatment of seedlings (for example rice) or for the treatment of other propagation material (for example potato tubers).

[0253]

When using the compounds (I) according to the invention in combination with herbicides, in addition to the safener action, enhanced action, in the herbicidal action, against harmful plants is frequently also observed. Furthermore, in many cases, there is an improved growth of the useful plants and crop plants, and it is possible to increase the harvest yields.

[0254]

The compositions according to the invention may comprise one or more pesticides. Suitable pesticides are, for example, herbicides, insecticides, fungicides, acaricides and nematicides, which, when used on their own, would cause phytotoxic damage to the crop plants or would probably cause damage. Of particular interest are corresponding pesticidally active compounds from the groups of the herbicides, insecticides, acaricides, nematicides and fungicides, in particular herbicides.

[0255]

The weight ratio of safener to pesticide can be varied within wide limits and is generally in the range from 1:100 to 100:1, preferably from 1:20 to 20:1, in particular from 1:10 to 10:1. The optimum weight ratio of safener to pesticide depends both on the respective safener used and the respective pesticide, and on the type of useful plant or crop plant to be protected. The required application rate of safener can, depending on the pesticide used and the type of useful plant to be protected, be varied within wide limits and is generally in the range from 0.001 to 10 kg, preferably from 0.01 to 1 kg, in particular from 0.05 to 0.5 kg, of safener per hectare. The weight ratios and amounts required for a successful treatment can be determined by simple preliminary experiments.

[0256]

For seed dressing, for example, from 0.005 to 20 g of safener per kilogram of seed, preferably from 0.01 to 10 g of safener per kilogram of seed, in particular from 0.05 to 5 g of safener per kilogram of seed, are used.

[0257]

If solutions of safener are used for seed treatment and the seeds or seedlings are wetted with the solutions, the suitable concentration is generally in the range from 1 to 10 000 ppm, preferably from 100 to 1000 ppm, based on the weight. The weight ratios and amounts required for a successful treatment can be determined by simple preliminary experiments.

[0258]

The safeners can be formulated in the customary manner, separately or together with the pesticides. Accordingly, the present invention also provides the useful-plant-protecting or crop-plant-protecting compositions.

[0259]

Preferred is the joint application of safener and pesticide, in particular that of safener and herbicide as a readymix or the use by the tankmix method.

[0260]

Preference is also given to using the safener (I) in the treatment of seed, followed by the application of pesticides, preferably herbicides, after sowing by the pre- or post-emergence method.

[0261]

The compounds of the formula (I) or their salts, as such or in the form of their preparations (formulations), can be used in combination with other pesticidally active compounds, such as, for example, insecticides, acaricides, nematicides, herbicides, fungicides, safeners, fertilizers and/or growth regulators, for example as finished formulation or as tank mixes. Here, the combination formulations can be prepared based on the formulations mentioned above, taking into account the physical properties and stabilities of the active compounds to be combined. Suitable as combination partners for the active compounds according to the invention in formulations of mixtures or in tank-mixes are, for example, known, preferably herbicidally active compounds whose action is based on the inhibition of, for example, acetolactate synthase, acetyl-coenzyme-A carboxylase, PS I, PS II, HPPDO, phytoene desaturase, protoporphyrinogen oxidase, glutamine synthetase, cellulose biosynthesis, 5-enolpyruvylshikimate 3-phosphate synthetase. Such compounds and also other compounds which can be used, in some cases having an unknown or a different mechanism of action, are described, for example, in Weed Research 26, 441-445 (1986), or in “The Pesticide Manual”, 12th edition 2000, or 13th edition 2003 or 14h edition 2006/2007, or in the corresponding “e-Pesticide Manual”, version 4 (2006), all published by the British Crop Protection Council, (hereinbelow also referred to in short as “PM”), and in the literature cited therein. Lists of “common names” are also available in “The Compendium of Pesticide Common Names” on the Internet. Examples of herbicides known from the literature which may be combined with the compounds of the formula (I) are, for example, the following active compounds (note: the compounds are referred to either by the “common name” according to the International Organization for Standardization (ISO) or by the chemical name, if appropriate together with a customary code number):

[0262]

acetochlor; acibenzolar-5-methyl; acifluorfen(-sodium); aclonifen; AD-67; AKH 7088, i.e. [[[1-[5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrophenyl]-2-methoxyethylidene]amino]oxy]acetic acid and methyl [[[1-[5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrophenyl]-2-methoxyethylidene]-amino]oxy]acetate; alachlor; alloxydim(-sodium); ametryn; amicarbazone, amidochlor, amidosulfuron; aminopyralid; amitrol; AMS, i.e. ammonium sulfamate; ancimidol; anilofos; asulam; atrazine; aviglycine; azafenidin, azimsulfuron (DPX-A8947); aziprotryn; barban; BAS 516 H, i.e. 5-fluoro-2-phenyl-4H-3,1-benzoxazin-4-one; beflubutamid (UBH-509), benazolin(-ethyl); bencarbazone; benfluralin; benfuresate; benoxacor; bensulfuron(-methyl); bensulide; bentazone; benzfendizone; benzobicyclon, benzofenap; benzofluor; benzoylprop(-ethyl); benzthiazuron; bialaphos; bifenox; bispyribac(-sodium) (KIH-2023); borax; bromacil; bromobutide; bromofenoxim; bromoxynil; bromuron; buminafos; busoxinone; butachlor; butafenacil, butamifos; butenachlor (KH-218); buthidazole; butralin; butroxydim, butylate; cafenstrole (CH-900); carbetamide; carfentrazone(-ethyl); CDAA, i.e. 2-chloro-N,N-di-2-propenylacetamide; CDEC, i.e. 2-chlorallyl diethyldithiocarbamate; chlomethoxyfen; chloramben; chlorazifop-butyl, chlorbromuron; chlorbufam; chlorfenac; chlorfenprop; chlorflurecol(-methyl); chlorflurenol(-methyl); chloridazon; chlorimuron(-ethyl); chlormequat(chloride); chlornitrofen; chlorophthalim (MK-616); chlorotoluron; chloroxuron; chlorpropham; chlorsulfuron; chlorthal-dimethyl; chlorthiamid; chlortoluron, cinidon(-methyl and -ethyl), cinmethylin; cinosulfuron; clefoxydim, clethodim; clodinafop and its ester derivatives (for example clodinafop-propargyl); clofencet; clomazone; clomeprop; cloprop; cloproxydim; clopyralid; clopyrasulfuron(-methyl), cloquintocet(-mexyl); cloransulam(-methyl), cumyluron (JC 940); cyanamide; cyanazine; cycloate; cyclosulfamuron (AC 104); cycloxydim; cycluron; cyhalofop and its ester derivatives (for example the butyl ester, DEH-112); cyperquat; cyprazine; cyprazole; cyprosulfamide; daimuron; 2,4-D, 2,4-DB; dalapon; daminozide; dazomet; n-decanol; desmedipham; desmetryn; di-allate; dicamba; dichlobenil; dichlormid; dichlorprop(-P) salts; diclofop and its esters, such as diclofop-methyl; diclofop-P(-methyl); diclosulam, diethatyl(-ethyl); difenoxuron; difenzoquat(metilsulfate); diflufenican; diflufenzopyr(-sodium); dimefuron; dimepiperate, dimethachlor; dimethametryn; dimethazone; dimethenamid (SAN-582H); dimethenamide-P; dimethylarsinic acid; dimethipin; dimetrasulfuron, dinitramine; dinoseb; dinoterb; diphenamid; dipropetryn; diquat salts; dithiopyr; diuron; DNOC; eglinazine-ethyl; EL 77, i.e. 5-cyano-1-(1,1-dimethylethyl)-N-methyl-1H-pyrazole-4-carboxamide; endothal; epoprodan, EPTC; esprocarb; ethalfluralin; ethametsulfuron-methyl; ethephon; ethidimuron; ethiozin; ethofumesate; ethoxyfen and its esters (for example the ethyl ester, HN-252); ethoxysulfuron, etobenzanid (HW 52); F5231, i.e. N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-4,5-dihydro-5-oxo-1H-tetrazol-1-yl]phenyl]ethanesulfonamide; fenchlorazole(-ethyl); fenclorim; fenoprop; fenoxan, fenoxaprop and fenoxaprop-P and also their esters, for example fenoxaprop-P-ethyl and fenoxaprop-ethyl; fenoxydim; fentrazamide, fenuron; ferrous sulfate; flamprop(-methyl or -isopropyl or -isopropyl-L); flamprop-M(-methyl or -isopropyl); flazasulfuron; florasulam, fluazifop and fluazifop-P and their esters, for example fluazifop-butyl and fluazifop-P-butyl; fluazolate, flucarbazone(-sodium), flucetosulfuron; fluchloralin; flufenacet; flufenpyr(-ethyl); flumetralin; flumetsulam; flumeturon; flumiclorac(-pentyl), flumioxazin (S-482); flumipropyn; fluometuron, fluorochloridone, fluorodifen; fluoroglycofen(-ethyl); flupoxam (KNW-739); flupropacil (UBIC-4243); flupropanoate; flupyrsulfuron(-methyl)(-sodium); flurazole; flurenol(-butyl); fluridone; flurochloridone; fluoroxypyr(-meptyl); flurprimidol, flurtamone; fluthiacet(-methyl) (KIH-9201); fluthiamide, fluxofenim; fomesafen; foramsulfuron, forchlorfenuron; fosamine; furilazole; furyloxyfen; gibberillic acid; glufosinate(-ammonium); glyphosate(-isopropylammonium); halosafen; halosulfuron(-methyl); haloxyfop and its esters; haloxyfop-P(═R-haloxyfop) and its esters; HC-252; hexazinone; imazamethabenz(-methyl); imazamethapyr, imazamox, imazapic, imazapyr; imazaquin and salts, such as the ammonium salt; imazethamethapyr; imazethapyr; imazosulfuron; inabenfide; indanofan; indole-3-acetic acid; 4-indol-3-ylbutyric acid; iodosulfuron-methyl(-sodium); ioxynil; isocarbamid; isopropalin; isoproturon; isouron; isoxaben; isoxachlortole, isoxadifen(-ethyl); isoxaflutole, isoxapyrifop; karbutilate; lactofen; lenacil; linuron; maleic hydrazide (MH), MCPA; MCPB; mecoprop(-P); mefenacet; mefenpyr(diethyl); mefluidid; mepiquat(-chloride); mesosulfuron(-methyl); mesotrione, metam; metamifop; metamitron; metazachlor; methabenzthiazuron; metham; methazole; methoxyphenone; methylarsonic acid; methylcyclopropene; methyldymron; methyl isothiocyanate; methabenzthiazuron; metobenzuron; metobromuron; (alpha-)metolachlor; metosulam (XRD 511); metoxuron; metribuzin; metsulfuron-methyl; molinate; monalide; monocarbamide dihydrogensulfate; monolinuron; monuron; MT 128, i.e. 6-chloro-N-(3-chloro-2-propenyl)-5-methyl-N-phenyl-3-pyridazinamine; MT 5950, i.e. N-[3-chloro-4-(1-methylethyl)phenyl]-2-methylpentanamide; naproanilide; napropamide; naptalam; NC 310, i.e. 4-(2,4-dichlorobenzoyl)-1-methyl-5-benzyloxypyrazole; neburon; nicosulfuron; nipyraclofen; nitralin; nitrofen; nitrophenolate mixture; nitrofluorfen; nonanoic acid; norflurazon; orbencarb; orthasulfamuron; oxabetrinil; oryzalin; oxadiargyl (RP-020630); oxadiazon; oxasulfuron, oxaziclomefone, oxyfluorfen; paclobutrazol; paraquat(dichloride); pebulate; pelargonic acid, pendimethalin; penoxsulam; pentachlorophenol; pentanochlor; pentoxazone, perfluidone; pethoxamid; phenisopham; phenmedipham; picloram; picolinafen, pinoxaden, piperophos; piributicarb; pirifenop-butyl; pretilachlor; primisulfuron(-methyl); probenazole; procarbazone-(sodium), propazine; prodiamine; profluralin; profoxydim; prohexadione(-calcium); prohydrojasmon; proglinazine(-ethyl); prometon; prometryn; propachlor; propanil; propaquizafop; propazine; propham; propisochlor; propoxycarbazone(-sodium) (MKH-6561); n-propyl dihydrojasmonate; propyzamide; prosulfalin; prosulfocarb; prosulfuron (CGA-152005); prynachlor; pyraclonil; pyraflufen(ethyl) (ET-751); pyrasulfotole; pyrazolynate; pyrazon; pyrazosulfuron(-ethyl); pyrazoxyfen; pyribenzoxim, pyributicarb, pyridafol, pyridate; pyriftalid; pyriminobac(-methyl) (KIH-6127); pyrimisulfan (KIH-5996); pyrithiobac(-sodium) (KIH-2031); pyroxasulfone (KIH-485); pyroxofop and its esters (for example the propargyl ester); pyroxsulam; quinclorac; quinmerac; quinoclamine, quinofop and its ester derivatives, quizalofop and quizalofop-P and their ester derivatives, for example quizalofop-ethyl; quizalofop-P-tefuryl and -ethyl; renriduron; rimsulfuron (DPX-E 9636); S 275, i.e. 2-[4-chloro-2-fluoro-5-(2-propynyloxy)phenyl]-4,5,6,7-tetrahydro-2H-indazol; saflufenacil (N′-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydro-1(2H)-pyrimidinyl)benzoyl]-N-isopropyl-N-methylsulfamide), secbumeton; sethoxydim; siduron; simazine; simetryn; sintofen; SN 106279, i.e. 2-[[7-[2-chloro-4-(trifluoromethyl)phenoxy]-2-naphthalenyl]oxy]propanoic acid and methyl 2-[[7-[2-chloro-4-(trifluoromethyl)phenoxy]-2-naphthalenyl]oxy]propanoate; sulcotrione, sulfentrazone (FMC-97285, F-6285); sulfazuron; sulfometuron(-methyl); sulfosate (ICI-A0224); sulfosulfuron, TCA; tebutam (GCP-5544); tebuthiuron; tecnacene; tembotrione; tefuryltrione; tepraloxydim, terbacil; terbucarb; terbuchlor; terbumeton; terbuthylazine; terbutryn; TFH 450, i.e. N,N-diethyl-3-[(2-ethyl-6-methylphenyl)sulfonyl]-1H-1,2,4-triazole-1-carboxamide; thenylchlor (NSK-850); thiafluamide, thiazafluoron; thiazopyr (Mon-13200); thidiazimin (SN-24085); thidiazuron; thiencarbazone; thifensulfuron(-methyl); thiobencarb; Ti 35; tiocarbazil; topramezone; tralkoxydim; tri-allate; triasulfuron; triaziflam, triazofenamide; tribenuron(-methyl); triclopyr; tridiphane; trietazine; trifloxysulfuron; trifluralin; triflusulfuron and esters (for example the methyl ester, DPX-66037); trimeturon; trinexapac; tritosulfuron, tsitodef; uniconazole; vernolate; WL 110547, i.e. 5-phenoxy-1-[3-(trifluoromethyl)phenyl]-1H-tetrazole; D-489; LS 82-556; KPP-300; NC-324; NC-330; DPX-N8189; SC-0774; DOWCO-535; DK-8910; V-53482; PP-600 and MBH-001.

[0263]

Insecticides which may cause damage to plants when used on their own or together with herbicides are, for example, the following:

[0264]

Organophosphates, for example terbufos (Counter®), fonofos (Dyfonate®), phorate (Thimet®), chlorpyriphos (Reldan®), carbamates, such as carbofuran (Furadan®), pyrethroid insecticides, such as tefluthrin (Force®), deltamethrin (Decis®) and tralomethrin (Scout®), and other insecticidal agents having a different mechanism of action.

[0265]

Herbicides, whose phytotoxic side effects on crop plants can be reduced using compounds of the formula (I) are, for example, herbicides from the group of the carbamates, thiocarbamates, haloacetanilides, substituted phenoxy-, naphthoxy- and phenoxyphenoxycarboxylic acid derivatives and heteroaryloxyphenoxyalkanecarboxylic acid derivatives, such as quinolyloxy-, quinoxalyloxy-, pyridyloxy-, benzoxazolyloxy- and benzothiazolyloxyphenoxyalkanecarboxylic acid esters, cyclo-hexanedione oximes, benzoylcyclohexanediones, benzoylisoxazoles, benzoylpyrazoles, imidazolinones, pyrimidinyloxypyridinecarboxylic acid derivatives, pyrimidyloxybenzoic acid derivatives, sulfonylureas, sulfonylaminocarbonyltriazolinones, triazolopyrimidinesulfonamide derivatives, phosphinic acid derivatives and salts thereof, glycine derivatives, triazolinones, triazinones and also S-(N-aryl-N-alkylcarbamoylmethyl)dithiophosphoric esters, pyridinecarboxylic acids, pyridines, pyridinecarboxamides, 1,3,5-triazines and others.

[0266]

Preference is given here to phenoxyphenoxy- and heteroaryloxyphenoxycarboxylic acid esters and salts, cyclohexanedione oximes, benzoylcyclohexanediones, benzoylisoxazoles, benzoylpyrazoles sulfonylureas, sulfonylaminocarbonyltriazolinones, imidazolinones and mixtures of the active compounds mentioned with one another and/or with active compounds used for broadening the activity spectrum of the herbicides, for example bentazone, cyanazine, atrazine, bromoxynil, dicamba and other leaf-acting herbicides.

[0267]

Herbicides which are suitable for combination with the safeners according to the invention are, for example:

[0268]

A) herbicides of the type of the phenoxyphenoxy- and heteroaryloxyphenoxycarboxylic acid derivatives, such as

[0269]

A1) phenoxyphenoxy- and benzyloxyphenoxycarboxylic acid derivatives, for example methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate (diclofop-methyl),

  • methyl 2-(4-(4-bromo-2-chlorophenoxy)phenoxy)propionate (DE-A 26 01 548 (U.S. Pat. No. 4,370,489)),
  • methyl 2-(4-(4-bromo-2-fluorophenoxy)phenoxy)propionate (U.S. Pat. No. 4,808,750),
  • methyl 2-(4-(2-chloro-4-trifluoromethylphenoxy)phenoxy)propionate (DE-A 24 33 067 (U.S. Pat. No. 4,332,960)),
  • methyl 2-(4-(2-fluoro-4-trifluoromethylphenoxy)phenoxy)propionate (U.S. Pat. No. 4,808,750),
  • methyl 2-(4-(2,4-dichlorobenzyl)phenoxy)propionate (DE-A 24 17 487 (U.S. Pat. No. 4,088,474)),
  • ethyl 4-(4-(4-trifluoromethylphenoxy)phenoxy)pent-2-enoate,
  • methyl 2-(4-(4-trifluoromethylphenoxy)phenoxy)propionate (DE-A 24 33 067),
  • butyl (R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propionate (cyhalofop-butyl)

[0278]

A2) “monocyclic” heteroaryloxyphenoxyalkanecarboxylic acid derivatives, for example ethyl 2-(4-(3,5-dichloropyridyl-2-oxy)phenoxy)propionate (EP-A 0 002 925),

  • propargyl 2-(4-(3,5-dichloropyridyl-2-oxy)phenoxy)propionate (EP-A 0 003 114 (U.S. Pat. No. 4,300,944)),
  • methyl (RS)- or (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate (haloxyfop-methyl or haloxyfop-P-methyl),
  • ethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate (EP-A 0 003 890 (U.S. Pat. No. 4,840,664)),
  • propargyl 2-(4-(5-chloro-3-fluoro-2-pyridyloxy)phenoxy)propionate (clodinafop-propargyl),
  • butyl (RS)- or (R)-2-(4-(5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate (fluazifop-butyl or fluazifop-P-butyl),
  • (R)-2-[4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy]propionic acid

[0285]

A3) “bicyclic” heteroaryloxyphenoxyalkanecarboxylic acid derivatives, for example methyl and ethyl (RS)- or (R)-2-(4-(6-chloro-2-quinoxalyloxy)phenoxy)propionate (quizalofop-methyl and -ethyl or quizalofop-P-methyl and -P-ethyl),

  • methyl 2-(4-(6-fluoro-2-quinoxalyloxy)phenoxy)propionate (see J. Pest. Sci. Vol. 10, 61 (1985)),
  • 2-isopropylidenaminooxyethyl (R)-2-(4-(6-chloro-2-quinoxalyloxy)phenoxy)propionate (propaquizafop),
  • ethyl (RS)- or (R)-2-(4-(6-chlorobenzoxazol-2-yloxy)phenoxy)propionate (fenoxaprop-ethyl or fenoxaprop-P-ethyl),
  • ethyl 2-(4-(6-chlorobenzthiazol-2-yloxy)phenoxy)propionate (DE-A-26 40 730 (U.S. Pat. No. 4,130,413)),
  • tetrahydro-2-furylmethyl (RS)- or (R)-2-(4-(6-chloroquinoxalyloxy)phenoxy) propionate (EP-A-0 323 727 (U.S. Pat. No. 5,120,348));
  • (R)-2-[4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy]-2′-fluoro-N-methylpropionanilide (metamifop);

[0292]

B) herbicides from the group of the sulfonylureas, such as pyrimidinyl- or triazinylaminocarbonyl[benzene-, -pyridine-, -pyrazole-, -thiophene- and -(alkyl-sulfonyl)alkylamino]sulfamides. Preferred substituents on the pyrimidine ring or the triazine ring are alkoxy, alkyl, haloalkoxy, haloalkyl, halogen or dimethylamino, it being possible to combine all substituents independently of one another. Preferred substituents in the benzene, pyridine, pyrazole, thiophene or (alkylsulfonyl)alkylamino moiety are alkyl, alkoxy, halogen, nitro, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxyaminocarbonyl, haloalkoxy, haloalkyl, alkylcarbonyl, alkoxyalkyl, (alkanesulfonyl)alkylamino. Such suitable sulfonylureas are, for example,

[0293]

B1) phenyl- and benzylsulfonylureas and related compounds, for example 1-(2-chlorophenylsulfonyl)-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea (chlorsulfuron),

  • 1-(2-ethoxycarbonylphenylsulfonyl)-3-(4-chloro-6-methoxypyrimidin-2-yl)urea (chlorimuron-ethyl),
  • 1-(2-methoxyphenylsulfonyl)-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea (metsulfuron-methyl),
  • 1-(2-chloroethoxyphenylsulfonyl)-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea (triasulfuron),
  • 1-(2-methoxycarbonylphenylsulfonyl)-3-(4,6-dimethylpyrimidin-2-yl)urea (sulfumeturon-methyl),
  • 1-(2-methoxycarbonylphenylsulfonyl)-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-methylurea (tribenuron-methyl),
  • 1-(2-methoxycarbonylbenzylsulfonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea (bensulfuron-methyl),
  • 1-(2-methoxycarbonylphenylsulfonyl)-3-(4,6-bis-(difluoromethoxy)pyrimidin-2-yl)urea (primisulfuron-methyl),
  • 3-(4-ethyl-6-methoxy-1,3,5-triazin-2-yl)-1-(2,3-dihydro-1,1-dioxo-2-methylbenzo[b]thiophene-7-sulfonyl)urea (EP-A 0 079 683 (U.S. Pat. No. 4,492,596),
  • 3-(4-ethoxy-6-ethyl-1,3,5-triazin-2-yl)-1-(2,3-dihydro-1,1-dioxo-2-methylbenzo[b]-thiophene-7-sulfonyl)urea (EP-A 0 079 683),
  • 3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-1-(2-methoxycarbonyl-5-iodophenylsulfonyl)urea (WO 92/13845 (U.S. Pat. No. 5,463,081)),
  • methyl 2-[4-dimethylamino-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-ylcarbamoylsulfamoyl]-3-methylbenzoate (DPX-66037, triflusulfuron-methyl),
  • oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)carbamoylsulfamoyl]benzoate (CGA-277476, oxasulfuron),
  • methyl 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl]benzoate, sodium salt (iodosulfuron-methyl-sodium),
  • methyl 2-[3-(4,6-dimethoxypyrimidin-2-yl)ureidosulfonyl]-4-methanesulfonylaminomethylbenzoate (mesosulfuron-methyl, WO 95/10507 (U.S. Pat. No. 5,648,315)),
  • N,N-dimethyl-2-[3-(4,6-dimethoxypyrimidin-2-yl)ureidosulfonyl]-4-formylaminobenzamide (foramsulfuron, WO 95/01344 (U.S. Pat. No. 5,658,854)),
  • 1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-3-[2-(2-methoxyethoxy)phenylsulfonyl]urea (cinosulfuron),
  • methyl 2-[(4-ethoxy-6-methylamino-1,3,5-triazin-2-yl)carbamoylsulfamoyl]benzoate (ethametsulfuron-methyl),
  • 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea (prosulfuron),
  • 1-(4-methoxy-6-trifluoromethyl-1,3,5-triazin-2-yl)-3-(2-trifluoromethylbenzenesulfonyl)urea (tritosulfuron);
  • N-[(4-methylpyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide (monosulfuron), methyl-2-[({[4-methoxy-6-(methylthio)pyrimidin-2-yl]carbamoyl}amino)sulfonyl]benzoate

[0314]

B2) thienylsulfonylureas, for example

  • 1-(2-methoxycarbonylthiophen-3-yl)-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea (thifensulfuron-methyl);

[0316]

B3) pyrazolylsulfonylureas, for example

  • 1-(4-ethoxycarbonyl-1-methylpyrazol-5-ylsulfonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea (pyrazosulfuron-ethyl),
  • methyl 3-chloro-5-(4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl)-1-methylpyrazole-4-carboxylate (halosulfuron-methyl),
  • methyl 5-(4,6-dimethylpyrimidin-2-yl-carbamoylsulfamoyl)-1-(2-pyridyl)pyrazole-4-carboxylate (NC-330, see Brighton Crop Prot. Conference ‘Weeds’ 1991, Vol. 1, p. 45 et seq.),
  • 1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea (DPX-A8947, azimsulfuron);
  • N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-4-(5,5-dimethyl-4,5-dihydroisoxazol-3-yl)-1,3-dimethyl-1H-pyrazole-5-sulfonamide;

[0322]

B4) sulfonediamide derivatives, for example

  • 3-(4,6-dimethoxypyrimidin-2-yl)-1-(N-methyl-N-methylsulfonylaminosulfonyl)urea (amidosulfuron) and its structural analogs (EP-A 0 131 258 (U.S. Pat. No. 4,601,747) and Z. Pfl. Krankh. Pfl. Schutz, special issue XII, 489-497 (1990));

[0324]

B5) pyridylsulfonylureas, for example

  • 1-(3-N,N-dimethylaminocarbonylpyridin-2-ylsulfonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea (nicosulfuron),
  • 1-(3-ethylsulfonylpyridin-2-ylsulfonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea (rimsulfuron),
  • methyl 2-[3-(4,6-dimethoxypyrimidin-2-yl)ureidosulfonyl]-6-trifluoromethyl-3-pyridinecarboxylate, sodium salt (DPX-KE 459, flupyrsulfuron-methyl-sodium),
  • 3-(4,6-dimethoxypyrimidin-2-yl)-1-(3-N-methylsulfonyl-N-methylaminopyridin-2-yl)sulfonylurea or its salts (DE-A 40 00 503 (U.S. Pat. No. 5,494,886) and DE-A 40 30 577),
  • 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea (flazasulfuron),
  • 1-(4,6-dimethoxypyrimidin-2-yl)-3-[3-(2,2,2-trifluoroethoxy)-2-pyridylsulfonyl]urea sodium salt (trifloxysulfuron-sodium);
  • (1RS,2RS; 1RS,2SR)-1-{3-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-2-pyridyl}-2-fluoropropyl methoxyacetate (flucetosulfuron);

[0332]

B6) alkoxyphenoxysulfonylureas, for example

  • 3-(4,6-dimethoxypyrimidin-2-yl)-1-(2-ethoxyphenoxy)sulfonylurea or its salts (ethoxysulfuron);

[0334]

B7) imidazolylsulfonylureas, for example

  • 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea (MON 37500, sulfosulfuron),
  • 1-(2-chloroimidazo[1,2-a]pyridin-3-ylsulfonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea (imazosulfuron);
  • 2-chloro-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]-6-propylimidazo[1,2-b]pyridazine-3-sulfonamide;

[0338]

B8) phenylaminosulfonylureas, for example

  • 1-[2-(cyclopropylcarbonyl)phenylaminosulfonyl]-3-(4,6-dimethoxypyrimidin-2-yl)urea (cyclosulfamuron);
  • 1-(4,6-dimethoxypyrimidin-2-yl)-3-[2-(dimethylcarbamoyl)phenylsulfamoyl]urea (orthosulfamuron);

[0341]

C) chloroacetanilides, for example

  • acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, dimethenamid-P; metazachlor, metolachlor, S-metolachlor, pethoxamid, pretilachlor, propachlor, propisochlor and thenylchlor;

[0343]

D) thiocarbamates, for example

  • S-ethyl N,N-dipropylthiocarbamate (EPTC),
  • S-ethyl N,N-diisobutylthiocarbamate (butylate);
  • cycloate, dimepiperate, esprocarb, molinate, orbencarb, pebulate, prosulfocarb, thiobencarb, tiocarbazil, tri-allate and vernolate;

[0347]

E) cyclohexanedione oximes, for example

  • alloxydim, butroxydim, clethodim, cloproxydim, cycloxydim, profoxydim, sethoxydim, tepraloxydim and tralkoxydim;

[0349]

F) imidazolinones, for example

  • imazamethabenz-methyl, imazapic, imazamox, imazapyr, imazaquin and imazethapyr;

[0351]

G) triazolopyrimidinesulfonamide derivatives, for example

  • chloransulam-methyl, diclosulam, florasulam, flumetsulam, metosulam and penoxsulam, i.e. 2-(2,2-difluoroethoxy)-N-(5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)-6-(trifluoromethyl)benzenesulfonamide, and pyroxsulam, i.e. N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl)-3-pyridinesulfonamide;

[0353]

H) benzoylcyclohexanediones, for example

  • 2-(2-chloro-4-methylsulfonylbenzoyl)cyclohexane-1,3-dione (SC-0051, sulcotrione),
  • 2-(2-nitrobenzoyl)-4,4-dimethylcyclohexane-1,3-dione (EP-A 0 274 634),
  • 2-(2-nitro-3-methylsulfonylbenzoyl)-4,4-dimethylcyclohexane-1,3-dione (WO 91/13548),
  • 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione (mesotrione)
  • 2-[2-chloro-3-(5-cyanomethyl-4,5-dihydroisoxazol-3-yl)-4-(ethylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-(5-cyanomethyl-4,5-dihydroisoxazol-3-yl)-4-(methylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-(5-ethoxymethyl-4,5-dihydroisoxazol-3-yl)-4-(ethylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-(5-ethoxymethyl-4,5-dihydroisoxazol-3-yl)-4-(methylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-[(2,2,2-trifluoroethoxy)methyl]-4-(ethylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-[(2,2,2-trifluoroethoxy)methyl]-4-(methylsulfonyl)benzoyl]-1,3-cyclohexanedione (tembotrione),
  • 2-[2-chloro-3-[(2,2-difluoroethoxy)methyl]-4-(ethylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-[(2,2-difluoroethoxy)methyl]-4-(methylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-[(2,2,3,3-tetrafluoropropoxy)methyl]-4-(ethylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-[(2,2,3,3-tetrafluoropropoxy)methyl]-4-(methylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-(cyclopropylmethoxy)-4-(ethylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-(cyclopropylmethoxy)-4-(methylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-(tetrahydrofuran-2-ylmethoxymethyl)-4-(ethylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-(tetrahydrofuran-2-ylmethoxymethyl)-4-(methylsulfonyl)benzoyl]-1,3-cyclohexanedione (tefuryltrione),
  • 2-[2-chloro-3-[2-(2-methoxyethoxy)ethoxymethyl]-4-(ethylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 2-[2-chloro-3-[2-(2-methoxyethoxy)ethoxymethyl]-4-(methylsulfonyl)benzoyl]-1,3-cyclohexanedione,
  • 3-({2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)pyridin-3-yl}carbonyl)-bicyclo[12.1]octane-2,4-dione (WO 2001094339);

[0375]

I) benzoylisoxazoles, for example

  • 5-cyclopropyl-[2-(methylsulfonyl)-4-(trifluoromethyl)benzoyl]isoxazole (isoxaflutole);
  • (4-chloro-2-mesylphenyl)(5-cyclopropyl-1,2-oxazol-4-yl)methanone (isoxachlortole);

[0378]

j) benzoylpyrazoles, for example

  • 2-[4-(2,4-dichloro-m-toluoyl)-1,3-dimethylpyrazol-5-yloxy]-4′-methylacetophenone (benzofenap),
  • 4-(2,4-dichlorobenzoyl)-1,3-dimethylpyrazol-5-yltoluene-4-sulfonate (pyrazolynate),
  • 2-[4-(2,4-dichlorobenzoyl)-1,3-dimethylpyrazol-5-yloxy]acetophenone (pyrazoxyfen);
  • 5-hydroxy-1-methyl-4-[2-(methylsulfonyl)-4-trifluoromethylbenzoyl]pyrazole (WO 01/74785 (U.S. Pat. No. 6,420,317)),
  • 1-ethyl-5-hydroxy-4-[2-(methylsulfonyl)-4-trifluoromethylbenzoyl]pyrazole (WO 01/74785),
  • 1,3-dimethyl-5-hydroxy-4-[2-(methylsulfonyl)-4-trifluoromethylbenzoyl]pyrazole (WO 01/74785),
  • 1-ethyl-5-hydroxy-3-methyl-4-[2-(methylsulfonyl)-4-trifluoromethylbenzoyl]pyrazole (pyrasulfotole, WO 01/74785),
  • 5-hydroxy-1-methyl-4-[-2-chlor-3-(4,5-dihydroisoxazol-3-yl)-4-methylsulfonylbenzoyl]pyrazole (WO 99/58509 (U.S. Pat. No. 6,525,204)),
  • 5-hydroxy-1-methyl-4-[3-(4,5-dihydroisoxazol-3-yl)-2-methyl-4-methylsulfonylbenzoyl]pyrazole (topramezone, WO 99/58509),
  • 1-ethyl-5-hydroxy-3-methyl-4-[2-methyl-4-methylsulfonyl-3-(2-methoxyethylamino)benzoyl]pyrazole (WO 96/26206 (us 5846907)),
  • 3-cyclopropyl-5-hydroxy-1-methyl-4-[2-methyl-4-methylsulfonyl-3-(2-methoxy-ethylamino)benzoyl]pyrazole (WO 96/26206),
  • 5-benzoxy-1-ethyl-4-[2-methyl-4-methylsulfonyl-3-(2-methoxyethylamino)benzoyl]pyrazole (WO 96/26206),
  • 1-ethyl-5-hydroxy-4-(3-dimethylamino-2-methyl-4-methylsulfonylbenzoyl)pyrazole (WO 96/26206),
  • 5-hydroxy-1-methyl-4-(2-chloro-3-dimethylamino-4-methylsulfonylbenzoyl)pyrazole (WO 96/26206),
  • 1-ethyl-5-hydroxy-4-(3-allylamino-2-chloro-4-methylsulfonylbenzoyl)pyrazole (WO 96/26206),
  • 1-ethyl-5-hydroxy-4-(2-methyl-4-methylsulfonyl-3-morpholinobenzoyl)pyrazole (WO 96/26206),
  • 5-hydroxy-1-isopropyl-4-(2-chloro-4-methylsulfonyl-3-morpholinobenzoyl)pyrazole (WO 96/26206),
  • 3-cyclopropyl-5-hydroxy-1-methyl-4-(2-chloro-4-methylsulfonyl-3-morpholinobenzoyl)pyrazole (WO 96/26206),
  • 1,3-dimethyl-5-hydroxy-4-(2-chloro-4-methylsulfonyl-3-pyrazol-1-ylbenzoyl)pyrazole WO 96/26206),
  • 1-ethyl-5-hydroxy-3-methyl-4-(2-chloro-4-methylsulfonyl-3-pyrazol-1-ylbenzoyl)pyrazole (WO 96/26206),
  • 1-ethyl-5-hydroxy-4-(2-chloro-4-methylsulfonyl-3-pyrazol-1-ylbenzoyl)pyrazole (WO 96/26206),
  • (5-hydroxy-1-methyl-1H-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothien-5-yl)methanone (US2002/0016262),
  • 1-methyl-4-[(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothien-5-yl)carbonyl]-1H-pyrazol-5-ylpropane-1-sulfonate (US2002/0016262, WO 2002/015695 (US 2002052296));
  • 3-(2-chloro-4-mesylbenzoyl)-2-phenylthiobicyclo[3.2.1]oct-2-en-4-one (benzobicyclon);

[0403]

K) sulfonylaminocarbonyltriazolinones, for example

  • 4,5-dihydro-3-methoxy-4-methyl-5-oxo-N-(2-trifluoromethoxyphenylsulfonyl)-1H-1,2,4-triazole-1-carboxamide sodium salt (flucarbazone-sodium),
  • methyl 2-(4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-yl)carboxamido-sulfonylbenzoate sodium salt (propoxycarbazone-Na);
  • methyl 4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonyl-sulfamoyl]-5-methylthiophene-3-carboxylate (thiencarbazone-methyl);

[0407]

L) triazolinones, for example

  • 4-amino-N-ten-butyl-4,5-dihydro-3-isopropyl-5-oxo-1,2,4-1H-triazole-1-carboxamide (amicarbazone),
  • 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one (azafenidin),
  • ethyl (RS)-2-chloro-3-[2-chloro-5-(4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)-4-fluorophenyl]propionate (carfentrazone-ethyl),
  • 2′,4′-dichloro-5′-(4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)-methanesulfonanilide (sulfentrazone);
  • 4-[4,5-dihydro-4-methyl-5-oxo-3-(trifluoromethyl)-1H-1,2,4-triazol-1-yl]-2-[(ethylsulfonyl)amino]-5-fluorobenzenecarbothioamide (bencarbazone);

[0413]

M) phosphinic acids and derivatives, for example

  • 4-[hydroxy(methyl)phosphinoyl]-L-homoalanyl-L-alanyl-L-alanine (bilanafos),
  • DL-homoalanin-4-yl(methyl)phosphinic acid ammonium salt (glufosinate-ammonium);

[0416]

N) glycine derivatives, for example

  • N-(phosphonomethyl)glycine and its salts (glyphosate and salts, for example the sodium salt or the isopropylammonium salt),
  • N-(phosphonomethyl)glycine trimesium salt (sulfosate);

[0419]

O) pyrimidinyloxypyridinecarboxylic acid derivatives; pyrimidinyloxybenzoic acid derivatives and pyrimidinylthiobenzoic acid derivatives, for example

  • benzyl 3-(4,6-dimethoxypyrimidin-2-yl)oxypyridine-2-carboxylate (EP-A 0 249 707 (U.S. Pat. No. 4,832,729)),
  • methyl 3-(4,6-dimethoxypyrimidin-2-yl)oxypyridine-2-carboxylate (EP-A 0 249 707),
  • 1-(ethoxycarbonyloxyethyl) 2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoate (EP-A 0 472 113 (U.S. Pat. No. 5,154,750)),
  • 2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid (bispyribac-sodium),
  • isopropyl 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]benzoate (pyribambenz-isopropyl, WO 2002034724 (U.S. Pat. No. 6,800,590)),
  • propyl 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]benzoate (pyribambenz-propyl, WO 2002034724),
  • pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrithiobac-sodium, pyrirmisulfan;

[0427]

P) S-(N-aryl-N-alkylcarbamoylmethyl)dithiophosphonic acid esters, such as S—[N-(4-chlorophenyl)-N-isopropylcarbamoylmethyl]O,O-dimethyl dithiophosphate (anilophos);

[0428]

Q) triazinones, for example

  • 3-cyclohexyl-6-dimethylamino-1-methyl-1,3,5-triazine-2,4-(1H,3H)-dione (hexazinone),
  • 4-amino-4,5-dihydro-3-methyl-6-phenyl-1,2,4-triazin-5-one (metamitron),
  • 4-amino-6-tert-butyl-4,5-dihydro-3-methylhio-1,2,4-triazin-5-one (metribuzin);

[0432]

R) pyridinecarboxylic acids, for example

  • aminopyralid, clopyralid, fluoroxypyr, picloram and triclopyr;

[0434]

S) pyridines, for example

  • dithiopyr and thiazopyr;

[0436]

T) pyridinecarboxamides, for example

  • diflufenican and picolinafen;

[0438]

U) 1,3,5-triazines, for example

  • ametryn, atrazine, cyanazine, dimethametrin, prometon, prometryn, propazine, simazine, symetryn, terbumeton, terbuthylazine, terbutryn and trietazine;

[0440]

V) plant growth regulators, for example

  • forchlorfenuron and thidiazuron;

[0442]

W) ketoenoles, for example

  • 8-(2,6-diethyl-p-tolyl)-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropionate (pinoxaden);

[0444]

X) pyrazoles, for example

  • 3-[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethylsulfonyl]-4,5-dihydro-5,5-dimethyl-1,2-oxazole (pyroxasulfone).

[0446]

The herbicides of groups A to W are known, for example, from the respective above-mentioned publications and from “The Pesticide Manual”, The British Crop Protection Council, 14th Edition, 2006, or the e-Pesticide Manual, Version 4.0, British Crop Protection Council 2006 or else from the “Compendium of Pesticide Common Names”.

[0447]

When used as active compound formulations or coformulations, they generally comprise, if appropriate, the respective customary tackifiers, wetting agents, dispersing agents, emulsifiers, penetrants, preservatives, antifreeze agents and solvents, fillers, carriers and colorants, antifoams, evaporation inhibitors and pH- and viscosity-modifying agents.

[0448]

The compounds of the formula I and their combinations with one or more of the above-mentioned pesticides can be formulated in various ways, depending on the prevailing physicochemical and biological parameters. Examples of suitable formulation types are:

    • emulsifiable concentrates which are prepared by dissolving the active compounds in an organic solvent, for example butanol, cyclohexanone, dimethylformamide, xylene or else relatively high-boiling hydrocarbons or mixtures of the organic solvents with addition of one or more ionic and/or nonionic surfactants (emulsifiers). Suitable emulsifiers are, for example, calcium alkylarylsulfonates, fatty acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide/ethylene oxide condensates, alkyl polyethers, sorbitan esters and polyoxyethylenesorbitan fatty acid esters;
    • dusts, which are obtained by grinding the active compounds with finely dispersed solid inorganic or organic substances, for example talc, natural clays, such as kaolin, bentonite and pyrophyllite, diatomaceous earth or meals;
    • water- or oil-based suspension concentrates, which can be prepared, for example, by wet grinding using bead mills;
    • water-soluble powders;
    • water-soluble concentrates;
    • granules, such as water-soluble granules, water-dispersible granules and granules for application by broadcasting and soil application;
    • wettable powders which, in addition to active compound, also contain diluents or inert substances and surfactants;
    • capsule suspensions and microcapsules;
    • ultra-low-volume formulations.

[0458]

The abovementioned formulation types are known to the person skilled in the art and described, for example, in: K. Martens, “Spray Drying Handbook”, 3rd Ed., G. Goodwin Ltd., London, 1979; W. van Valkenburg, “Pesticide Formulations”, Marcel Dekker, N.Y. 1973; Winnaker-Küchler, “Chemische Technologie” [Chemical Technology], volume 7, C. Hanser Verlag Munich, 4th edition 1986; “Perry's Chemical Engineer's Handbook”, 5th Ed., McGraw-Hill, N.Y. 1973, pages 8-57.

[0459]

The formulation auxiliaries required, such as inert materials, surfactants, solvents and other additives are also known and are described, for example, in: McCutcheon's “Detergents and Emulsifiers Annual”, MC Publ. Corp., Ridgewood N.J.; C. Marsden, “Solvents Guide”, 2nd Ed., Interscience, N.Y. 1963; H. von Olphen, “Introduction to Clay Colloid Chemistry”, 2nd Ed., J. Wiley & Sons, N.Y.; Schönfeldt, “Grenzflächenaktive Äthylenoxidaddukte” [Surface-active ethylene oxide adducts], Wiss. Verlagsgesellschaft, Stuttgart 1976; Sisley and Wood, “Encyclopedia of Surface Active Agents”, Chem. Publ. Co. Inc., N.Y. 1964; Watkins, “Handbook of Insecticide Dust Diluents and Carriers”, 2nd Ed., Darland Books, Caldwell N.J.; Winnacker-Küchler, “Chemische Technologie” [Chemical Technology], volume 7, C. Hanser Verlag Munich, 4th edition 1986.

[0460]

In addition to the abovementioned formulation auxiliaries, the useful-plant-protecting compositions may comprise, if appropriate, customary tackifiers, wetting agents, dispersants, penetrants, emulsifiers, preservatives, antifreeze agents, fillers, carriers, colorants, anti-foams, evaporation inhibitors and pH or viscosity regulators.

[0461]

Depending on the formulation type, the useful-plant-protecting compositions generally comprise 0.1 to 99% by weight, in particular 0.2 to 95% by weight, of one or more safeners of the formula I or a combination of safener and pesticide. Furthermore, they comprise 1 to 99.9, in particular 4 to 99.5,% by weight of one or more solid or liquid additives and 0 to 25, in particular 0.1 to 25,% by weight of a surfactant. In emulsifiable concentrates, the concentration of active compound, i.e. the concentration of safener and/or pesticide, is generally 1 to 90, in particular 5 to 80,% by weight. Dusts usually comprise 1 to 30, preferably 5 to 20,% by weight of active compound. In wettable powders, the concentration of active compound is generally 10 to 90% by weight. In water-dispersible granules, the content of active compound is, for example, between 1 and 95% by weight, preferably between 10 and 80% by weight.

[0462]

For use, the formulations, which are present in commercially available form, are, if appropriate, diluted in a customary manner, for example in the case of wettable powders, emulsifiable concentrates, dispersions and water-dispersible granules, with water. Preparations in the form of dusts, granules and sprayable solutions are usually not diluted with any further inert substances prior to use. The required application rate of the safeners varies with the external conditions such as, inter alia, temperature, humidity and the type of herbicide used.

[0463]

In the examples below, which illustrate the invention but do not limit it, the amounts are based on weight, unless defined otherwise.

EXAMPLES

1 Formulation Examples

1.1 Dusting Agent

[0464]

A dusting agent is obtained by mixing 10 parts by weight of a compound of the formula (I) or of an active compound mixture of a pesticide (eg. herbicide) and a safener of the formula (I) and 90 parts by weight of talc as inert material and comminuting in a hammer mill.

1.2 Water-Dispersible Powder

[0465]

A wettable powder which is readily dispersible in water is obtained by mixing 25 parts by weight of a compound of the formula (I) or of an active compound mixture of a pesticide (eg. herbicide) and a safener of the formula (I), 64 parts by weight of kaolin-containing quartz as inert material, 10 parts by weight of potassium ligninsulfonate and 1 part by weight of sodium oleoylmethyltaurinate as wetting and dispersing agent, and grinding in a pin mill.

1.3 Water-Dispersible Concentrate

[0466]

A dispersion concentrate which is readily dispersible in water is obtained by mixing 20 parts by weight of a compound of the formula (I) or of an active compound mixture of a pesticide (eg. herbicide) and a safener of the formula (I) with 6 parts by weight of alkylphenol polyglycol ether (®Triton X 207), 3 parts by weight of isotridecanol polyglycol ether and 71 parts by weight of paraffinic mineral oil and grinding in a ball mill to a fineness of below 5 microns.

1.4 Emulsifiable Concentrate

[0467]

An emulsifiable concentrate is obtained from 15 parts by weight of a compound of the formula (I) or of an active compound mixture of a pesticide (eg. herbicide) and a safener of the formula (I), 75 parts by weight of cyclohexanone as solvent and 10 parts by weight of ethoxylated nonylphenol as emulsifier.

1.5 Water-Dispersible Granules

[0468]

Water-dispersible granules are obtained by mixing

[0000]

75 parts by weightof a safener of the formula (I) or of a mixture of a
pesticide and a safener of the formula (I),
10 parts by weightof calcium ligninsulfonate,
 5 parts by weightof sodium lauryl sulfate,
 3 parts by weightof polyvinyl alcohol and
 7 parts by weightof kaolin,

grinding in a pin mill and granulating the powder in a fluidized bed by spraying on water as granulation liquid.

[0469]

Water-dispersible granules are also obtained by homogenizing

[0000]

25 parts by weightof a safener of the formula (I) or of a mixture
of a pesticide and a safener of the formula (I),
 5 parts by weightof sodium 2,2′-dinaphthylmethane-6,6′-disulfonate,
 2 parts by weightof sodium oleoylmethyltaurinate,
17 parts by weightof calcium carbonate,
50 parts by weightof water and
 1 part by weightof polyvinyl alcohol

in a colloid mill, comminuting, then grinding in a bead mill and atomizing and drying the resulting suspension in a spray tower using a single-fluid nozzle.

2. Preparation Examples

Example A1

[0470]

N-Cyclobutyl-2-oxo-6 (trifluoromethyl)-1,2-dihydropyridine-3-carboxamide

A1.1) 4-Butoxy-1,1,1-trifluorobut-3-en-2-one

[0471]

At 5° C., 79.9 g (0.38 mol) of trifluoroacetic anhydride—dissolved in 100 ml of trichloromethane—were added with stirring to a mixture of 29.9 g (0.38 mol) of pyridine and 50.0 g (0.38 mol) of butyl vinyl ether in 200 ml of trichloromethane. After the addition, stirring was continued at room temperature for another 15 h. 300 ml of water were then added to the mixture, and the organic phase was separated off, dried and concentrated. This gave 59 g (79% of theory) of a yellowish oil.

[0472]

1H-NMR: [CDCl3] 0.96 (t, 3H); 1.41 (m, 2H); 1.73 (m, 2H); 4.04 (t, 2H); 5.85 (d, 1H); 7.90 (d, 1H).

A1.2) Methyl 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylate

[0473]

2.15 g (94 mmol) of sodium were dissolved in 300 ml of methanol, 15.3 g (78 mmol) of 4-butoxy-1,1,1-trifluorobut-3-en-2-one and 9.13 g (78 mmol) of methyl malonatemonoamide were added and the mixture was heated under reflux for 18 h. The mixture was concentrated, and the residue was taken up in water and washed with dichloromethane. The aqueous phase was then adjusted to pH 2 by addition of 2N hydrochloric acid and extracted with dichloromethane. Drying and concentration of the extract gave 12 g (69% of theory) of a colorless powder.

[0474]

1H-NMR: [CDCl3] 4.03 (s, 3H); 7.31 (d, 1H); 8.39 (d, 1H).

A1.3) 2-Oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylic acid

[0475]

At room temperature, 4.73 g (21.4 mmol) of methyl 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylate were dissolved in 45 ml of methanol and 15 ml of water, 1.80 g (42.8 mmol) of lithium hydroxide monohydrate were added and the mixture was then heated under reflux for 2 h. The mixture was concentrated to about 15 ml and then washed with dichloromethane and the aqueous phase was adjusted to pH 2 by addition of 2N hydrochloric acid. The mixture was again extracted with dichloromethane, and the organic phase was dried and concentrated. This gave 4.2 g (94% of theory) of a colorless powder.

[0476]

1H-NMR: 7.41 (d, 1H); 8.35 (d, 1H).

A1.4) N-Cyclobutyl-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide

[0477]

600 mg (2.9 mmol) of 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylic acid were dissolved in 5 ml of tetrahydrofuran, 658 mg (4.1 mmol) of N,N-carbonyldiimidazole were added and the mixture was heated initially at room temperature for 30 min and then under reflux for 30 min. A solution of 247 mg (3.5 mmol) of cyclobutylamine in 5 ml tetrahydrofuran was then added dropwise, and the mixture was heated under reflux for a further 2 h. The solution was evaporated to dryness and then taken up in ethyl acetate, washed with 1 N hydrochloric acid and water, dried and concentrated. Purification by column chromatography gave 160 mg (19% of theory) of a light-brown powder.

[0478]

1H-NMR: [CDCl3] 1.80 (m, 2H); 2.00 (m, 2H); 2.42 (m, 2H); 4.55 (m, 1H); 6.88 (d, 1H); 8.65 (d, 1H); 9.50 (br, 1H).

Example A2

[0479]

6-[Chloro(difluoro)methyl]-N-(2-methoxyethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

A2.1) 4-Butoxy-1-chloro-1,1-difluorobut-3-en-2-one

[0480]

Under stirring at 5° C., 5.0 g (20.2 mmol) of chlorodifluoroacetic anhydride—dissolved in 10 ml of trichloromethane—were added to a mixture of 1.60 g (20.2 mmol) of pyridine and 2.1 g (20.2 mmol) of butyl vinyl ether in 30 ml of trichloromethane. After the addition, stirring was continued at room temperature for another 15 h. 100 ml of water were then added to the mixture, and the organic phase was separated off, dried and concentrated. This gave 3.4 g (80% of theory) of a yellowish oil.

[0481]

1H-NMR: 0.90 (t, 3H); 1.35 (m, 2H); 1.65 (m, 2H); 4.20 (t, 2H); 6.04 (d, 1H); 8.10 (d, 1H).

A2.2) Methyl 6-[chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridine-3-carboxylate

[0482]

1.47 g (61 mmol) of sodium were dissolved in 220 ml of methanol, 10 g (47 mmol) of 4-butoxy-1-chloro-1,1-difluorobut-3-en-2-one and 5.51 g (47 mmol) of methyl malonatemonoamide were added and the mixture was heated under reflux for 21 h. The pH was adjusted to 4-5 by addition of 2N hydrochloric acid, and about 200 ml were then distilled off. The solution that remained was extracted with ethyl acetate, and the extract was dried and concentrated. The residue was triturated with diisopropyl ether, filtered off with suction and dried. This gave 7.4 g (66% of theory) of a colorless powder.

[0483]

1H-NMR: [CDCl3] 4.01 (s, 3H); 7.30 (d, 1H); 8.38 (d, 1H); 11.5 (br, 1H).

A2.3a) 6-[Chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridine-3-carboxylic acid

[0484]

1.70 g (74 mmol) of sodium were dissolved in 250 ml of methanol, 13.1 g (61.7 mmol) of 4-butoxy-1-chloro-1,1-difluorobut-3-en-2-one and 7.22 g (61.7 mmol) of methyl malonatemonoamide were added and the mixture was heated under reflux for 21 h. 250 ml of water and 2.9 g (67.9 mmol) of lithium hydroxide monohydrate were then added, and heating under reflux was continued for a further 2 h. The mixture was concentrated to about 200 ml and washed with dichloromethane, and the aqueous phase was acidified with 2N hydrochloric acid to pH 2. The precipitated solid was filtered off with suction and dried under reduced pressure. 9.3 g (68% of theory).

A2.3b) 6-[Chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridine-3-carboxylic acid

[0485]

11.0 g (49.4 mmol) of 6-[chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridine-3-carboxamide were heated in 77 ml of 50% strength sulfuric acid. The mixture was then added to ice water, and the precipitate was filtered off with suction and dried. This gave 7.2 g (65% of theory) of a yellowish powder.

[0486]

m.p.: 145-147° C.

[0487]

1H-NMR: 7.36 (d, 1H); 8.34 (d, 1H).

A2.4) 6-[Chloro(difluoro)methyl]-N-(2-methoxyethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

[0488]

500 mg (2.2 mmol) of 6-[chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridine-3-carboxylic acid were dissolved in 10 ml of tetrahydrofuran, 508 mg (3.1 mmol) of N,N-carbonyldiimidazole were added and the mixture was then stirred initially at room temperature for 30 min and then under reflux for min. A solution of 202 mg (2.7 mmol) of 2-methoxyethylamine in 2 ml of tetrahydrofuran was then added dropwise, and the mixture was heated under reflux for a further 2 h. The solution was evaporated to dryness, the residue was taken up in ethyl acetate and the solution was washed with 1N hydrochloric acid and water, dried and concentrated. This gave 360 mg (54% of theory) of a light-brown powder.

[0489]

1H-NMR: [CDCl3] 3.40 (s, 3H); 3.58 (m, 2H); 3.67 (m, 2H); 6.84 (d, 1H), 8.62 (d, 1H); 9.40 (br, 1H).

Example A3

[0490]

Methyl N-({6-[chloro(difluoro)methyl]2 oxo-1,2-dihydropyridin-3-yl}carbonyl)glycinate

[0491]

300 mg (1.34 mmol) of 6-[chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridine-3-carboxylic acid were dissolved in 5 ml of tetrahydrofuran, 435 mg (2.68 mmol) of N,N-carbonyldiimidazole were added and the mixture was stirred initially at room temperature for 30 min and then under reflux for 30 min. A mixture of 168 mg (1.34 mmol) of glycine methyl ester hydrochloride in 3 ml of tetrahydrofuran was then added, and the mixture was heated under reflux for a further 2 h. The solution was evaporated to dryness, the residue was taken up in ethyl acetate and the solution was washed with 1N hydrochloric acid and water, dried and concentrated. This gave 92 mg (23% of theory) of a light-brown powder.

[0492]

1H-NMR: 3.65 (s, 3H); 4.12 (d, 2H); 7.28 (d, br, 1H); 8.42 (d, 1H); 9.25 (t, br, 1H), 13.6 (br, 1H)

Example A4

[0493]

N-(1-Methylpropyl)-2-oxo-6 (pentafluoroethyl)-1,2-dihydropyridine-3-carboxamide

A4.1) 1-Butoxy-4,4,5,5,5-pentafluoropent-1-en-3-one

[0494]

With stirring at −10° C., 17.0 g (93.2 mmol) of pentafluoropropionyl chloride—dissolved in 20 ml of dichloromethane—were added to a mixture of 8.11 g (102 mmol) pyridine and 9.33 g (93.2 mmol) of butyl vinyl ether in 200 ml of dichloromethane. After the addition, stirring was continued at room temperature for a further 15 h. 200 ml of water were then added to the mixture, and the organic phase was separated off, dried and concentrated. This gave 18.9 g (82% of theory) of a yellowish oil.

[0495]

1H-NMR: 0.85 (t, 3H); 1.32 (m, 2H); 1.63 (m, 2H); 4.20 (t, 2H); 6.06 (d, 1H); 8.11 (d, 1H).

A4.2) Ethyl 2-oxo-6-(pentafluoroethyl)-1,2-dihydropyridine-3-carboxylate

[0496]

0.56 g (24.4 mmol) of sodium was dissolved in 150 ml of ethanol, 5 g (20.3 mmol) of 1-butoxy-4,4,5,5,5-pentafluoropent-1-en-3-one and 2.66 g (20.3 mmol) of methyl malonatemonoamide were added and the mixture was heated under reflux for 6 h. The mixture was concentrated to about 50 ml, 500 ml of 1N hydrochloric acid were added and the mixture was then extracted with ethyl acetate. Drying and concentration gave 2.3 g (40% of theory) of a yellowish resin.

[0497]

1H-NMR: [CDCl3] 1.45 (t, 3H); 4.50 (q, 2H); 7.35 (d, 1H); 8.40 (d, 1H); 11.4 (br, 1H).

A4.3) N-(1-Methylpropyl)-2-oxo-6-(pentafluoroethyl)-1,2-dihydropyridine-3-carboxamide

[0498]

At room temperature, 160 mg (0.56 mmol) of ethyl 2-oxo-6-(pentafluoroethyl)-1,2-dihydropyridine-3-carboxylate were stirred in 5 ml of 2-butylamine for 14 h. The pH was then adjusted to 2 by addition of 1N hydrochloric acid, which resulted in the precipitation of a colorless solid. Filtration with suction and drying gave 160 mg (91% of theory) of the product.

[0499]

1H-NMR: [CDCl3] 0.97 (t, 3H); 1.22 (d, 3H); 1.59 (m, 2H); 4.10 (m, 1H); 6.88 (d, 1H); 8.72 (d, 1H); 9.24 (d, br, 1H); 13.6 (br).

Example A5

[0500]

2-Oxo-6-(pentafluoroethyl)-1,2-dihydropyridine-3-carboxamide

[0501]

0.22 g (9.7 mmol) of sodium was dissolved in 50 ml of ethanol, 2 g (8.1 mmol) of 1-butoxy-4,4,5,5,5-pentafluoropent-1-en-3-one and 0.86 g (8.1 mmol) malonamide were added and the mixture was heated under reflux for 7 h. The mixture was concentrated, and 1N hydrochloric acid was added.

[0502]

The resulting precipitate was filtered off with suction and dried. This gave 1.9 g (94% of theory) of a yellow powder.

[0503]

1H-NMR: 7.45 (d, 1H); 8.15 (br, 1H); 8.45 (br, 1H); 8.50 (d, 1H); 13.7 (br, 1H).

Example A6

[0504]

N-[(Dimethylamino)methylene]-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide

[0505]

0.87 g (7.28 mmol) of N,N-dimethylformamide dimethyl acetal was added to 1.00 g (4.85 mmol) of 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide in 5 ml of toluene, and the mixture was heated under reflux for 4 h. After cooling, the resulting precipitate was filtered off with suction and dried: 0.5 g (39% of theory).

[0506]

1H-NMR: [CDCl3] 3.25 (s, 3H); 3.35 (3. 3H); 7.25 (d, 1H); 8.58 (d, 1H); 8.76 (s, 1H)

[0507]

13C-NMR. [CDCl3] 35 (NMe2); 106 (C-5); 115 (C-3); 122 (q, CF3); 143 (C-4); 151 (C-6); 164 (N═CN); 167 (C-2); 171 (CON).

Example A7

[0508]

5-Chloro-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide

[0509]

At room temperature, 0.39 g (2.9 mmol) of sulfuryl chloride was added to 300 mg (1.46 mmol) of 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide in 5 ml of 1,2-dichloroethane and 2.3 g (0.25 ml) of pyridine, and the mixture was then heated under reflux for 2 h. The mixture was then added to 0.5N hydrochloric acid. The organic phase was removed and then dried and concentrated, which gave 144 mg (41% of theory) of a brownish powder.

[0510]

1H-NMR: 8.25 (br, 1H); 8.35 (br, 1H); 8.50 (s, 1H); 13.8 (br, 1H)

[0511]

13C-NMR. 118 (C-5); 120 (C-6),: 120.5 (q, CF3); 144 (C-4), 161 (C-2); 166 (COONH2).

Example A8

[0512]

N-Allyl-5-bromo-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide

A8.1) Methyl 5-bromo-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylate

[0513]

At room temperature, 0.36 g (2.04 mmol) of N-bromosuccinimide was added to a suspension of 0.3 g (1.36 mmol) of methyl 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylate in 10 ml of glacial acetic acid, and the mixture was then heated under reflux for 2 days. The reaction mixture was then added to water and extracted with dichloromethane. The extract was concentrated, and the residue was purified further by preparative HPLC. This gave 227 mg (56% of theory) of a colorless powder.

[0514]

1H-NMR: 3.85 (s, 3H); 8.45 (s, 1H); 12.80 (br, 1H);

[0515]

13C-NMR. 53 (OCH3); 105 (C-3); 148 (C-4), 161 (C-2); 164 (COOMe).

A8.2) N-Allyl-5-bromo-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide

[0516]

At room temperature, 250 mg (0.83 mmol) of methyl 5-bromo-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylate were stirred in 5 ml of allylamine for 18 h. By addition of 2N hydrochloric acid, the pH was then adjusted to 2, resulting in the precipitation of a colorless solid. Filtration with suction and drying gave 134 mg (50% of theory) of the product.

[0517]

1H-NMR: 3.94 (t, 2H); 5.18 (dd, 2H); 5.89 (m, 1H); 8.52 (s, 1H); 8.85 (t, br, 1H).

Example A9

[0518]

6-Difluoromethyl-N-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide

A9.1) 4-Butoxy-1,1-difluorobut-3-en-2-one

[0519]

With stirring at 5° C., 10.0 g (55.7 mmol) of difluoroacetic anhydride were added to a mixture of 4.41 g (4.5 ml, 55.7 mmol) of pyridine and 5.7 g (55.7 mmol) butyl vinyl ether in 330 ml of trichloromethane. After the addition, stirring was continued at room temperature for a further 15 h. 300 ml of water were then added to the mixture, and the organic phase was separated off, dried and concentrated. This gave 5.7 g (57% of theory) of a yellowish oil.

[0520]

1H-NMR: [CDCl3] 0.95 (t, 3H); 1.42 (m, 2H); 1.72 (m, 2H); 4.00 (t, 2H); 5.78 (t, 1H); 5.90 (d, 1H); 7.85 (d, 1H).

A9.2) Methyl 6-(difluoromethyl)-2-oxo-1,2-dihydropyridine-3-carboxylate

[0521]

1.21 g (52.9 mmol) of sodium were dissolved in 200 ml of methanol, 7.9 g (44 mmol) of 4-butoxy-1,1-difluorobut-3-en-2-one and 5.3 g (44 mmol) of methyl malonatemonoamide were then added and the mixture was heated under reflux for 15 h. The mixture was concentrated and the residue was then triturated with 100 ml of 1N hydrochloric acid. The solid obtained was filtered off with suction and dried: 7.4 g (82% of theory).

[0522]

1H-NMR: 3.82 (s, 3H); 6.85 (t, 1H); 7.02 (d, br, 1H); 8.20 (d, 1H); 12.4 (br, 1H).

A9.3) 6-(Difluoromethyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid

[0523]

7.4 g (36.4 mmol) of methyl 6-(difluoromethyl)-2-oxo-1,2-dihydropyridine-3-carboxylate were dissolved in 100 ml of methanol, and a solution of 1.3 g (54.6 mmol) of lithium hydroxide in 50 ml of water was added. After two hours of heating under reflux, the mixture was concentrated to a volume of about 50 ml and the solution was washed with dichloromethane. The aqueous phase was then acidified with 2N hydrochloric acid and extracted with ethyl acetate. Drying and concentration of the extract gave 5.6 g (82% of theory) of a brownish powder.

A9.4) 6-(Difluoromethyl)-N-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide

[0524]

After dissolution of 200 mg (1.1 mmol) of 6-(difluoromethyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid in 25 ml of tetrahydrofuran and addition of 206 mg (1.3 mmol) of N,N-carbonyldiimidazole, the mixture was stirred initially at room temperature for 30 min and then under reflux for 30 min. A solution of 66 mg (1.1 mmol) of isopropylamine in 5 ml of tetrahydrofuran was then added dropwise, and the mixture was heated under reflux for a further 2 h. The solution was evaporated to dryness, the residue was then taken up in ethyl acetate and the mixture was washed with 2N hydrochloric acid and water, dried and concentrated. Purification by column chromatography gave 150 mg (61% of theory) of a colorless powder.

[0525]

1H-NMR: [CDCl3] 1.25 (d, 6H); 4.22 (m, 1H); 6.55 (t, 1H); 6.69 (d, 1H); 8.64 (d, 1H); 9.42 (d, br, 1H); 13.0 (br, 1H).

Example A10

[0526]

6-(Heptafluoropropyl)-2-oxo-N-propyl-1,2-dihydropyridine-3-carboxamide

A10.1) 1-Butoxy-4,4,5,5,6,6,6-heptafluorohex-1-en-3-one

[0527]

With stirring and at −10° C., 21.7 g (93.2 mmol) of heptafluorobutyryl chloride—dissolved in 50 ml of dichloromethane—were added to a mixture of 8.11 g (102 mmol) of pyridine and 9.33 g (93.2 mmol) of butyl vinyl ether in 200 ml of dichloromethane. After the addition, stirring was continued at room temperature for another 15 h. 300 ml of water were then added to the mixture, and the organic phase was separated off, dried and concentrated.

[0528]

This gave 28.2 g (82% of theory) of a yellowish oil which was reacted further without further purification.

[0529]

1H-NMR: [CDCl3] 0.96 (t, 3H); 1.40 (m, 2H); 1.75 (m, 2H); 4.04 (t, 2H); 5.95 (d, 1H); 7.93 (d, 1H).

A10.2) Methyl 6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxylate

[0530]

After dissolution of 2.63 g (114 mmol) of sodium in 250 ml of methanol, 28.2 g (95.5 mmol) of 1-butoxy-4,4,5,5,6,6,6-heptafluorohex-1-en-3-one and 11.18 g (95.5 mmol) of methyl malonatemonoamide were added, and the mixture was heated under reflux for 18 h. The mixture was concentrated and the residue was then taken up in water and washed with dichloromethane. The aqueous phase was then adjusted to pH 2 by addition of 2N hydrochloric acid and extracted with dichloromethane, Drying, concentration and purification of the extract by column chromatography gave 15.2 g (49% of theory) of a yellow powder.

[0531]

1H-NMR: [CDCl3] 4.06 (s, 3H); 7.35 (d, 1H); 8.40 (d, 1H); 11.4 (br, 1H).

A10.3) 6-(Heptafluoropropyl) 2 oxo N propyl-1,2-dihydropyridine-3-carboxamide

[0532]

250 mg (0.78 mmol) of methyl 6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxylate in 5 ml of propylamine were heated under reflux for 5 h. The mixture was then adjusted to pH 2 by addition of 1N hydrochloric acid and extracted with dichloromethane. Drying and concentration gave 240 mg (88% of theory) of a beige powder.

[0533]

1H-NMR: 0.90 (t, 3H); 1.54 (m, 2H); 3.25 (q, 2H); 7.41 (d, 1H); 8.40 (d, 1H); 8.85 (br, 1H); 13.45 (br, 1H).

Example A11

[0534]

N-Methyl-2-oxo-6-(1,1,2,2-tetrafluoroethyl)-1,2-dihydropyridine-3-carboxamide

A11.1) 1-Butoxy-4,4,5,5-tetrafluoropent-1-en-3-one

[0535]

With stirring and at 0° C., 25.0 g (152 mmol) of 3H-tetrafluoropropionyl chloride—dissolved in 20 ml dichloromethane—were added to a mixture of 14.4 g (182 mmol) of pyridine and 15.2 g (152 mmol) of butyl vinyl ether in 250 ml of dichloromethane. After the addition, stirring was continued at room temperature for another 15 h. 250 ml of water were then added to the mixture, and the organic phase was separated off, dried and concentrated. This gave 12.5 g (36% of theory) of a yellowish oil.

[0536]

1H-NMR: [CDCl3] 0.96 (t, 3H); 1.46 (m, 2H); 1.75 (m, 2H); 4.03 (t, 2H); 6.00 (d, 1H); 6.09 (tt, 1H); 7.90 (d, 1H).

A11.2) Methyl 2-oxo-6-(1,1,2,2-tetrafluoroethyl)-1,2-dihydropyridine-3-carboxylate

[0537]

After dissolution of 1.39 g (60.3 mmol) of sodium in 500 ml of methanol, 11.5 g (50.3 mmol) of 1-butoxy-4,4,5,5-tetrafluoropent-1-en-3-one and 6.07 g (50.3 mmol) of methyl malonatemonoamide were added, and the mixture was heated under reflux for 6 h. The mixture was concentrated to about 100 ml, 500 ml of 1N hydrochloric acid were then added and the mixture was subsequently extracted with ethyl acetate. Drying and concentration gave 10.3 g (67% of theory) of a yellowish resin.

[0538]

1H-NMR: [CDCl3] 4.03 (s, 3H); 6.40 (tt, 1H); 7.38 (d, 1H); 8.39 (d, 1H).

A11.3) N-Methyl-2-oxo-6-(1,1,2,2-tetrafluoroethyl)-1,2-dihydropyridine-3-carb oxamide

[0539]

At room temperature, 300 mg (1.19 mmol) of methyl 2-oxo-6-(1,1,2,2-tetrafluoroethyl)-1,2-dihydropyridine-3-carboxylate were stirred in 3.3 ml of a 40% strength aqueous methylamine solution for 14 h. The pH was then adjusted to 2 by addition of 1N hydrochloric acid, and the mixture was extracted with dichloromethane. Drying and concentration of the extract gave 230 mg (77% of theory) of the product.

[0540]

1H-NMR: 2.83 (d, 3H); 6.81 (tt, 1H); 7.22 (br, 1H); 8.41 (d, 1H); 9.00 (br, 1H); 13.4 (br, 1H).

Example A12

[0541]

2-Oxo-N-(2-propynyl)-6-(1,1,2,2-tetrafluoroethyl)-1,2-dihydropyridine-3-carboxamide

[0542]

At room temperature, 300 mg (1.19 mmol) of methyl 2-oxo-6-(1,1,2,2-tetrafluoroethyl)-1,2-dihydropyridine-3-carboxylate were stirred in 3.3 ml (41 mmol) of propargylamine for 14 h. The pH was then adjusted to 2 by addition of 1N hydrochloric acid, and the mixture was extracted with dichloromethane. Drying and concentration of the extract gave 280 mg (85% of theory) of the product.

[0543]

1H-NMR: 3.15 (t, 1H); 4.13 (m, 2H); 6.82 (tt, 1H); 7.18 (br, 1H); 8.41 (d, 1H); 9.35 (br, 5H); 13.3 (br, 1H).

Example A13

[0544]

5-Bromo-6-(difluoromethyl)-N-(2-methoxy-1-methylethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

A13.1) Methyl 5-bromo-6-(difluoromethyl)-2-oxo-1,2-dihydropyridine-3-carboxylate

[0545]

4.1 g (20 mmol) of methyl 6-(difluoromethyl)-2-oxo-1,2-dihydropyridine-3-carboxylate were dissolved in 20 ml of N,N-dimethylformamide, and 5.35 g (30 mmol) of N-bromosuccinimide were added at room temperature. After 2 hours of stirring, the reaction mixture was added to water and extracted with tert-butyl methyl ether. The extract was subsequently washed repeatedly with water. Drying and concentration finally gave 3.7 g (65% of theory) of the product.

[0546]

1H-NMR: 3.83 (s, 3H); 7.07 (t, 1H); 8.34 (s, 1H); 12.5 (s, br, 1H).

A13.2) 5-Bromo-6-(difluoromethyl)-N-(2-methoxy-methylethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

[0547]

At room temperature, 334 mg (1.19 mmol) of methyl 5-bromo-6-(difluoromethyl)-2-oxo-1,2-dihydropyridine-3-carboxylate in 3.3 ml (41 mmol) of 2-amino-1-methoxypropane were stirred for 14 h. The pH was then adjusted to 2 by addition of 1N hydrochloric acid, and the mixture was extracted with dichloromethane. Drying and concentration of the extract gave 360 mg (89% of theory) of the product.

[0548]

1H-NMR: 1.27 (d, 3H); 3.40 (s, 3H); 3.43 (m, 2H); 4.37 (m, 1H); 6.85 (t, 1H); 8.68 (s, 1H); 9.42 (d, br, 1H); 12.7 (br, 1H).

Example A14

[0549]

5-Bromo-6-[chloro(difluoro)methyl]-N-(cyclopropylmethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

A14.1) Methyl 5-bromo-6-[chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridine-3-carboxylate

[0550]

1.30 g (5.47 mmol) of methyl 6-[chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridinecarboxylate were dissolved in 50 ml of N,N-dimethylformamide, and 1.46 g (8.21 mmol) of N-bromosuccinimide were added at room temperature. After 3 hours of stirring, the reaction mixture was added to water, resulting in the formation of a colorless precipitate. Drying and concentration gave 1.23 g (71% of theory) of the product.

[0551]

1H-NMR: 3.85 (s, 3H); 8.45 (s, 1H); 12.7 (s, br, 1H).

A14.2) 5-Bromo-6-[chloro(difluoro)methyl]-N-(cyclopropylmethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

[0552]

At room temperature, 350 mg (1.11 mmol) of methyl 5-bromo-6-[chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridine-3-carboxylate were dissolved in 5 ml of acetonitrile and stirred with 0.5 ml of aminomethylcyclopropane for 12 h. The reaction mixture was then added to 1N hydrochloric acid, and the resulting precipitate was filtered off with suction. The precipitate was dried, again triturated with 1N hydrochloric acid, filtered off with suction and washed with water. Drying gave 240 mg (62% of theory) of the product.

[0553]

1H-NMR: 0.25 (m, 2H); 0.46 (m, 2H); 1.04 (m, 1H); 3.20 (t, 2H); 8.55 (s, 1H); 8.82 (t, br, 1H); 13.6 (br, 1H).

Example A15

[0554]

6-[Chloro (difluoro)methyl]-N-(1-ethylpropyl)-5-iodo-2-oxo-1,2-dihydropyridine-3-carboxamide

A15.1) Methyl 6-[chloro(difluoro)methyl]-5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate

[0555]

10.0 g (42.1 mmol) of methyl 6-[chloro(difluoro)methyl]-2-oxo-1,2-dihydropyridinecarboxylate were dissolved in 50 ml of N,N-dimethylformamide, and 6.32 g (63.1 mmol) of calcium carbonate and 20.5 g (126 mmol) of iodine chloride were added at room temperature. After 6 hours of stirring at 50° C., the reaction mixture was added to water, resulting in the formation of a colorless precipitate, which was washed with dilute sodium bisulfite solution and water. Filtration with suction and drying gave 13.6 g (89% of theory) of the product.

[0556]

1H-NMR: 3.84 (s, 3H); 8.61 (s, 1H); 12.6 (s, br, 1H).

A15.2) 6-[Chloro(difluoro)methyl]-N-(1-ethylpropyl)-5-iodo-2-oxo-1,2-dihydropyridine-3-carboxamide

[0557]

At room temperature, 400 mg (1.1 mmol) of methyl 6-[chloro(difluoro)methyl]-5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate were dissolved in 5 ml of acetonitrile and stirred with 0.5 ml of 3-pentylamine for 12 h. The reaction mixture was then added to 1N of hydrochloric acid, and the resulting precipitate was filtered off with suction and washed with water. Drying gave 370 mg (72% of theory) of the product.

[0558]

1H-NMR: 0.87 (t, 6H); 1.43 (m, 21H); 1.55 (m, 2H); 3.78 (m, 1H); 8.55 (br, 1H); 8.67 (s, 1H); 13.5 (br, 1H).

Example A16

[0559]

5-Chloro-N,N-diethyl-6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

A16.1) Methyl 5-chloro-6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxylate

[0560]

16.7 g (52 mmol) of methyl 6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxylate were dissolved in 160 ml of N,N-dimethylformamide, and 7.08 g (52 mmol) of N-chlorosuccinimide were added at room temperature. After 3 hours of stirring at 50° C., the reaction mixture was added to water and extracted repeatedly with ethyl acetate. The organic phase was then separated off, washed with water and dried. The resulting crude product was then purified by preparative RP-HPLC. This gave 10.1 g (54% of theory) of the product as a colorless powder.

[0561]

1H-NMR: 3.85 (s, 3H); 8.35 (s, 1H); 12.8 (s, br, 1H).

A16.2) 5-Chloro-6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid

[0562]

1.54 g (4.33 mmol) of methyl 5-chloro-6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxylate were dissolved in 23 ml of methanol, and a solution of 0.16 g (6.5 mmol) of lithium hydroxide in 13 ml of water was added. After two hours of heating under reflux, the methanol was distilled off, and the aqueous solution that remained was washed with dichloromethane. The aqueous phase was then acidfied with 2N hydrochloric acid and extracted with dichloromethane. Drying and concentration of the extract gave 1.45 g (98% o of theory) of a brownish powder.

[0563]

1H-NMR: 8.30 (s, 1H).

A16.3) 5-Chloro-N,N-diethyl-6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

[0564]

After dissolution of 355 mg (1.04 mmol) of 5-chloro-6-(heptafluoropropyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid in 30 ml tetrahydrofuran and addition of 337 mg (2.08 mmol) of N,N-carbonyldiimidazole, the mixture was stirred initially at room temperature for 30 min and then under reflux for 30 min. 152 mg (0.22 ml, 2.08 mmol) of diethylamine were then added, and the mixture was heated under reflux for a further 2 h. The solution was evaporated to dryness and then taken up in dichloromethane, washed with 1N hydrochloric acid and water, dried and concentrated. This gave 300 mg (72% of theory) of the product.

[0565]

1H-NMR: 1.03 (t, 3H); 1.15 (t, 3H); 3.12 (q, 2H); 3.45 (q, 2H); 8.05 (s, 1H); 12.5 (br, 1H).

Example A17

[0566]

6-(2-Chloro-1,1,2,2-tetrafluoroethyl)-N-ethyl-2-oxo-1,2-dihydropyridine-3-carboxamide

A17.1) 1-Butoxy-5-chloro-4,4,5,5-tetrafluoropent-1-en-3-one

[0567]

With stirring and at 0° C., 10.0 g (50.2 mmol) of 3-chlorotetrafluoropropionyl chloride—dissolved in ml of chloroform—were added to a mixture of 3.97 g (50.2 mmol) of pyridine and 5.03 g (50.2 mmol) of butyl vinyl ether in 80 ml of chloroform. After the addition, stirring was continued at room temperature for a further 15 h. 100 ml of water were then added to the mixture, and the organic phase was separated off, dried and concentrated. This gave 10.4 g (78% of theory) of a yellowish oil.

[0568]

1H-NMR: [CDCl3] 0.96 (t, 3H); 1.43 (m, 2H); 1.75 (m, 2H); 4.04 (t, 2H); 5.97 (d, 1H); 7.91 (d, 1H).

A17.2) Methyl 6-(2-chloro-1,1,2,2-tetrafluoroethyl)-2-oxo-1,2-dihydropyridine-3-carboxylate

[0569]

0.32 g (13.7 mmol) of sodium were dissolved in 50 ml of methanol, 3.0 g (11.4 mmol) of 1-butoxy-5-chloro-4,4,5,5-tetrafluoropent-1-en-3-one and 1.34 g (11.4 mmol) of methyl malonatemonoamide were added and the mixture was heated under reflux for 6 h. The mixture was concentrated to about ml, 50 ml of 1N hydrochloric acid were then added and the mixture was subsequently extracted repeatedly with ethyl acetate. After drying and concentration, the resulting residue was taken up in diethyl ether and filtered. Concentration of the filtrate gave 1.74 g (52% of theory) of a yellowish powder.

[0570]

1H-NMR: 3.84 (s, 3H); 7.44 (d, 1H); 8.32 (d, 1H); 12.4 (br, 1H).

A17.3) 6-(2-Chloro-1,1,2,2-tetrafluoroethyl)-N-ethyl-2-oxo-1,2-dihydropyridine-3-carboxamide

[0571]

At room temperature, 300 mg (1.04 mmol) of methyl 6-(2-chloro-1,1,2,2-tetrafluoroethyl)-2-oxo-1,2-dihydropyridine-3-carboxylate were stirred in 5 ml of aqueous ethylamine solution (70%) for 14 h. The pH was then adjusted to 2 by addition of 1N hydrochloric acid, and the mixture was extracted with dichloromethane. Drying and concentration of the extract gave 310 mg (98% of theory) of the product.

[0572]

1H-NMR: [CDCl3] 1.27 (t, 3H); 3.50 (m, 2H); 6.88 (d, 1H); 8.68 (d, 1H); 9.32 (br, 1H); 12.6 (br, 1H).

Example A18

[0573]

5-Bromo-6-(2-chloro-1,1,2,2-tetrafluoroethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

A18.1) 6-(2-Chloro-1,1,2,2-tetrafluoroethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

[0574]

0.53 g (22.8 mmol) of sodium were dissolved in 50 ml of methanol, 5.0 g (19.0 mmol) of 1-butoxy-5-chloro-4,4,5,5-tetrafluoropent-1-en-3-one and 2.0 g (19.0 mmol) of malonamide were then added and the mixture was heated under reflux for 6 h. The mixture was concentrated, and 1N hydrochloric acid was then added. The resulting precipitate was filtered off with suction and dried. This gave 3.8 g (73% of theory) of a brownish powder.

[0575]

1H-NMR: 7.42 (br, 1H); 8.10 (br, 1H); 8.40 (br, 1H); 8.46 (d, 1H), 13.6 (br, 1H).

A18.2) 5-Bromo-6-(2-chloro-1,1,2,2-tetrafluoroethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

[0576]

0.49 g (1.8 mmol) of 6-(2-chloro-1 μl, 2,2-tetrafluoroethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide were dissolved in 5 ml of N,N-dimethylformamide, and 0.48 g (2.7 mmol) of N-bromosuccinimide was added at room temperature. After 2 hours of stirring at room temperature, the reaction mixture was poured into water, resulting in the formation of a precipitate. Filtration with suction, washing with water and drying gave 610 mg (96% of theory) of the product as a yellowish powder.

[0577]

1H-NMR: 8.25 (br, 1H); 8.35 (br, 1H); 8.61 (s, 1H); 13.7 (br, 1H).

Example A19

[0578]

6-(1 Chloro-1,2,2,2-tetrafluoroethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

A19.1) 1-Butoxy-4-chloro-4,5,5,5-tetrafluoropent-1-en-3-one

[0579]

With stirring and at 0° C., 9.59 g (48.2 mmol) of 2-chlorotetrafluoropropionyl chloride were added dropwise to a mixture of 4.19 g (50.0 mmol) of pyridine and 4.83 g (48.2 mmol) of butyl vinyl ether in 75 ml of dichloromethane. After the addition, stirring was continued at room temperature for another 15 h. The mixture was then washed with 1N hydrochloric acid and 2×100 ml of water, and the organic phase was separated off, dried and concentrated. This gave 6.33 g (50% of theory) of a brown oil.

[0580]

1H-NMR: [CDCl3] 0.97 (t, 3H); 1.48 (m, 2H); 1.75 (m, 2H); 4.03 (t, 2H); 5.98 (d, 1H); 7.89 (d, 1H).

A19.2) 6-(1-Chloro-1,2,2,2-tetrafluoroethyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

[0581]

0.33 g (14.4 mmol) of sodium were dissolved in 50 ml of methanol, 3.16 g (12.03 mmol) of 1-butoxy-4-chloro-4,5,5,5-tetrafluoropent-1-en-3-one and 1.27 g (12.03 mmol) of malonamide were added and the mixture was heated under reflux for 7 h. The mixture was concentrated, and 1N hydrochloric acid was then added. The resulting precipitate was filtered off with suction and dried. This gave 380 mg (12% of theory) of a yellowish powder.

[0582]

1H-NMR: 7.45 (d, 1H); 8.14 (br, 1H); 8.42 (br, 1H); 8.48 (d, 1H); 13.7 (br, 1H).

[0583]

In an exemplary manner, Table I below lists a number of compounds of the general formula (I) which can be obtained in a manner analogous to Examples A1 to A10 above and to the methods mentioned further above.

[0584]

In the table:

[0000]

Bu=butyl
Me=methyl
Pr=propyl
i=iso
t=tertiary
Et=ethyl
Ph=phenyl
s=secondary
c=cyclo

[0585]

This applies correspondingly to composite terms such as

[0000]

iPr=isopropyl
iBu=isobutyl
sBu=sec-butyl
tBu=tert-butyl
cPr=cyclopropyl
cPentyl=cyclopentyl
cHexyl=cyclohexyl

[0586]

If an alkyl radical is listed in the tables without further specification, the radical in question is the straight-chain alkyl radical, i.e., for example, Bu=n-Bu=n-butyl.

[0587]

In the table, the number indices in the formula are not subscript but arranged in the same line height and font size as the symbols for the atoms.

[0588]

For example, the formula CF3 in the table corresponds to the formula CF3according to the customary notation with subscript index, or the formula CH2CH(CH2CH3)2 corresponds to the formula CH2CH(CH2CH)2with subscript indices.

[0589]

For some compounds (I) in Table 1, physicochemical data (in general1H-NMR data) are listed in Table 2. Here, the data are assigned to the compounds via the example number according to Table 1.

[0000]

Compounds of the formula (I)
(I)
Ex.R1R2R3R4
1CF3HHMe
2CF3HHEt
3CF3HHPr
4CF3HHiPr
5CF3HHcPr
6CF3HHBu
7CF3HHcBu
8CF3HHtBu
9CF3HMeMe
10CF3HMeEt
11CF3HMeBu
12CF3HMePr
13CF3HMeiPr
14CF3HEtEt
15CF3HEtPr
16CF3HEtiPr
17CF3HPrPr
18CF3HHcPentyl
19CF3HHcHexyl
20CF3HHCH2(CH2)3CH3
21CF3HHCH2(CH2)4CH3
22CF3HHCH2—cPr
23CF3HHCH2—CN
24CF3HHCH2—C(CH3)3
25CF3HHCH2CF2CF3
26CF3HHCH2CF3
27CF3HHCH2(CF2)2CF3
28CF3HHCH2CH(CH3)CH2CH3
29CF3HHCH2C(CH3)2CH2F
30CF3HHCH2CH(CH3)2
31CF3HHCH2CH(CH2CH3)2
32CF3HHCH2CH2CH(CH3)2
33CF3HHCH2CH2C(CH3)3
34CF3HHCH2CH═CH2
35CF3HMeCH2CH═CH2
36CF3HCH2CH═CH2CH2CH═CH2
37CF3HHCH2CH═CHCH3
38CF3HHCH2—C(CH3)═CH2
39CF3HHCH2—C≡CH
40CF3HMeCH2—C≡CH
41CF3HHCH(CH3)CH2CH3
42CF3HHCH(CH3)cPr
43CF3HHCH(CH3)(CH2)2CH3
44CF3HHCH(CH3)(CH2)4CH3
45CF3HHCH(CH3)(CH2)5CH3
46CF3HHCH(CH2CH3)(CH2)3CH3
47CF3HHCH(CH3)CH2CH(CH3)2
48CF3HHCH(CH3)C(CH3)3
49CF3HHCH(CH3)CH(CH3)2
50CF3HHCH(CH3)CH2CH2CH(CH3)2
51CF3HHCH(CH2CH3)2
52CF3HHC(CH3)2CH2CH3
53CF3HHC(CH3)2CH2C(CH3)3
54CF3HHCH2—CH(OMe)2
55CF3HHCH2—CH(OEt)2
56CF3HHCH2CH2—OH
57CF3HHCH2CH2—OMe
58CF3HMeCH2CH2—OMe
59CF3HHCH2CH2—OEt
60CF3HHCH2CH2—SMe
61CF3HHCH2CH2—CN
62CF3HHCH2CH2—NMe2
63CF3HHCH2CH2-morpholin-4-yl
64CF3HHCH(CH3)CH2—OMe
65CF3HHCH(CH3)CH2—NMe2
66CF3HHCH2CH2CH2—OMe
67CF3HHCH2CH2CH2—SMe
68CF3HHCH2CH2CH2—OEt
69CF3HHCH2CH2CH2—OiPr
70CF3HHCH2CH2CH2—OBu
71CF3HHCH2—COOCH3
72CF3HMeCH2—COOCH3
73CF3HHCH(CH3)COOMe
74CF3HHCH(CH3)COOEt
75CF3HHCH2CH2—COOCH3
76CF3HHCH(COOCH3)2
77CF3HHCH(COOEt)CH2—CH(CH3)2
78CF3HHCH(COOMe)CH(CH3)2
79CF3HHO—CH2CH3
80CF3HMeO—CH3
81CF3HHO—CH2CH═CH2
82CF3HHO—tBu
83CF3HHO—Pr
84CF3HHO—CH2cPr
85CF3HHO—CH2CH(CH3)2
86CF3HHO—CH2CF3
87CF3HHO—CH(CH3)cPr
88CF3HHO—CH2CH2Cl
89CF3HHO—CH2C≡CH
90CF3HHO—CH2C≡CCH3
91CF3HHO—CH(CH3)C≡CH
92CF3HHCH2—Ph
93CF3HMeCH2—Ph
94CF3HHCH2-pyridin-3-yl
95CF3HHCH2-6-Cl-pyridin-3-yl
96CF3HHCH(CH3)Ph
97CF3HHCH2CH2—Ph
98CF3HHCH2-2-CF3—Ph
99CF3HHCH2CH2CHPh2
100CF3Hmorpholin-4-yl
101CF3Hpiperidin-1-yl
102CF3Hthiazolidin-3-yl
103CF3Hpyrrolidin-1-yl
104CF3H2-methylpyrrolidin-1-yl
105CF3H═CH—N(CH3)2
106CF3H═C(CH3)N(CH3)2
107CF3H═CH—N(C2H5)2
108CF3H═C(CH3)N(C2H5)2
109CF3H═CH-piperidine
110CF3H═CH-morpholine
111CF3H═CH-pyrrolidine
112CF3HHindan-1-yl
113CF3HHtetrahydrofuran-2-ylmethyl
114CF2ClHHH
115CF2ClHHMe
116CF2ClHHEt
117CF2ClHHPr
118CF2ClHHiPr
119CF2ClHHcPr
120CF2ClHHBu
121CF2ClHHcBu
122CF2ClHHtBu
123CF2ClHMeMe
124CF2ClHMeEt
125CF2ClHMeBu
126CF2ClHMePr
127CF2ClHMeiPr
128CF2ClHEtEt
129CF2ClHEtPr
130CF2ClHEtiPr
131CF2ClHPrPr
132CF2ClHHcPentyl
133CF2ClHHcHexyl
134CF2ClHHCH2(CH2)3CH3
135CF2ClHHCH2(CH2)4CH3
136CF2ClHHCH2—cPr
137CF2ClHHCH2—CN
138CF2ClHHCH2—C(CH3)3
139CF2ClHHCH2CF2CF3
140CF2ClHHCH2CF3
141CF2ClHHCH2(CF2)2CF3
142CF2ClHHCH2CH(CH3)CH2CH3
143CF2ClHHCH2C(CH3)2CH2F
144CF2ClHHCH2CH(CH3)2
145CF2ClHHCH2CH(CH2CH3)2
146CF2ClHHCH2CH2CH(CH3)2
147CF2ClHHCH2CH2C(CH3)3
148CF2ClHHCH2CH═CH2
149CF2ClHMeCH2CH═CH2
150CF2ClHCH2CH═CH2CH2CH═CH2
151CF2ClHHCH2CH═CHCH3
152CF2ClHHCH2—C(CH3)═CH2
153CF2ClHHCH2—C≡CH
154CF2ClHMeCH2—C≡CH
155CF2ClHHCH(CH3)CH2CH3
156CF2ClHHCH(CH3)cPr
157CF2ClHHCH(CH3)(CH2)2CH3
158CF2ClHHCH(CH3)(CH2)4CH3
159CF2ClHHCH(CH3)(CH3)5CH3
160CF2ClHHCH(CH2CH3)(CH2)3CH3
161CF2ClHHCH(CH3)CH2CH(CH3)2
162CF2ClHHCH(CH3)C(CH3)3
163CF2ClHHCH(CH3)CH(CH3)2
164CF2ClHHCH(CH3)CH2CH2CH(CH3)2
165CF2ClHHCH(CH2CH3)2
166CF2ClHHC(CH3)2CH2CH3
167CF2ClHHC(CH3)2CH2C(CH3)3
168CF2ClHHCH2—CH(OMe)2
169CF2ClHHCH2—CH(OEt)2
170CF2ClHHCH2CH2—OH
171CF2ClHHCH2CH2—OMe
172CF2ClHMeCH2CH2—OMe
173CF2ClHHCH2CH2—OEt
174CF2ClHHCH2CH2—SMe
175CF2ClHHCH2CH2—CN
176CF2ClHHCH2CH2—NMe2
177CF2ClHHCH2CH2-morpholin-4-yl
178CF2ClHHCH(CH3)CH2—OMe
179CF2ClHHCH(CH3)CH2—NMe2
180CF2ClHHCH2CH2CH2—OMe
181CF2ClHHCH2CH2CH2—SMe
182CF2ClHHCH2CH2CH2—OEt
183CF2ClHHCH2CH2CH2—OiPr
184CF2ClHHCH2CH2CH2—OBu
185CF2ClHHCH2—COOCH3
186CF2ClHMeCH2—COOCH3
187CF2ClHHCH(CH3)COOMe
188CF2ClHHCH(CH3)COOEt
189CF2ClHHCH2CH2—COOCH3
190CF2ClHHCH(COOCH3)2
191CF2ClHHCH(COOEt)CH2—CH(CH3)2
192CF2ClHHCH(COOMe)CH(CH3)2
193CF2ClHHO—CH2CH3
194CF2ClHHO—CH3
195CF2ClHHO—CH2CH═CH2
196CF2ClHHO—tBu
197CF2ClHHO—Pr
198CF2ClHHO—CH2cPr
199CF2ClHHO—CH2CH(CH3)2
200CF2ClHHO—CH2CF3
201CF2ClHHO—CH(CH3)cPr
202CF2ClHHO—CH2CH2Cl
203CF2ClHHO—CH2C≡CH
204CF2ClHHO—CH2C≡CCH3
205CF2ClHHO—CH(CH3)C≡CH
206CF2ClHHCH2—Ph
207CF2ClHMeCH2—Ph
208CF2ClHHCH2-pyridin-3-yl
209CF2ClHHCH2-6-Cl-pyridin-3-yl
210CF2ClHHCH(CH3)Ph
211CF2ClHHCH2CH2—Ph
212CF2ClHHCH2-2-CF3—Ph
213CF2ClHHCH2CH2CHPh
214CF2ClHmorpholin-4-yl
215CF2ClHpiperidin-1-yl
216CF2ClHthiazolidin-3-yl
217CF2ClHpyrrolidin-1-yl
218CF2ClH2-methylpyrrolidin-1-yl
219CF2ClH═CH—N(CH3)2
220CF2ClH═C(CH3)N(CH3)2
221CF2ClH═CH—N(C2H5)2
222CF2ClH═C(CH3)N(C2H5)2
223CF2ClH═CH-piperidine
224CF2ClH═CH-morpholine
225CF2ClH═CH-pyrrolidine
226CF2ClHHindan-1-yl
227CF2ClHHtetrahydrofuran-2-ylmethyl
228CHF2HHH
229CHF2HHMe
230CHF2HHEt
231CHF2HHPr
232CHF2HHiPr
233CHF2HHcPr
234CHF2HHBu
235CHF2HHcBu
236CHF2HHtBu
237CHF2HMeMe
238CHF2HMeEt
239CHF2HMeBu
240CHF2HMePr
241CHF2HMeiPr
242CHF2HEtEt
243CHF2HEtPr
244CHF2HEtiPr
245CHF2HPrPr
246CHF2HHcPentyl
247CHF2HHcHexyl
248CHF2HHCH2(CH2)3CH3
249CHF2HHCH2(CH2)4CH3
250CHF2HHCH2—cPr
251CHF2HHCH2—CN
252CHF2HHCH2—C(CH3)3
253CHF2HHCH2CF2CF3
254CHF2HHCH2CF3
255CHF2HHCH2(CF2)2CF3
256CHF2HHCH2CH(CH3)CH2CH3
257CHF2HHCH2C(CH3)2CH2F
258CHF2HHCH2CH(CH3)2
259CHF2HHCH2CH(CH2CH3)2
260CHF2HHCH2CH2CH(CH3)2
261CHF2HHCH2CH2C(CH3)3
262CHF2HHCH2CH═CH2
263CHF2HMeCH2CH═CH2
264CHF2HCH2CH═CH2CH2CH═CH2
265CHF2HHCH2CH═CHCH3
266CHF2HHCH2—C(CH3)═CH2
267CHF2HHCH2—C≡CH
268CHF2HMeCH2—C≡CH
269CHF2HHCH(CH3)CH2CH3
270CHF2HHCH(CH3)cPr
271CHF2HHCH(CH3)(CH2)2CH3
272CHF2HHCH(CH3)(CH2)4CH3
273CHF2HHCH(CH3)(CH2)5CH3
274CHF2HHCH(CH2CH3)(CH2)3CH3
275CHF2HHCH(CH3)CH2CH(CH3)2
276CHF2HHCH(CH3)C(CH3)3
277CHF2HHCH(CH3)CH(CH3)2
278CHF2HHCH(CH3)CH2CH2CH(CH3)2
279CHF2HHCH(CH2CH3)2
280CHF2HHC(CH3)2CH2CH3
281CHF2HHC(CH3)2CH2C(CH3)3
282CHF2HHCH2—CH(OMe)2
283CHF2HHCH2—CH(OEt)2
284CHF2HHCH2CH2—OH
285CHF2HHCH2CH2—OMe
286CHF2HHCH2CH2—OEt
287CHF2HHCH2CH2—SMe
288CHF2HHCH2CH2—CN
289CHF2HHCH2CH2—NMe2
290CHF2HHCH2CH2-morpholin-4-yl
291CHF2HHCH(CH3)CH2—OMe
292CHF2HHCH(CH3)CH2—NMe2
293CHF2HHCH2CH2CH2—OMe
294CHF2HHCH2CH2CH2—SMe
295CHF2HHCH2CH2CH2—OEt
296CHF2HHCH2CH2CH2—OiPr
297CHF2HHCH2CH2CH2—OBu
298CHF2HHCH2—COOCH3
299CHF2HMeCH2—COOCH3
300CHF2HHCH(CH3)COOMe
301CHF2HHCH(CH3)COOEt
302CHF2HHCH2CH2—COOCH3
303CHF2HHCH(COOCH3)2
304CHF2HHCH(COOEt)CH2—CH(CH3)2
305CHF2HHCH(COOMe)CH(CH3)2
306CHF2HHO—CH2CH3
307CHF2HHO—CH3
308CHF2HHO—CH2CH═CH2
309CHF2HHO—tBu
310CHF2HHO—Pr
311CHF2HHO—CH2cPr
312CHF2HHO—CH2CH(CH3)2
313CHF2HHO—CH2CF3
314CHF2HHO—CH(CH3)cPr
315CHF2HHO—CH2CH2Cl
316CHF2HHO—CH2C≡CH
317CHF2HHO—CH2C≡CCH3
318CHF2HHO—CH(CH3)C≡CH
319CHF2HHCH2—Ph
320CHF2HMeCH2—Ph
321CHF2HHCH2-pyridin-3-yl
322CHF2HHCH2-6-Cl-pyridin-3-yl
323CHF2HHCH(CH3)Ph
324CHF2HHCH2CH2—Ph
325CHF2HHCH2-2-CF3—Ph
326CHF2HHCH2CH2CHPh
327CHF2Hmorpholin-4-yl
328CHF2Hpiperidin-1-yl
329CHF2Hthiazolidin-3-yl
330CHF2Hpyrrolidin-1-yl
331CHF2H2-methylpyrrolidin-1-yl
332CHF2H═CH—N(CH3)2
333CHF2H═C(CH3)N(CH3)2
334CHF2H═CH—N(C2H5)2
335CHF2H═C(CH3)N(C2H5)2
336CHF2H═CH-piperidine
337CHF2H═CH-morpholine
338CHF2H═CH-pyrrolidine
339CHF2HHindan-1-yl
340CHF2HHtetrahydrofuran-2-ylmethyl
341CF2CF3HHH
342CF2CF3HHMe
343CF2CF3HHEt
344CF2CF3HHPr
345CF2CF3HHiPr
346CF2CF3HHcPr
347CF2CF3HHBu
348CF2CF3HHcBu
349CF2CF3HHtBu
350CF2CF3HMeMe
351CF2CF3HMeEt
352CF2CF3HMeBu
353CF2CF3HMePr
354CF2CF3HMeiPr
355CF2CF3HEtEt
356CF2CF3HEtPr
357CF2CF3HEtiPr
358CF2CF3HPrPr
359CF2CF3HHcPentyl
360CF2CF3HHcHexyl
361CF2CF3HHCH2(CH2)3CH3
362CF2CF3HHCH2(CH2)4CH3
363CF2CF3HHCH2—cPr
364CF2CF3HHCH2—CN
365CF2CF3HHCH2—C(CH3)3
366CF2CF3HHCH2CF2CF3
367CF2CF3HHCH2CF3
368CF2CF3HHCH2(CF2)2CF3
369CF2CF3HHCH2CH(CH3)CH2CH3
370CF2CF3HHCH2C(CH3)2CH2F
371CF2CF3HHCH2CH(CH3)2
372CF2CF3HHCH2CH(CH2CH3)2
373CF2CF3HHCH2CH2CH(CH3)2
374CF2CF3HHCH2CH2C(CH3)3
375CF2CF3HHCH2CH═CH2
376CF2CF3HMeCH2CH═CH2
377CF2CF3HCH2CH═CH2CH2CH═CH2
378CF2CF3HHCH2CH═CHCH3
379CF2CF3HHCH2—C(CH3)═CH2
380CF2CF3HHCH2—C≡CH
381CF2CF3HMeCH2—C≡CH
382CF2CF3HHCH(CH3)CH2CH3
383CF2CF3HHCH(CH3)cPr
384CF2CF3HHCH(CH3)(CH2)2CH3
385CF2CF3HHCH(CH3)(CH2)4CH3
386CF2CF3HHCH(CH3)(CH2)5CH3
387CF2CF3HHCH(CH2CH3)(CH2)3CH3
388CF2CF3HHCH(CH3)CH2CH(CH3)2
389CF2CF3HHCH(CH3)C(CH3)3
390CF2CF3HHCH(CH3)CH(CH3)2
391CF2CF3HHCH(CH3)CH2CH2CH(CH3)2
392CF2CF3HHCH(CH2CH3)2
393CF2CF3HHC(CH3)2CH2CH3
394CF2CF3HHC(CH3)2CH2C(CH3)3
395CF2CF3HHCH2—CH(OMe)2
396CF2CF3HHCH2—CH(OEt)2
397CF2CF3HHCH2CH2—OH
398CF2CF3HHCH2CH2—OMe
399CF2CF3HMeCH2CH2—OMe
400CF2CF3HHCH2CH2—OEt
401CF2CF3HHCH2CH2—SMe
402CF2CF3HHCH2CH2—CN
403CF2CF3HHCH2CH2—NMe2
404CF2CF3HHCH2CH2-morpholin-4-yl
405CF2CF3HHCH(CH3)CH2—OMe
406CF2CF3HHCH(CH3)CH2—NMe2
407CF2CF3HHCH2CH2CH2—OMe
408CF2CF3HHCH2CH2CH2—SMe
409CF2CF3HHCH2CH2CH2—OEt
410CF2CF3HHCH2CH2CH2—OiPr
411CF2CF3HHCH2CH2CH2—OBu
412CF2CF3HHCH2—COOCH3
413CF2CF3HMeCH2—COOCH3
414CF2CF3HHCH(CH3)COOMe
415CF2CF3HHCH(CH3)COOEt
416CF2CF3HHCH2CH2—COOCH3
417CF2CF3HHCH(COOCH3)2
418CF2CF3HHCH(COOEt)CH2—CH(CH3)2
419CF2CF3HHCH(COOMe)CH(CH3)2
420CF2CF3HHO—CH2CH3
421CF2CF3HHO—CH3
422CF2CF3HHO—CH2CH═CH2
423CF2CF3HHO—tBu
424CF2CF3HHO—Pr
425CF2CF3HHO—CH2cPr
426CF2CF3HHO—CH2CH(CH3)2
427CF2CF3HHO—CH2CF3
428CF2CF3HHO—CH(CH3)cPr
429CF2CF3HHO—CH2CH2Cl
430CF2CF3HHO—CH2C≡CH
431CF2CF3HHO—CH2C≡CCH3
432CF2CF3HHO—CH(CH3)C≡CH
433CF2CF3HHCH2—Ph
434CF2CF3HMeCH2—Ph
435CF2CF3HHCH2-pyridin-3-yl
436CF2CF3HHCH2-6-Cl-pyridin-3-yl
437CF2CF3HHCH(CH3)Ph
438CF2CF3HHCH2CH2—Ph
439CF2CF3HHCH2-2-CF3—Ph
440CF2CF3HHCH2CH2CHPh
441CF2CF3Hmorpholin-4-yl
442CF2CF3Hpiperidin-1-yl
443CF2CF3Hthiazolidin-3-yl
444CF2CF3Hpyrrolidin-1-yl
445CF2CF3H2-methylpyrrolidin-1-yl
446CF2CF3H═CH—N(CH3)2
447CF2CF3H═C(CH3)N(CH3)2
448CF2CF3H═CH—N(C2H5)2
449CF2CF3H═C(CH3)N(C2H5)2
450CF2CF3H═CH-piperidine
451CF2CF3H═CH-morpholine
452CF2CF3H═CH-pyrrolidine
453CF2CF3HHindan-1-yl
454CF2CF3HHtetrahydrofuran-2-ylmethyl
455CF3ClHH
456CF3ClHMe
457CF3ClHEt
458CF3ClHPr
459CF3ClHiPr
460CF3ClHcPr
461CF3ClHBu
462CF3ClHcBu
463CF3ClHtBu
464CF3ClMeMe
465CF3ClMeEt
466CF3ClMeBu
467CF3ClMePr
468CF3ClMeiPr
469CF3ClEtEt
470CF3ClEtPr
471CF3ClEtiPr
472CF3ClPrPr
473CF3ClHcPentyl
474CF3ClHcHexyl
475CF3ClHCH2(CH2)3CH3
476CF3ClHCH2(CH2)4CH3
477CF3ClHCH2—cPr
478CF3ClHCH2—CN
479CF3ClHCH2—C(CH3)3
480CF3ClHCH2CF2CF3
481CF3ClHCH2CF3
482CF3ClHCH2(CF2)2CF3
483CF3ClHCH2CH(CH3)CH2CH3
484CF3ClHCH2C(CH3)2CH2F
485CF3ClHCH2CH(CH3)2
486CF3ClHCH2CH(CH2CH3)2
487CF3ClHCH2CH2CH(CH3)2
488CF3ClHCH2CH2C(CH3)3
489CF3ClHCH2CH═CH2
490CF3ClMeCH2CH═CH2
491CF3ClCH2CH═CH2CH2CH═CH2
492CF3ClHCH2CH═CHCH3
493CF3ClHCH2—C(CH3)═CH2
494CF3ClHCH2—C≡CH
495CF3ClMeCH2—C≡CH
496CF3ClHCH(CH3)CH2CH3
497CF3ClHCH(CH3)cPr
498CF3ClHCH(CH3)(CH2)2CH3
499CF3ClHCH(CH3)(CH2)4CH3
500CF3ClHCH(CH3)(CH2)5CH3
501CF3ClHCH(CH2CH3)(CH2)3CH3
502CF3ClHCH(CH3)CH2CH(CH3)2
503CF3ClHCH(CH3)C(CH3)3
504CF3ClHCH(CH3)CH(CH3)2
505CF3ClHCH(CH3)CH2CH2CH(CH3)2
506CF3ClHCH(CH2CH3)2
507CF3ClHC(CH3)2CH2CH3
508CF3ClHC(CH3)2CH2C(CH3)3
509CF3ClHCH2—CH(OMe)2
510CF3ClHCH2—CH(OEt)2
511CF3ClHCH2CH2—OH
512CF3ClHCH2CH2—OMe
513CF3ClMeCH2CH2—OMe
514CF3ClHCH2CH2—OEt
515CF3ClHCH2CH2—SMe
516CF3ClHCH2CH2—CN
517CF3ClHCH2CH2—NMe2
518CF3ClHCH2CH2-morpholin-4-yl
519CF3ClHCH(CH3)CH2—OMe
520CF3ClHCH(CH3)CH2—NMe2
521CF3ClHCH2CH2CH2—OMe
522CF3ClHCH2CH2CH2—SMe
523CF3ClHCH2CH2CH2—OEt
524CF3ClHCH2CH2CH2—OiPr
525CF3ClHCH2CH2CH2—OBu
526CF3ClHCH2—COOCH3
527CF3ClMeCH2—COOCH3
528CF3ClHCH(CH3)COOMe
529CF3ClHCH(CH3)COOEt
530CF3ClHCH2CH2—COOCH3
531CF3ClHCH(COOCH3)2
532CF3ClHCH(COOEt)CH2—CH(CH3)2
533CF3ClHCH(COOMe)CH(CH3)2
534CF3ClHO—CH2CH3
535CF3ClMeO—CH3
536CF3ClHO—CH2CH═CH2
537CF3ClHO—tBu
538CF3ClHO—Pr
539CF3ClHO—CH2cPr
540CF3ClHO—CH2CH(CH3)2
541CF3ClHO—CH2CF3
542CF3ClHO—CH(CH3)cPr
543CF3ClHO—CH2CH2Cl
544CF3ClHO—CH2C≡CH
545CF3ClHO—CH2C≡CCH3
546CF3ClHO—CH(CH3)C≡CH
547CF3ClHCH2—Ph
548CF3ClMeCH2—Ph
549CF3ClHCH2-pyridin-3-yl
550CF3ClHCH2-6-Cl-pyridin-3-yl
551CF3ClHCH(CH3)Ph
552CF3ClHCH2CH2—Ph
553CF3ClHCH2-2-CF3—Ph
554CF3ClHCH2CH2CHPh
555CF3Clmorpholin-4-yl
556CF3Clpiperidin-1-yl
557CF3Clthiazolidin-3-yl
558CF3Clpyrrolidin-1-yl
559CF3Cl2-methylpyrrolidin-1-yl
560CF3Cl═CH—N(CH3)2
561CF3Cl═C(CH3)N(CH3)2
562CF3Cl═CH—N(C2H5)2
563CF3Cl═C(CH3)N(C2H5)2
564CF3Cl═CH-piperidine
565CF3Cl═CH-morpholine
566CF3Cl═CH-pyrrolidine
567CF3ClHindan-1-yl
568CF3ClHtetrahydrofuran-2-ylmethyl
569CF2ClClHH
570CF2ClClHMe
571CF2ClClHEt
572CF2ClClHPr
573CF2ClClHiPr
574CF2ClClHcPr
575CF2ClClHBu
576CF2ClClHcBu
577CF2ClClHtBu
578CF2ClClMeMe
579CF2ClClMeEt
580CF2ClClMeBu
581CF2ClClMePr
582CF2ClClMeiPr
583CF2ClClEtEt
584CF2ClClEtPr
585CF2ClClEtiPr
586CF2ClClPrPr
587CF2ClClHcPentyl
588CF2ClClHcHexyl
589CF2ClClHCH2(CH2)3CH3
590CF2ClClHCH2(CH2)4CH3
591CF2ClClHCH2—cPr
592CF2ClClHCH2—CN
593CF2ClClHCH2—C(CH3)3
594CF2ClClHCH2CF2CF3
595CF2ClClHCH2CF3
596CF2ClClHCH2(CF2)2CF3
597CF2ClClHCH2CH(CH3)CH2CH3
598CF2ClClHCH2C(CH3)2CH2F
599CF2ClClHCH2CH(CH3)2
600CF2ClClHCH2CH(CH2CH3)2
601CF2ClClHCH2CH2CH(CH3)2
602CF2ClClHCH2CH2C(CH3)3
603CF2ClClHCH2CH═CH2
604CF2ClClMeCH2CH═CH2
605CF2ClClCH2CH═CH2CH2CH═CH2
606CF2ClClHCH2CH═CHCH3
607CF2ClClHCH2—C(CH3)═CH2
608CF2ClClHCH2—C≡CH
609CF2ClClMeCH2—C≡CH
610CF2ClClHCH(CH3)CH2CH3
611CF2ClClHCH(CH3)cPr
612CF2ClClHCH(CH3)(CH2)2CH3
613CF2ClClHCH(CH3)(CH2)4CH3
614CF2ClClHCH(CH3)(CH2)5CH3
615CF2ClClHCH(CH2CH3)(CH2)3CH3
616CF2ClClHCH(CH3)CH2CH(CH3)2
617CF2ClClHCH(CH3)C(CH3)3
618CF2ClClHCH(CH3)CH(CH3)2
619CF2ClClHCH(CH3)CH2CH2CH(CH3)2
620CF2ClClHCH(CH2CH3)2
621CF2ClClHC(CH3)2CH2CH3
622CF2ClClHC(CH3)2CH2C(CH3)3
623CF2ClClHCH2—CH(OMe)2
624CF2ClClHCH2—CH(OEt)2
625CF2ClClHCH2CH2—OH
626CF2ClClHCH2CH2—OMe
627CF2ClClMeCH2CH2—OMe
628CF2ClClHCH2CH2—OEt
629CF2ClClHCH2CH2—SMe
630CF2ClClHCH2CH2—CN
631CF2ClClHCH2CH2—NMe2
632CF2ClClHCH2CH2-morpholin-4-yl
633CF2ClClHCH(CH3)CH2—OMe
634CF2ClClHCH(CH3)CH2—NMe2
635CF2ClClHCH2CH2CH2—OMe
636CF2ClClHCH2CH2CH2—SMe
637CF2ClClHCH2CH2CH2—OEt
638CF2ClClHCH2CH2CH2—OiPr
639CF2ClClHCH2CH2CH2—OBu
640CF2ClClHCH2—COOCH3
641CF2ClClMeCH2—COOCH3
642CF2ClClHCH(CH3)COOMe
643CF2ClClHCH(CH3)COOEt
644CF2ClClHCH2CH2—COOCH3
645CF2ClClHCH(COOCH3)2
646CF2ClClHCH(COOEt)CH2—CH(CH3)2
647CF2ClClHCH(COOMe)CH(CH3)2
648CF2ClClHO—CH2CH3
649CF2ClClHO—CH3
650CF2ClClHO—CH2CH═CH2
651CF2ClClHO—tBu
652CF2ClClHO—Pr
653CF2ClClHO—CH2cPr
654CF2ClClHO—CH2CH(CH3)2
655CF2ClClHO—CH2CF3
656CF2ClClHO—CH(CH3)cPr
657CF2ClClHO—CH2CH2Cl
658CF2ClClHO—CH2C≡CH
659CF2ClClHO—CH2C≡CCH3
660CF2ClClHO—CH(CH3)C≡CH
661CF2ClClHCH2—Ph
662CF2ClClMeCH2—Ph
663CF2ClClHCH2-pyridin-3-yl
664CF2ClClHCH2-6-Cl-pyridin-3-yl
665CF2ClClHCH(CH3)Ph
666CF2ClClHCH2CH2—Ph
667CF2ClClHCH2-2-CF3—Ph
668CF2ClClHCH2CH2CHPh
669CF2ClClmorpholin-4-yl
670CF2ClClpiperidin-1-yl
671CF2ClClthiazolidin-3-yl
672CF2ClClpyrrolidin-1-yl
673CF2ClCl2-methylpyrrolidin-1-yl
674CF2ClCl═CH—N(CH3)2
675CF2ClCl═C(CH3)N(CH3)2
676CF2ClCl═CH—N(C2H5)2
677CF2ClCl═C(CH3)N(C2H5)2
678CF2ClCl═CH-piperidine
679CF2ClCl═CH-morpholine
680CF2ClCl═CH-pyrrolidine
681CF2ClClHindan-1-yl
682CF2ClClHtetrahydrofuran-2-ylmethyl
683CHF2ClHH
684CHF2ClHMe
685CHF2ClHEt
686CHF2ClHPr
687CHF2ClHiPr
688CHF2ClHcPr
689CHF2ClHBu
690CHF2ClHcBu
691CHF2ClHtBu
692CHF2ClMeMe
693CHF2ClMeEt
694CHF2ClMeBu
695CHF2ClMePr
696CHF2ClMeiPr
697CHF2ClEtEt
698CHF2ClEtPr
699CHF2ClEtiPr
700CHF2ClPrPr
701CHF2ClHcPentyl
702CHF2ClHcHexyl
703CHF2ClHCH2(CH2)3CH3
704CHF2ClHCH2(CH2)4CH3
705CHF2ClHCH2—cPr
706CHF2ClHCH2—CN
707CHF2ClHCH2—C(CH3)3
708CHF2ClHCH2CF2CF3
709CHF2ClHCH2CF3
710CHF2ClHCH2(CF2)2CF3
711CHF2ClHCH2CH(CH3)CH2CH3
712CHF2ClHCH2C(CH3)2CH2F
713CHF2ClHCH2CH(CH3)2
714CHF2ClHCH2CH(CH2CH3)2
715CHF2ClHCH2CH2CH(CH3)2
716CHF2ClHCH2CH2C(CH3)3
717CHF2ClHCH2CH═CH2
718CHF2ClMeCH2CH═CH2
719CHF2ClCH2CH═CH2CH2CH═CH2
720CHF2ClHCH2CH═CHCH3
721CHF2ClHCH2—C(CH3)═CH2
722CHF2ClHCH2—C≡CH
723CHF2ClMeCH2—C≡CH
724CHF2ClHCH(CH3)CH2CH3
725CHF2ClHCH(CH3)cPr
726CHF2ClHCH(CH3)(CH2)2CH3
727CHF2ClHCH(CH3)(CH2)4CH3
728CHF2ClHCH(CH3)(CH2)5CH3
729CHF2ClHCH(CH2CH3)(CH2)3CH3
730CHF2ClHCH(CH3)CH2CH(CH3)2
731CHF2ClHCH(CH3)C(CH3)3
732CHF2ClHCH(CH3)CH(CH3)2
733CHF2ClHCH(CH3)CH2CH2CH(CH3)2
734CHF2ClHCH(CH2CH3)2
735CHF2ClHC(CH3)2CH2CH3
736CHF2ClHC(CH3)2CH2C(CH3)3
737CHF2ClHCH2—CH(OMe)2
738CHF2ClHCH2—CH(OEt)2
739CHF2ClHCH2CH2—OH
740CHF2ClHCH2CH2—OMe
741CHF2ClMeCH2CH2—OMe
742CHF2ClHCH2CH2—OEt
743CHF2ClHCH2CH2—SMe
744CHF2ClHCH2CH2—CN
745CHF2ClHCH2CH2—NMe2
746CHF2ClHCH2CH2-morpholin-4-yl
747CHF2ClHCH(CH3)CH2—OMe
748CHF2ClHCH(CH3)CH2—NMe2
749CHF2ClHCH2CH2CH2—OMe
750CHF2ClHCH2CH2CH2—SMe
751CHF2ClHCH2CH2CH2—OEt
752CHF2ClHCH2CH2CH2—OiPr
753CHF2ClHCH2CH2CH2—OBu
754CHF2ClHCH2—COOCH3
755CHF2ClMeCH2—COOCH3
756CHF2ClHCH(CH3)COOMe
757CHF2ClHCH(CH3)COOEt
758CHF2ClHCH2CH2—COOCH3
759CHF2ClHCH(COOCH3)2
760CHF2ClHCH(COOEt)CH2—CH(CH3)2
761CHF2ClHCH(COOMe)CH(CH3)2
762CHF2ClHO—CH2CH3
763CHF2ClHO—CH3
764CHF2ClHO—CH2CH═CH2
765CHF2ClHO—tBu
766CHF2ClHO—Pr
767CHF2ClHO—CH2cPr
768CHF2ClHO—CH2CH(CH3)2
769CHF2ClHO—CH2CF3
770CHF2ClHO—CH(CH3)cPr
771CHF2ClHO—CH2CH2Cl
772CHF2ClHO—CH2C≡CH
773CHF2ClHO—CH2C≡CCH3
774CHF2ClHO—CH(CH3)C≡CH
775CHF2ClHCH2—Ph
776CHF2ClMeCH2—Ph
777CHF2ClHCH2-pyridin-3-yl
778CHF2ClHCH2-6-Cl-pyridin-3-yl
779CHF2ClHCH(CH3)Ph
780CHF2ClHCH2CH2—Ph
781CHF2ClHCH2-2-CF3—Ph
782CHF2ClHCH2CH2CHPh
783CHF2Clmorpholin-4-yl
784CHF2Clpiperidin-1-yl
785CHF2Clthiazolidin-3-yl
786CHF2Clpyrrolidin-1-yl
787CHF2Cl2-methylpyrrolidin-1-yl
788CHF2Cl═CH—N(CH3)2
789CHF2Cl═C(CH3)N(CH3)2
790CHF2Cl═CH—N(C2H5)2
791CHF2Cl═C(CH3)N(C2H5)2
792CHF2Cl═CH-piperidine
793CHF2Cl═CH-morpholine
794CHF2Cl═CH-pyrrolidine
795CHF2ClHindan-1-yl
796CHF2ClHtetrahydrofuran-2-ylmethyl
797CF2CF3ClHH
798CF2CF3ClHMe
799CF2CF3ClHEt
800CF2CF3ClHPr
801CF2CF3ClHiPr
802CF2CF3ClHcPr
803CF2CF3ClHBu
804CF2CF3ClHcBu
805CF2CF3ClHtBu
806CF2CF3ClMeMe
807CF2CF3ClMeEt
808CF2CF3ClMeBu
809CF2CF3ClMePr
810CF2CF3ClMeiPr
811CF2CF3ClEtEt
812CF2CF3ClEtPr
813CF2CF3ClEtiPr
814CF2CF3ClPrPr
815CF2CF3ClHcPentyl
816CF2CF3ClHcHexyl
817CF2CF3ClHCH2(CH2)3CH3
818CF2CF3ClHCH2(CH2)4CH3
819CF2CF3ClHCH2—cPr
820CF2CF3ClHCH2—CN
821CF2CF3ClHCH2—C(CH3)3
822CF2CF3ClHCH2CF2CF3
823CF2CF3ClHCH2CF3
824CF2CF3ClHCH2(CF2)2CF3
825CF2CF3ClHCH2CH(CH3)CH2CH3
826CF2CF3ClHCH2C(CH3)2CH2F
827CF2CF3ClHCH2CH(CH3)2
828CF2CF3ClHCH2CH(CH2CH3)2
829CF2CF3ClHCH2CH2CH(CH3)2
830CF2CF3ClHCH2CH2C(CH3)3
831CF2CF3ClHCH2CH═CH2
832CF2CF3ClMeCH2CH═CH2
833CF2CF3ClCH2CH═CH2CH2CH═CH2
834CF2CF3ClHCH2CH═CHCH3
835CF2CF3ClHCH2—C(CH3)═CH2
836CF2CF3ClHCH2—C≡CH
837CF2CF3ClMeCH2—C≡CH
838CF2CF3ClHCH(CH3)CH2CH3
839CF2CF3ClHCH(CH3)cPr
840CF2CF3ClHCH(CH3)(CH2)2CH3
841CF2CF3ClHCH(CH3)(CH2)4CH3
842CF2CF3ClHCH(CH3)(CH2)5CH3
843CF2CF3ClHCH(CH2CH3)(CH2)3CH3
844CF2CF3ClHCH(CH3)CH2CH(CH3)2
845CF2CF3ClHCH(CH3)C(CH3)3
846CF2CF3ClHCH(CH3)CH(CH3)2
847CF2CF3ClHCH(CH3)CH2CH2CH(CH3)2
848CF2CF3ClHCH(CH2CH3)2
849CF2CF3ClHC(CH3)2CH2CH3
850CF2CF3ClHC(CH3)2CH2C(CH3)3
851CF2CF3ClHCH2—CH(OMe)2
852CF2CF3ClHCH2—CH(OEt)2
853CF2CF3ClHCH2CH2—OH
854CF2CF3ClHCH2CH2—OMe
855CF2CF3ClMeCH2CH2—OMe
856CF2CF3ClHCH2CH2—OEt
857CF2CF3ClHCH2CH2—SMe
858CF2CF3ClHCH2CH2—CN
859CF2CF3ClHCH2CH2—NMe2
860CF2CF3ClHCH2CH2-morpholin-4-yl
861CF2CF3ClHCH(CH3)CH2—OMe
862CF2CF3ClHCH(CH3)CH2—NMe2
863CF2CF3ClHCH2CH2CH2—OMe
864CF2CF3ClHCH2CH2CH2—SMe
865CF2CF3ClHCH2CH2CH2—OEt
866CF2CF3ClHCH2CH2CH2—OiPr
867CF2CF3ClHCH2CH2CH2—OBu
868CF2CF3ClHCH2—COOCH3
869CF2CF3ClMeCH2—COOCH3
870CF2CF3ClHCH2CH2—COOCH3
871CF2CF3ClHCH(COOCH3)2
872CF2CF3ClHCH(COOEt)CH2—CH(CH3)2
873CF2CF3ClHCH(COOMe)CH(CH3)2
874CF2CF3ClHO—CH2CH3
875CF2CF3ClHO—CH3
876CF2CF3ClHO—CH2CH═CH2
877CF2CF3ClHO—tBu
878CF2CF3ClHO—Pr
879CF2CF3ClHO—CH2cPr
880CF2CF3ClHO—CH2CH(CH3)2
881CF2CF3ClHO—CH2CF3
882CF2CF3ClHO—CH(CH3)cPr
883CF2CF3ClHO—CH2CH2Cl
884CF2CF3ClHO—CH2C≡CH
885CF2CF3ClHO—CH2C≡CCH3
886CF2CF3ClHO—CH(CH3)C≡CH
887CF2CF3ClHCH2—Ph
888CF2CF3ClMeCH2—Ph
889CF2CF3ClHCH2-pyridin-3-yl
890CF2CF3ClHCH2-6-Cl-pyridin-3-yl
891CF2CF3ClHCH(CH3)Ph
892CF2CF3ClHCH2CH2—Ph
893CF2CF3ClHCH2-2-CF3—Ph
894CF2CF3ClHCH2CH2CHPh
895CF2CF3Clmorpholin-4-yl
896CF2CF3Clpiperidin-1-yl
897CF2CF3Clthiazolidin-3-yl
898CF2CF3Clpyrrolidin-1-yl
899CF2CF3Cl2-methylpyrrolidin-1-yl
900CF2CF3Cl═CH—N(CH3)2
901CF2CF3Cl═C(CH3)N(CH3)2
902CF2CF3Cl═CH—N(C2H5)2
903CF2CF3Cl═C(CH3)N(C2H5)2
904CF2CF3Cl═CH-piperidine
905CF2CF3Cl═CH-morpholine
906CF2CF3Cl═CH-pyrrolidine
907CF2CF3ClHindan-1-yl
908CF2CF3ClHtetrahydrofuran-2-ylmethyl
909CF3BrHH
910CF3BrHMe
911CF3BrHEt
912CF3BrHPr
913CF3BrHiPr
914CF3BrHcPr
915CF3BrHBu
916CF3BrHcBu
917CF3BrHtBu
918CF3BrMeMe
919CF3BrMeEt
920CF3BrMeBu
921CF3BrMePr
922CF3BrMeiPr
923CF3BrEtEt
924CF3BrEtPr
925CF3BrEtiPr
926CF3BrPrPr
927CF3BrHcPentyl
928CF3BrHcHexyl
929CF3BrHCH2(CH2)3CH3
930CF3BrHCH2(CH2)4CH3
931CF3BrHCH2—cPr
932CF3BrHCH2—CN
933CF3BrHCH2—C(CH3)3
934CF3BrHCH2CF2CF3
935CF3BrHCH2CF3
936CF3BrHCH2(CF2)2CF3
937CF3BrHCH2CH(CH3)CH2CH3
938CF3BrHCH2C(CH3)2CH2F
939CF3BrHCH2CH(CH3)2
940CF3BrHCH2CH(CH2CH3)2
941CF3BrHCH2CH2CH(CH3)2
942CF3BrHCH2CH2C(CH3)3
943CF3BrHCH2CH═CH2
944CF3BrMeCH2CH═CH2
945CF3BrCH2CH═CH2CH2CH═CH2
946CF3BrHCH2CH═CHCH3
947CF3BrHCH2—C(CH3)═CH2
948CF3BrHCH2—C≡CH
949CF3BrMeCH2—C≡CH
950CF3BrHCH(CH3)CH2CH3
951CF3BrHCH(CH3)cPr
952CF3BrHCH(CH3)(CH2)2CH3
953CF3BrHCH(CH3)(CH2)4CH3
954CF3BrHCH(CH3)(CH2)5CH3
955CF3BrHCH(CH2CH3)(CH2)3CH3
956CF3BrHCH(CH3)CH2CH(CH3)2
957CF3BrHCH(CH3)C(CH3)3
958CF3BrHCH(CH3)CH(CH3)2
959CF3BrHCH(CH3)CH2CH2CH(CH3)2
960CF3BrHCH(CH2CH3)2
961CF3BrHC(CH3)2CH2CH3
962CF3BrHC(CH3)2CH2C(CH3)3
963CF3BrHCH2—CH(OMe)2
964CF3BrHCH2—CH(OEt)2
965CF3BrHCH2CH2—OH
966CF3BrHCH2CH2—OMe
967CF3BrMeCH2CH2—OMe
968CF3BrHCH2CH2—OEt
969CF3BrHCH2CH2—SMe
970CF3BrHCH2CH2—CN
971CF3BrHCH2CH2—NMe2
972CF3BrHCH2CH2-morpholin-4-yl
973CF3BrHCH(CH3)CH2—OMe
974CF3BrHCH(CH3)CH2—NMe2
975CF3BrHCH2CH2CH2—OMe
976CF3BrHCH2CH2CH2—SMe
977CF3BrHCH2CH2CH2—OEt
978CF3BrHCH2CH2CH2—OiPr
979CF3BrHCH2CH2CH2—OBu
980CF3BrHCH2—COOCH3
981CF3BrMeCH2—COOCH3
982CF3BrHCH(CH3)COOMe
983CF3BrHCH(CH3)COOEt
984CF3BrHCH2CH2—COOCH3
985CF3BrHCH(COOCH3)2
986CF3BrHCH(COOEt)CH2—CH(CH3)2
987CF3BrHCH(COOMe)CH(CH3)2
988CF3BrHO—CH2CH3
989CF3BrMeO—CH3
990CF3BrHO—CH2CH═CH2
991CF3BrHO—tBu
992CF3BrHO—Pr
993CF3BrHO—CH2cPr
994CF3BrHO—CH2CH(CH3)2
995CF3BrHO—CH2CF3
996CF3BrHO—CH(CH3)cPr
997CF3BrHO—CH2CH2Cl
998CF3BrHO—CH2C≡CH
999CF3BrHO—CH2C≡CCH3
1000CF3BrHO—CH(CH3)C≡CH
1001CF3BrHCH2—Ph
1002CF3BrMeCH2—Ph
1003CF3BrHCH2-pyridin-3-yl
1004CF3BrHCH2-6-Cl-pyridin-3-yl
1005CF3BrHCH(CH3)Ph
1006CF3BrHCH2CH2—Ph
1007CF3BrHCH2-2-CF3—Ph
1008CF3BrHCH2CH2CHPh2
1009CF3Brmorpholin-4-yl
1010CF3Brpiperidin-1-yl
1011CF3Brthiazolidin-3-yl
1012CF3Brpyrrolidin-1-yl
1013CF3Br2-methylpyrrolidin-1-yl
1014CF3Br═CH—N(CH3)2
1015CF3Br═C(CH3)N(CH3)2
1016CF3Br═CH—N(C2H5)2
1017CF3Br═C(CH3)N(C2H5)2
1018CF3Br═CH-piperidine
1019CF3Br═CH-morpholine
1020CF3Br═CH-pyrrolidine
1021CF3BrHindan-1-yl
1022CF3BrHtetrahydrofuran-2-ylmethyl
1023CF2ClBrHH
1024CF2ClBrHMe
1025CF2ClBrHEt
1026CF2ClBrHPr
1027CF2ClBrHiPr
1028CF2ClBrHcPr
1029CF2ClBrHBu
1030CF2ClBrHcBu
1031CF2ClBrHtBu
1032CF2ClBrMeMe
1033CF2ClBrMeEt
1034CF2ClBrMeBu
1035CF2ClBrMePr
1036CF2ClBrMeiPr
1037CF2ClBrEtEt
1038CF2ClBrEtPr
1039CF2ClBrEtiPr
1040CF2ClBrPrPr
1041CF2ClBrHcPentyl
1042CF2ClBrHcHexyl
1043CF2ClBrHCH2(CH2)3CH3
1044CF2ClBrHCH2(CH2)4CH3
1045CF2ClBrHCH2—cPr
1046CF2ClBrHCH2—CN
1047CF2ClBrHCH2—C(CH3)3
1048CF2ClBrHCH2CF2CF3
1049CF2ClBrHCH2CF3
1050CF2ClBrHCH2(CF2)2CF3
1051CF2ClBrHCH2CH(CH3)CH2CH3
1052CF2ClBrHCH2C(CH3)2CH2F
1053CF2ClBrHCH2CH(CH3)2
1054CF2ClBrHCH2CH(CH2CH3)2
1055CF2ClBrHCH2CH2CH(CH3)2
1056CF2ClBrHCH2CH2C(CH3)3
1057CF2ClBrHCH2CH═CH2
1058CF2ClBrMeCH2CH═CH2
1059CF2ClBrCH2CH═CH2CH2CH═CH2
1060CF2ClBrHCH2CH═CHCH3
1061CF2ClBrHCH2—C(CH3)═CH2
1062CF2ClBrHCH2—C≡CH
1063CF2ClBrMeCH2—C≡CH
1064CF2ClBrHCH(CH3)CH2CH3
1065CF2ClBrHCH(CH3)cPr
1066CF2ClBrHCH(CH3)(CH2)2CH3
1067CF2ClBrHCH(CH3)(CH2)4CH3
1068CF2ClBrHCH(CH3)(CH2)5CH3
1069CF2ClBrHCH(CH2CH3)(CH2)3CH3
1070CF2ClBrHCH(CH3)CH2CH(CH3)2
1071CF2ClBrHCH(CH3)C(CH3)3
1072CF2ClBrHCH(CH3)CH(CH3)2
1073CF2ClBrHCH(CH3)CH2CH2CH(CH3)2
1074CF2ClBrHCH(CH2CH3)2
1075CF2ClBrHC(CH3)2CH2CH3
1076CF2ClBrHC(CH3)2CH2C(CH3)3
1077CF2ClBrHCH2—CH(OMe)2
1078CF2ClBrHCH2—CH(OEt)2
1079CF2ClBrHCH2CH2—OH
1080CF2ClBrHCH2CH2—OMe
1081CF2ClBrMeCH2CH2—OMe
1082CF2ClBrHCH2CH2—OEt
1083CF2ClBrHCH2CH2—SMe
1084CF2ClBrHCH2CH2—CN
1085CF2ClBrHCH2CH2—NMe2
1086CF2ClBrHCH2CH2-morpholin-4-yl
1087CF2ClBrHCH(CH3)CH2—OMe
1088CF2ClBrHCH(CH3)CH2—NMe2
1089CF2ClBrHCH2CH2CH2—OMe
1090CF2ClBrHCH2CH2CH2—SMe
1091CF2ClBrHCH2CH2CH2—OEt
1092CF2ClBrHCH2CH2CH2—OiPr
1093CF2ClBrHCH2CH2CH2—OBu
1094CF2ClBrHCH2—COOCH3
1095CF2ClBrMeCH2—COOCH3
1096CF2ClBrHCH(CH3)COOMe
1097CF2ClBrHCH(CH3)COOEt
1098CF2ClBrHCH2CH2—COOCH3
1099CF2ClBrHCH(COOCH3)2
1100CF2ClBrHCH(COOEt)CH2—CH(CH3)2
1101CF2ClBrHCH(COOMe)CH(CH3)2
1102CF2ClBrHO—CH2CH3
1103CF2ClBrMeO—CH3
1104CF2ClBrHO—CH2CH═CH2
1105CF2ClBrHO—tBu
1106CF2ClBrHO—Pr
1107CF2ClBrHO—CH2cPr
1108CF2ClBrHO—CH2CH(CH3)2
1109CF2ClBrHO—CH2CF3
1110CF2ClBrHO—CH(CH3)cPr
1111CF2ClBrHO—CH2CH2Cl
1112CF2ClBrHO—CH2C≡CH
1113CF2ClBrHO—CH2C≡CCH3
1114CF2ClBrHO—CH(CH3)C≡CH
1115CF2ClBrHCH2—Ph
1116CF2ClBrMeCH2—Ph
1117CF2ClBrHCH2-pyridin-3-yl
1118CF2ClBrHCH2-6-Cl-pyridin-3-yl
1119CF2ClBrHCH(CH3)Ph
1120CF2ClBrHCH2CH2—Ph
1121CF2ClBrHCH2-2-CF3—Ph
1122CF2ClBrHCH2CH2CHPh2
1123CF2ClBrmorpholin-4-yl
1124CF2ClBrpiperidin-1-yl
1125CF2ClBrthiazolidin-3-yl
1126CF2ClBrpyrrolidin-1-yl
1127CF2ClBr2-methylpyrrolidin-1-yl
1128CF2ClBr═CH—N(CH3)2
1129CF2ClBr═C(CH3)N(CH3)2
1130CF2ClBr═CH—N(C2H5)2
1131CF2ClBr═C(CH3)N(C2H5)2
1132CF2ClBr═CH-piperidine
1133CF2ClBr═CH-morpholine
1134CF2ClBr═CH-pyrrolidine
1135CF2ClBrHindan-1-yl
1136CF2ClBrHtetrahydrofuran-2-ylmethyl
1137CHF2BrHH
1138CHF2BrHMe
1139CHF2BrHEt
1140CHF2BrHPr
1141CHF2BrHiPr
1142CHF2BrHcPr
1143CHF2BrHBu
1144CHF2BrHcBu
1145CHF2BrHtBu
1146CHF2BrMeMe
1147CHF2BrMeEt
1148CHF2BrMeBu
1149CHF2BrMePr
1150CHF2BrMeiPr
1151CHF2BrEtEt
1152CHF2BrEtPr
1153CHF2BrEtiPr
1154CHF2BrPrPr
1155CHF2BrHcPentyl
1156CHF2BrHcHexyl
1157CHF2BrHCH2(CH2)3CH3
1158CHF2BrHCH2(CH2)4CH3
1159CHF2BrHCH2—cPr
1160CHF2BrHCH2—CN
1161CHF2BrHCH2—C(CH3)3
1162CHF2BrHCH2CF2CF3
1163CHF2BrHCH2CF3
1164CHF2BrHCH2(CF2)2CF3
1165CHF2BrHCH2CH(CH3)CH2CH3
1166CHF2BrHCH2C(CH3)2CH2F
1167CHF2BrHCH2CH(CH3)2
1168CHF2BrHCH2CH(CH2CH3)2
1169CHF2BrHCH2CH2CH(CH3)2
1170CHF2BrHCH2CH2C(CH3)3
1171CHF2BrHCH2CH═CH2
1172CHF2BrMeCH2CH═CH2
1173CHF2BrCH2CH═CH2CH2CH═CH2
1174CHF2BrHCH2CH═CHCH3
1175CHF2BrHCH2—C(CH3)═CH2
1176CHF2BrHCH2—C≡CH
1177CHF2BrMeCH2—C≡CH
1178CHF2BrHCH(CH3)CH2CH3
1179CHF2BrHCH(CH3)cPr
1180CHF2BrHCH(CH3)(CH2)2CH3
1181CHF2BrHCH(CH3)(CH2)4CH3
1182CHF2BrHCH(CH3)(CH2)5CH3
1183CHF2BrHCH(CH2CH3)(CH2)3CH3
1184CHF2BrHCH(CH3)CH2CH(CH3)2
1185CHF2BrHCH(CH3)C(CH3)3
1186CHF2BrHCH(CH3)CH(CH3)2
1187CHF2BrHCH(CH3)CH2CH2CH(CH3)2
1188CHF2BrHCH(CH2CH3)2
1189CHF2BrHC(CH3)2CH2CH3
1190CHF2BrHC(CH3)2CH2C(CH3)3
1191CHF2BrHCH2—CH(OMe)2
1192CHF2BrHCH2—CH(OEt)2
1193CHF2BrHCH2CH2—OH
1194CHF2BrHCH2CH2—OMe
1195CHF2BrMeCH2CH2—OMe
1196CHF2BrHCH2CH2—OEt
1197CHF2BrHCH2CH2—SMe
1198CHF2BrHCH2CH2—CN
1199CHF2BrHCH2CH2—NMe2
1200CHF2BrHCH2CH2-morpholin-4-yl
1201CHF2BrHCH(CH3)CH2—OMe
1202CHF2BrHCH(CH3)CH2—NMe2
1203CHF2BrHCH2CH2CH2—OMe
1204CHF2BrHCH2CH2CH2—SMe
1205CHF2BrHCH2CH2CH2—OEt
1206CHF2BrHCH2CH2CH2—OiPr
1207CHF2BrHCH2CH2CH2—OBu
1208CHF2BrHCH2—COOCH3
1209CHF2BrMeCH2—COOCH3
1210CHF2BrHCH(CH3)COOMe
1211CHF2BrHCH(CH3)COOEt
1212CHF2BrHCH2CH2—COOCH3
1213CHF2BrHCH(COOCH3)2
1214CHF2BrHCH(COOEt)CH2—CH(CH3)2
1215CHF2BrHCH(COOMe)CH(CH3)2
1216CHF2BrHO—CH2CH3
1217CHF2BrMeO—CH3
1218CHF2BrHO—CH2CH═CH2
1219CHF2BrHO—tBu
1220CHF2BrHO—Pr
1221CHF2BrHO—CH2cPr
1222CHF2BrHO—CH2CH(CH3)2
1223CHF2BrHO—CH2CF3
1224CHF2BrHO—CH(CH3)cPr
1225CHF2BrHO—CH2CH2Cl
1226CHF2BrHO—CH2C≡CH
1227CHF2BrHO—CH2C≡CCH3
1228CHF2BrHO—CH(CH3)C≡CH
1229CHF2BrHCH2—Ph
1230CHF2BrMeCH2—Ph
1231CHF2BrHCH2-pyridin-3-yl
1232CHF2BrHCH2-6-Cl-pyridin-3-yl
1233CHF2BrHCH(CH3)Ph
1234CHF2BrHCH2CH2—Ph
1235CHF2BrHCH2-2-CF3—Ph
1236CHF2BrHCH2CH2CHPh2
1237CHF2Brmorpholin-4-yl
1238CHF2Brpiperidin-1-yl
1239CHF2Brthiazolidin-3-yl
1240CHF2Brpyrrolidin-1-yl
1241CHF2Br2-methylpyrrolidin-1-yl
1242CHF2Br═CH—N(CH3)2
1243CHF2Br═C(CH3)N(CH3)2
1244CHF2Br═CH—N(C2H5)2
1245CHF2Br═C(CH3)N(C2H5)2
1246CHF2Br═CH-piperidine
1247CHF2Br═CH-morpholine
1248CHF2Br═CH-pyrrolidine
1249CHF2BrHindan-1-yl
1250CHF2BrHtetrahydrofuran-2-yl
1251CF2CF3BrHH
1252CF2CF3BrHMe
1253CF2CF3BrHEy
1254CF2CF3BrHPr
1255CF2CF3BrHiPr
1256CF2CF3BrHcPr
1257CF2CF3BrHBu
1258CF2CF3BrHcBu
1259CF2CF3BrHtBu
1260CF2CF3BrMeMe
1261CF2CF3BrMeEt
1262CF2CF3BrMeBu
1263CF2CF3BrMePr
1264CF2CF3BrMeiPr
1265CF2CF3BrEtEt
1266CF2CF3BrEtPr
1267CF2CF3BrEtiPr
1268CF2CF3BrPrPr
1269CF2CF3BrHcPentyl
1270CF2CF3BrHcHexyl
1271CF2CF3BrHCH2(CH2)3CH3
1272CF2CF3BrHCH2(CH2)4CH3
1273CF2CF3BrHCH2—cPr
1274CF2CF3BrHCH2—CN
1275CF2CF3BrHCH2—C(CH3)3
1276CF2CF3BrHCH2CF2CF3
1277CF2CF3BrHCH2CF3
1278CF2CF3BrHCH2(CF2)2CF3
1279CF2CF3BrHCH2CH(CH3)CH2CH3
1280CF2CF3BrHCH2C(CH3)2CH2F
1281CF2CF3BrHCH2CH(CH3)2
1282CF2CF3BrHCH2CH(CH2CH3)2
1283CF2CF3BrHCH2CH2CH(CH3)2
1284CF2CF3BrHCH2CH2C(CH3)3
1285CF2CF3BrHCH2CH═CH2
1286CF2CF3BrMeCH2CH═CH2
1287CF2CF3BrCH2CH═CH2CH2CH═CH2
1288CF2CF3BrHCH2CH═CHCH3
1289CF2CF3BrHCH2—C(CH3)═CH2
1290CF2CF3BrHCH2—C≡CH
1291CF2CF3BrMeCH2—C≡CH
1292CF2CF3BrHCH(CH3)CH2CH3
1293CF2CF3BrHCH(CH3)cPr
1294CF2CF3BrHCH(CH3)(CH2)2CH3
1295CF2CF3BrHCH(CH3)(CH2)4CH3
1296CF2CF3BrHCH(CH3)(CH2)5CH3
1297CF2CF3BrHCH(CH2CH3)(CH2)3CH3
1298CF2CF3BrHCH(CH3)CH2CH(CH3)2
1299CF2CF3BrHCH(CH3)C(CH3)3
1300CF2CF3BrHCH(CH3)CH(CH3)2
1301CF2CF3BrHCH(CH3)CH2CH2CH(CH3)2
1302CF2CF3BrHCH(CH2CH3)2
1303CF2CF3BrHC(CH3)2CH2CH3
1304CF2CF3BrHC(CH3)2CH2C(CH3)3
1305CF2CF3BrHCH2—CH(OMe)2
1306CF2CF3BrHCH2—CH(OEt)2
1307CF2CF3BrHCH2CH2—OH
1308CF2CF3BrHCH2CH2—OMe
1309CF2CF3BrMeCH2CH2—OMe
1310CF2CF3BrHCH2CH2—OEt
1311CF2CF3BrHCH2CH2—SMe
1312CF2CF3BrHCH2CH2—CN
1313CF2CF3BrHCH2CH2—NMe2
1314CF2CF3BrHCH2CH2-morpholin-4-yl
1315CF2CF3BrHCH(CH3)CH2—OMe
1316CF2CF3BrHCH(CH3)CH2—NMe2
1317CF2CF3BrHCH2CH2CH2—OMe
1318CF2CF3BrHCH2CH2CH2—SMe
1319CF2CF3BrHCH2CH2CH2—OEt
1320CF2CF3BrHCH2CH2CH2—OiPr
1321CF2CF3BrHCH2CH2CH2—OBu
1322CF2CF3BrHCH2—COOCH3
1323CF2CF3BrMeCH2—COOCH3
1324CF2CF3BrHCH(CH3)COOMe
1325CF2CF3BrHCH(CH3)COOEt
1326CF2CF3BrHCH2CH2—COOCH3
1327CF2CF3BrHCH(COOCH3)2
1328CF2CF3BrHCH(COOEt)CH2—CH(CH3)2
1329CF2CF3BrHCH(COOMe)CH(CH3)2
1330CF2CF3BrHO—CH2CH3
1331CF2CF3BrMeO—CH3
1332CF2CF3BrHO—CH2CH═CH2
1333CF2CF3BrHO—tBu
1334CF2CF3BrHO—Pr
1335CF2CF3BrHO—CH2cPr
1336CF2CF3BrHO—CH2CH(CH3)2
1337CF2CF3BrHO—CH2CF3
1338CF2CF3BrHO—CH(CH3)cPr
1339CF2CF3BrHO—CH2CH2Cl
1340CF2CF3BrHO—CH2C≡CH
1341CF2CF3BrHO—CH2C≡CCH3
1342CF2CF3BrHO—CH(CH3)C≡CH
1343CF2CF3BrHCH2—Ph
1344CF2CF3BrMeCH2—Ph
1345CF2CF3BrHCH2-pyridin-3-yl
1346CF2CF3BrHCH2-6-Cl-pyridin-3-yl
1347CF2CF3BrHCH(CH3)Ph
1348CF2CF3BrHCH2CH2—Ph
1349CF2CF3BrHCH2-2-CF3—Ph
1350CF2CF3BrHCH2CH2CHPh2
1351CF2CF3Brmorpholin-4-yl
1352CF2CF3Brpiperidin-1-yl
1353CF2CF3Brthiazolidin-3-yl
1354CF2CF3Brpyrrolidin-1-yl
1355CF2CF3Br2-methylpyrrolidin-1-yl
1356CF2CF3Br═CH—N(CH3)2
1357CF2CF3Br═C(CH3)N(CH3)2
1358CF2CF3Br═CH—N(C2H5)2
1359CF2CF3Br═C(CH3)N(C2H5)2
1360CF2CF3Br═CH-piperidine
1361CF2CF3Br═CH-morpholine
1362CF2CF3Br═CH-pyrrolidine
1363CF2CF3BrHindan-1-yl
1364CF2CF3BrHtetrahydrofuran-2-ylmethyl
1365CF2CF3IHH
1366CF3IHH
1367CF2CHF2HHH
1368CF2CHF2HHMe
1369CF2CHF2HHEt
1370CF2CHF2HHPr
1371CF2CHF2HHiPr
1372CF2CHF2HHcPr
1373CF2CHF2HHBu
1374CF2CHF2HHcBu
1375CF2CHF2HHtBu
1376CF2CHF2HMeMe
1377CF2CHF2HMeEt
1378CF2CHF2HMeBu
1379CF2CHF2HMePr
1380CF2CHF2HMeiPr
1381CF2CHF2HEtEt
1382CF2CHF2HEtPr
1383CF2CHF2HEtiPr
1384CF2CHF2HPrPr
1385CF2CHF2HHcPentyl
1386CF2CHF2HHcHexyl
1387CF2CHF2HHCH2(CH2)3CH3
1388CF2CHF2HHCH2(CH2)4CH3
1389CF2CHF2HHCH2—cPr
1390CF2CHF2HHCH2—CN
1391CF2CHF2HHCH2—C(CH3)3
1392CF2CHF2HHCH2CF2CF3
1393CF2CHF2HHCH2CF3
1394CF2CHF2HHCH2(CF2)2CF3
1395CF2CHF2HHCH2CH(CH3)CH2CH3
1396CF2CHF2HHCH2C(CH3)2CH2F
1397CF2CHF2HHCH2CH(CH3)2
1398CF2CHF2HHCH2CH(CH2CH3)2
1399CF2CHF2HHCH2CH2CH(CH3)2
1400CF2CHF2HHCH2CH2C(CH3)3
1401CF2CHF2HHCH2CH═CH2
1402CF2CHF2HMeCH2CH═CH2
1403CF2CHF2HCH2CH═CH2CH2CH═CH2
1404CF2CHF2HHCH2CH═CHCH3
1405CF2CHF2HHCH2—C(CH3)═CH2
1406CF2CHF2HHCH2—C≡CH
1407CF2CHF2HMeCH2—C≡CH
1408CF2CHF2HHCH(CH3)CH2CH3
1409CF2CHF2HHCH(CH3)cPr
1410CF2CHF2HHCH(CH3)(CH2)2CH3
1411CF2CHF2HHCH(CH3)(CH2)4CH3
1412CF2CHF2HHCH(CH3)(CH2)5CH3
1413CF2CHF2HHCH(CH2CH3)(CH2)3CH3
1414CF2CHF2HHCH(CH3)CH2CH(CH3)2
1415CF2CHF2HHCH(CH3)C(CH3)3
1416CF2CHF2HHCH(CH3)CH(CH3)2
1417CF2CHF2HHCH(CH3)CH2CH2CH(CH3)2
1418CF2CHF2HHCH(CH2CH3)2
1419CF2CHF2HHC(CH3)2CH2CH3
1420CF2CHF2HHC(CH3)2CH2C(CH3)3
1421CF2CHF2HHCH2—CH(OMe)2
1422CF2CHF2HHCH2—CH(OEt)2
1423CF2CHF2HHCH2CH2—OH
1424CF2CHF2HHCH2CH2—OMe
1425CF2CHF2HMeCH2CH2—OMe
1426CF2CHF2HHCH2CH2—OEt
1427CF2CHF2HHCH2CH2—SMe
1428CF2CHF2HHCH2CH2—CN
1429CF2CHF2HHCH2CH2—NMe2
1430CF2CHF2HHCH2CH2-morpholin-4-yl
1431CF2CHF2HHCH(CH3)CH2—OMe
1432CF2CHF2HHCH(CH3)CH2—NMe2
1433CF2CHF2HHCH2CH2CH2—OMe
1434CF2CHF2HHCH2CH2CH2—SMe
1435CF2CHF2HHCH2CH2CH2—OEt
1436CF2CHF2HHCH2CH2CH2—OiPr
1437CF2CHF2HHCH2CH2CH2—OBu
1438CF2CHF2HHCH2—COOCH3
1439CF2CHF2HMeCH2—COOCH3
1440CF2CHF2HHCH(CH3)COOMe
1441CF2CHF2HHCH(CH3)COOEt
1442CF2CHF2HHCH2CH2—COOCH3
1443CF2CHF2HHCH(COOCH3)2
1444CF2CHF2HHCH(COOEt)CH2—CH(CH3)2
1445CF2CHF2HHCH(COOMe)CH(CH3)2
1446CF2CHF2HHO—CH2CH3
1447CF2CHF2HHO—CH3
1448CF2CHF2HHO—CH2CH═CH2
1449CF2CHF2HHO—tBu
1450CF2CHF2HHO—Pr
1451CF2CHF2HHO—CH2cPr
1452CF2CHF2HHO—CH2CH(CH3)2
1453CF2CHF2HHO—CH2CF3
1454CF2CHF2HHO—CH(CH3)cPr
1455CF2CHF2HHO—CH2CH2Cl
1456CF2CHF2HHO—CH2C≡CH
1457CF2CHF2HHO—CH2C≡CCH3
1458CF2CHF2HHO—CH(CH3)C≡CH
1459CF2CHF2HHCH2—Ph
1460CF2CHF2HMeCH2—Ph
1461CF2CHF2HHCH2-pyridin-3-yl
1462CF2CHF2HHCH2-6-Cl-pyridin-3-yl
1463CF2CHF2HHCH(CH3)Ph
1464CF2CHF2HHCH2CH2—Ph
1465CF2CHF2HHCH2-2-CF3—Ph
1466CF2CHF2HHCH2CH2CHPh
1467CF2CHF2Hmorpholin-4-yl
1468CF2CHF2Hpiperidin-1-yl
1469CF2CHF2Hthiazolidin-3-yl
1470CF2CHF2Hpyrrolidin-1-yl
1471CF2CHF2H2-methylpyrrolidin-1-yl
1472CF2CHF2H═CH—N(CH3)2
1473CF2CHF2H═C(CH3)N(CH3)2
1474CF2CHF2H═CH—N(C2H5)2
1475CF2CHF2H═C(CH3)N(C2H5)2
1476CF2CHF2H═CH-piperidine
1477CF2CHF2H═CH-morpholine
1478CF2CHF2H═CH-pyrrolidine
1479CF2CHF2HHindan-1-yl
1480CF2CHF2HHtetrahydrofuran-2-ylmethyl
1481CF2CF2ClHHH
1482CF2CF2ClHHMe
1483CF2CF2ClHHEt
1484CF2CF2ClHHPr
1485CF2CF2ClHHiPr
1486CF2CF2ClHHcPr
1487CF2CF2ClHHBu
1488CF2CF2ClHHcBu
1489CF2CF2ClHHtBu
1490CF2CF2ClHMeMe
1491CF2CF2ClHMeEt
1492CF2CF2ClHMeBu
1493CF2CF2ClHMePr
1494CF2CF2ClHMeiPr
1495CF2CF2ClHEtEt
1496CF2CF2ClHEtPr
1497CF2CF2ClHEtiPr
1498CF2CF2ClHPrPr
1499CF2CF2ClHHcPentyl
1500CF2CF2ClHHcHexyl
1501CF2CF2ClHHCH2(CH2)3CH3
1502CF2CF2ClHHCH2(CH2)4CH3
1503CF2CF2ClHHCH2—cPr
1504CF2CF2ClHHCH2—CN
1505CF2CF2ClHHCH2—C(CH3)3
1506CF2CF2ClHHCH2CF2CF3
1507CF2CF2ClHHCH2CF3
1508CF2CF2ClHHCH2(CF2)2CF3
1509CF2CF2ClHHCH2CH(CH3)CH2CH3
1510CF2CF2ClHHCH2C(CH3)2CH2F
1511CF2CF2ClHHCH2CH(CH3)2
1512CF2CF2ClHHCH2CH(CH2CH3)2
1513CF2CF2ClHHCH2CH2CH(CH3)2
1514CF2CF2ClHHCH2CH2C(CH3)3
1515CF2CF2ClHHCH2CH═CH2
1516CF2CF2ClHMeCH2CH═CH2
1517CF2CF2ClHCH2CH═CH2CH2CH═CH2
1518CF2CF2ClHHCH2CH═CHCH3
1519CF2CF2ClHHCH2—C(CH3)═CH2
1520CF2CF2ClHHCH2—C≡CH
1521CF2CF2ClHMeCH2—C≡CH
1522CF2CF2ClHHCH(CH3)CH2CH3
1523CF2CF2ClHHCH(CH3)cPr
1524CF2CF2ClHHCH(CH3)(CH2)2CH3
1525CF2CF2ClHHCH(CH3)(CH2)4CH3
1526CF2CF2ClHHCH(CH3)(CH2)5CH3
1527CF2CF2ClHHCH(CH2CH3)(CH2)3CH3
1528CF2CF2ClHHCH(CH3)CH2CH(CH3)2
1529CF2CF2ClHHCH(CH3)C(CH3)3
1530CF2CF2ClHHCH(CH3)CH(CH3)2
1531CF2CF2ClHHCH(CH3)CH2CH2CH(CH3)2
1532CF2CF2ClHHCH(CH2CH3)2
1533CF2CF2ClHHC(CH3)2CH2CH3
1534CF2CF2ClHHC(CH3)2CH2C(CH3)3
1535CF2CF2ClHHCH2—CH(OMe)2
1536CF2CF2ClHHCH2—CH(OEt)2
1537CF2CF2ClHHCH2CH2—OH
1538CF2CF2ClHHCH2CH2—OMe
1539CF2CF2ClHMeCH2CH2—OMe
1540CF2CF2ClHHCH2CH2—OEt
1541CF2CF2ClHHCH2CH2—SMe
1542CF2CF2ClHHCH2CH2—CN
1543CF2CF2ClHHCH2CH2—NMe2
1544CF2CF2ClHHCH2CH2-morpholin-4-yl
1545CF2CF2ClHHCH(CH3)CH2—OMe
1546CF2CF2ClHHCH(CH3)CH2—NMe2
1547CF2CF2ClHHCH2CH2CH2—OMe
1548CF2CF2ClHHCH2CH2CH2—SMe
1549CF2CF2ClHHCH2CH2CH2—OEt
1550CF2CF2ClHHCH2CH2CH2—OiPr
1551CF2CF2ClHHCH2CH2CH2—OBu
1552CF2CF2ClHHCH2—COOCH3
1553CF2CF2ClHMeCH2—COOCH3
1554CF2CF2ClHHCH(CH3)COOMe
1555CF2CF2ClHHCH(CH3)COOEt
1556CF2CF2ClHHCH2CH2—COOCH3
1557CF2CF2ClHHCH(COOCH3)2
1558CF2CF2ClHHCH(COOEt)CH2—CH(CH3)2
1559CF2CF2ClHHCH(COOMe)CH(CH3)2
1560CF2CF2ClHHO—CH2CH3
1561CF2CF2ClHHO—CH3
1562CF2CF2ClHHO—CH2CH═CH2
1563CF2CF2ClHHO—tBu
1564CF2CF2ClHHO—Pr
1565CF2CF2ClHHO—CH2cPr
1566CF2CF2ClHHO—CH2CH(CH3)2
1567CF2CF2ClHHO—CH2CF3
1568CF2CF2ClHHO—CH(CH3)cPr
1569CF2CF2ClHHO—CH2CH2Cl
1570CF2CF2ClHHO—CH2C≡CH
1571CF2CF2ClHHO—CH2C≡CCH3
1572CF2CF2ClHHO—CH(CH3)C≡CH
1573CF2CF2ClHHCH2—Ph
1574CF2CF2ClHMeCH2—Ph
1575CF2CF2ClHHCH2-pyridin-3-yl
1576CF2CF2ClHHCH2-6-Cl-pyridin-3-yl
1577CF2CF2ClHHCH(CH3)Ph
1578CF2CF2ClHHCH2CH2—Ph
1579CF2CF2ClHHCH2-2-CF3—Ph
1580CF2CF2ClHHCH2CH2CHPh
1581CF2CF2ClHmorpholin-4-yl
1582CF2CF2ClHpiperidin-1-yl
1583CF2CF2ClHthiazolidin-3-yl
1584CF2CF2ClHpyrrolidin-1-yl
1585CF2CF2ClH2-methylpyrrolidin-1-yl
1586CF2CF2ClH═CH—N(CH3)2
1587CF2CF2ClH═C(CH3)N(CH3)2
1588CF2CF2ClH═CH—N(C2H5)2
1589CF2CF2ClH═C(CH3)N(C2H5)2
1590CF2CF2ClH═CH-piperidine
1591CF2CF2ClH═CH-morpholine
1592CF2CF2ClH═CH-pyrrolidine
1593CF2CF2ClHHindan-1-yl
1594CF2CF2ClHHtetrahydrofuran-2-ylmethyl
1595C3F7HHH
1596C3F7HHMe
1597C3F7HHEt
1598C3F7HHPr
1599C3F7HHiPr
1600C3F7HHcPr
1601C3F7HHBu
1602C3F7HHcBu
1603C3F7HHtBu
1604C3F7HMeMe
1605C3F7HMeEt
1606C3F7HMeBu
1607C3F7HMePr
1608C3F7HMeiPr
1609C3F7HEtEt
1610C3F7HEtPr
1611C3F7HEtiPr
1612C3F7HPrPr
1613C3F7HHcPentyl
1614C3F7HHcHexyl
1615C3F7HHCH2(CH2)3CH3
1616C3F7HHCH2(CH2)4CH3
1617C3F7HHCH2—cPr
1618C3F7HHCH2—CN
1619C3F7HHCH2—C(CH3)3
1620C3F7HHCH2CF2CF3
1621C3F7HHCH2CF3
1622C3F7HHCH2(CF2)2CF3
1623C3F7HHCH2CH(CH3)CH2CH3
1624C3F7HHCH2C(CH3)2CH2F
1625C3F7HHCH2CH(CH3)2
1626C3F7HHCH2CH(CH2CH3)2
1627C3F7HHCH2CH2CH(CH3)2
1628C3F7HHCH2CH2C(CH3)3
1629C3F7HHCH2CH═CH2
1630C3F7HMeCH2CH═CH2
1631C3F7HCH2CH═CH2CH2CH═CH2
1632C3F7HHCH2CH═CHCH3
1633C3F7HHCH2—C(CH3)═CH2
1634C3F7HHCH2—C≡CH
1635C3F7HMeCH2—C≡CH
1636C3F7HHCH(CH3)CH2CH3
1637C3F7HHCH(CH3)cPr
1638C3F7HHCH(CH3)(CH2)2CH3
1639C3F7HHCH(CH3)(CH2)4CH3
1640C3F7HHCH(CH3)(CH2)5CH3
1641C3F7HHCH(CH2CH3)(CH2)3CH3
1642C3F7HHCH(CH3)CH2CH(CH3)2
1643C3F7HHCH(CH3)C(CH3)3
1644C3F7HHCH(CH3)CH(CH3)2
1645C3F7HHCH(CH3)CH2CH2CH(CH3)2
1646C3F7HHCH(CH2CH3)2
1647C3F7HHC(CH3)2CH2CH3
1648C3F7HHC(CH3)2CH2C(CH3)3
1649C3F7HHCH2—CH(OMe)2
1650C3F7HHCH2—CH(OEt)2
1651C3F7HHCH2CH2—OH
1652C3F7HHCH2CH2—OMe
1653C3F7HMeCH2CH2—OMe
1654C3F7HHCH2CH2—OEt
1655C3F7HHCH2CH2—SMe
1656C3F7HHCH2CH2—CN
1657C3F7HHCH2CH2—NMe2
1658C3F7HHCH2CH2-morpholin-4-yl
1659C3F7HHCH(CH3)CH2—OMe
1660C3F7HHCH(CH3)CH2—NMe2
1661C3F7HHCH2CH2CH2—OMe
1662C3F7HHCH2CH2CH2—SMe
1663C3F7HHCH2CH2CH2—OEt
1664C3F7HHCH2CH2CH2—OiPr
1665C3F7HHCH2CH2CH2—OBu
1666C3F7HHCH2—COOCH3
1667C3F7HMeCH2—COOCH3
1668C3F7HHCH(CH3)COOMe
1669C3F7HHCH(CH3)COOEt
1670C3F7HHCH2CH2—COOCH3
1671C3F7HHCH(COOCH3)2
1672C3F7HHCH(COOEt)CH2—CH(CH3)2
1673C3F7HHCH(COOMe)CH(CH3)2
1674C3F7HHO—CH2CH3
1675C3F7HHO—CH3
1676C3F7HHO—CH2CH═CH2
1677C3F7HHO—tBu
1678C3F7HHO—Pr
1679C3F7HHO—CH2cPr
1680C3F7HHO—CH2CH(CH3)2
1681C3F7HHO—CH2CF3
1682C3F7HHO—CH(CH3)cPr
1683C3F7HHO—CH2CH2Cl
1684C3F7HHO—CH2C≡CH
1685C3F7HHO—CH2C≡CCH3
1686C3F7HHO—CH(CH3)C≡CH
1687C3F7HHCH2—Ph
1688C3F7HMeCH2—Ph
1689C3F7HHCH2-pyridin-3-yl
1690C3F7HHCH2-6-Cl-pyridin-3-yl
1691C3F7HHCH(CH3)Ph
1692C3F7HHCH2CH2—Ph
1693C3F7HHCH2-2-CF3—Ph
1694C3F7HHCH2CH2CHPh
1695C3F7Hmorpholin-4-yl
1696C3F7Hpiperidin-1-yl
1697C3F7Hthiazolidin-3-yl
1698C3F7Hpyrrolidin-1-yl
1699C3F7H2-methylpyrrolidin-1-yl
1700C3F7H═CH—N(CH3)2
1701C3F7H═C(CH3)N(CH3)2
1702C3F7H═CH—N(C2H5)2
1703C3F7H═C(CH3)N(C2H5)2
1704C3F7H═CH-piperidine
1705C3F7H═CH-morpholine
1706C3F7H═CH-pyrrolidine
1707C3F7HHindan-1-yl
1708C3F7HHtetrahydrofuran-2-ylmethyl
1709CF(CF3)2HHH
1710C3F7ClHH
1711C3F7ClHMe
1712C3F7ClHEt
1713C3F7ClHPr
1714C3F7ClHiPr
1715C3F7ClHcPr
1716C3F7ClHBu
1717C3F7ClHcBu
1718C3F7ClHtBu
1719C3F7ClMeMe
1720C3F7ClEtEt
1721C3F7ClHCH2—cPr
1722C3F7ClHCH2—C(CH3)3
1723C3F7ClHCH2CH(CH3)2
1724C3F7ClHCH2CH(CH2CH3)2
1725C3F7ClHCH2CH2CH(CH3)2
1726C3F7ClHCH2CH2C(CH3)3
1727C3F7ClHCH2CH═CH2
1728C3F7ClHCH2—C(CH3)═CH2
1729C3F7ClHCH2—CCH
1730C3F7ClMeCH2—CCH
1731C3F7ClHCH(CH3)CH2CH3
1732C3F7ClHCH(CH3)cPr
1733C3F7ClHCH(CH3)(CH2)2CH3
1734C3F7ClHCH(CH3)(CH2)4CH3
1735C3F7ClHCH(CH3)CH2CH(CH3)2
1736C3F7ClHCH(CH3)C(CH3)3
1737C3F7ClHCH(CH3)CH(CH3)2
1738C3F7ClHCH(CH2CH3)2
1739C3F7ClHCH2—CH(OMe)2
1740C3F7ClHCH2—CH(OEt)2
1741C3F7ClHCH2CH2—OH
1742C3F7ClHCH2CH2—OMe
1743C3F7ClMeCH2CH2—OMe
1744C3F7ClHCH(CH3)CH2—OMe
1745C3F7ClHCH2CH2CH2—OMe
1746C3F7ClHCH2—COOCH3
1747C3F7ClMeCH2—COOCH3
1748C3F7ClHCH(CH3)COOMe
1749C3F7ClHCH(CH3)COOEt
1750C3F7ClHCH2CH2—COOCH3
1751C3F7BrHH
1752C3F7BrHMe
1753C3F7BrHEt
1754C3F7BrHPr
1755C3F7BrHiPr
1756C3F7BrHcPr
1757C3F7BrHBu
1758C3F7BrHcBu
1759C3F7BrHtBu
1760C3F7BrMeMe
1761C3F7BrEtEt
1762C3F7BrHCH2-cPr
1763C3F7BrHCH2—C(CH3)3
1764C3F7BrHCH2CH(CH3)2
1765C3F7BrHCH2CH(CH2CH3)2
1766C3F7BrHCH2CH2CH(CH3)2
1767C3F7BrHCH2CH2C(CH3)3
1768C3F7BrHCH2CH═CH2
1769C3F7BrHCH2—C(CH3)═CH2
1770C3F7BrHCH2—CCH
1771C3F7BrMeCH2—CCH
1772C3F7BrHCH(CH3)CH2CH3
1773C3F7BrHCH(CH3)cPr
1774C3F7BrHCH(CH3)(CH2)2CH3
1775C3F7BrHCH(CH3)(CH2)4CH3
1776C3F7BrHCH(CH3)CH2CH(CH3)2
1777C3F7BrHCH(CH3)C(CH3)3
1778C3F7BrHCH(CH3)CH(CH3)2
1779C3F7BrHCH(CH3)CH2CH2CH(CH3)2
1780C3F7BrHCH(CH2CH3)2
1781C3F7BrHCH2—CH(OMe)2
1782C3F7BrHCH2—CH(OEt)2
1783C3F7BrHCH2CH2—OH
1784C3F7BrHCH2CH2—OMe
1785C3F7BrHCH(CH3)CH2—OMe
1786C3F7BrHCH2CH2CH2—OMe
1787C3F7BrHCH2—COOCH3
1788C3F7BrMeCH2—COOCH3
1789C3F7BrHCH(CH3)COOMe
1790C3F7BrHCH(CH3)COOEt
1791C3F7BrHCH2CH2—COOCH3
1792C3F7IHH
1793C3F7IHMe
1794C3F7IHEt
1795C3F7IHPr
1796C3F7IHiPr
1797C3F7IHcPr
1798C3F7IHBu
1799C3F7IHcBu
1800C3F7IHtBu
1801C3F7IMeMe
1802C3F7IEtEt
1803C3F7IHCH2—cPr
1804C3F7IHCH2—C(CH3)3
1805C3F7IHCH2CH(CH3)2
1806C3F7IHCH2CH(CH2CH3)2
1807C3F7IHCH2CH2CH(CH3)2
1808C3F7IHCH2CH2C(CH3)3
1809C3F7IHCH2CH═CH2
1810C3F7IHCH2—C(CH3)═CH2
1811C3F7IHCH2—CCH
1812C3F7IMeCH2—CCH
1813C3F7IHCH(CH3)CH2CH3
1814C3F7IHCH(CH3)cPr
1815C3F7IHCH(CH3)(CH2)2CH3
1816C3F7IHCH(CH3)(CH2)4CH3
1817C3F7IHCH(CH3)CH2CH(CH3)2
1818C3F7IHCH(CH3)C(CH3)3
1819C3F7IHCH(CH3)CH(CH3)2
1820C3F7IHCH(CH2CH3)2
1821C3F7IHCH2—CH(OMe)2
1822C3F7IHCH2—CH(OEt)2
1823C3F7IHCH2CH2—OH
1824C3F7IHCH2CH2—OMe
1825C3F7IMeCH2CH2—OMe
1826C3F7IHCH(CH3)CH2—OMe
1827C3F7IHCH2CH2CH2—OMe
1828C3F7IHCH2—COOCH3
1829C3F7IMeCH2—COOCH3
1830C3F7IHCH(CH3)COOMe
1831C3F7IHCH(CH3)COOEt
1832C3F7IHCH2CH2—COOCH3
1833CF3IHMe
1834CF3IHEt
1835CF3IHPr
1836CF3IHiPr
1837CF3IHcPr
1838CF3IHBu
1839CF3IHcBu
1840CF3IHtBu
1841CF3IMeMe
1842CF3IEtEt
1843CF3IHCH2(CH2)3CH3
1844CF3IHCH2(CH2)4CH3
1845CF3IHCH2—cPr
1846CF3IHCH2—C(CH3)3
1847CF3IHCH2CH(CH3)2
1848CF3IHCH2CH(CH2CH3)2
1849CF3IHCH2CH2CH(CH3)2
1850CF3IHCH2CH2C(CH3)3
1851CF3IHCH2CH═CH2
1852CF3IHCH2—C(CH3)═CH2
1853CF3IHCH2—CCH
1854CF3IHCH(CH3)CH2CH3
1855CF3IHCH(CH3)cPr
1856CF3IHCH(CH3)(CH2)2CH3
1857CF3IHCH(CH3)(CH2)4CH3
1858CF3IHCH(CH3)CH2CH(CH3)2
1859CF3IHCH(CH3)C(CH3)3
1860CF3IHCH(CH3)CH(CH3)2
1861CF3IHCH(CH2CH3)2
1862CF3IHC(CH3)2CH2CH3
1863CF3IHC(CH3)2CH2C(CH3)3
1864CF3IHCH2—CH(OMe)2
1865CF3IHCH2—CH(OEt)2
1866CF3IHCH2CH2—OH
1867CF3IHCH2CH2—OMe
1868CF3IMeCH2CH2—OMe
1869CF3IHCH(CH3)CH2—OMe
1870CF3IHCH2CH2CH2—OMe
1871CF3IHCH2—COOCH3
1872CF3IMeCH2—COOCH3
1873CF3IHCH(CH3)COOMe
1874CF3IHCH(CH3)COOEt
1875CF3IHCH2CH2—COOCH3
1876CF2ClIHH
1877CF2ClIHMe
1878CF2ClIHEt
1879CF2ClIHPr
1880CF2ClIHiPr
1881CF2ClIHcPr
1882CF2ClIHBu
1883CF2ClIHcBu
1884CF2ClIHtBu
1885CF2ClIMeMe
1886CF2ClIHCH2—cPr
1887CF2ClIHCH2—C(CH3)3
1888CF2ClIHCH2CH(CH3)2
1889CF2ClIHCH2CH(CH2CH3)2
1890CF2ClIHCH2CH2CH(CH3)2
1891CF2ClIHCH2CH2C(CH3)3
1892CF2ClIHCH2CH═CH2
1893CF2ClIMeCH2CH═CH2
1894CF2ClIHCH2—C(CH3)═CH2
1895CF2ClIHCH2—CCH
1896CF2ClIMeCH2—CCH
1897CF2ClIHCH(CH3)CH2CH3
1898CF2ClIHCH(CH3)cPr
1899CF2ClIHCH(CH3)(CH2)2CH3
1900CF2ClIHCH(CH3)(CH2)4CH3
1901CF2ClIHCH(CH3)(CH2)5CH3
1902CF2ClIHCH(CH2CH3)(CH2)3CH3
1903CF2ClIHCH(CH3)CH2CH(CH3)2
1904CF2ClIHCH(CH3)C(CH3)3
1905CF2ClIHCH(CH3)CH(CH3)2
1906CF2ClIHCH(CH3)CH2CH2CH(CH3)2
1907CF2ClIHCH(CH2CH3)2
1908CF2ClIHC(CH3)2CH2CH3
1909CF2ClIHC(CH3)2CH2C(CH3)3
1910CF2ClIHCH2—CH(OMe)2
1911CF2ClIHCH2—CH(OEt)2
1912CF2ClIHCH2CH2—OH
1913CF2ClIHCH2CH2—OMe
1914CF2ClIMeCH2CH2—OMe
1915CF2ClIHCH2CH2—OEt
1916CF2ClIHCH(CH3)CH2—OMe
1917CF2ClIHCH2CH2CH2—OMe
1918CF2ClIHCH2—COOCH3
1919CF2ClIMeCH2—COOCH3
1920CF2ClIHCH(CH3)COOMe
1921CF2ClIHCH(CH3)COOEt
1922CF2ClIHCH2CH2—COOCH3
1923CF2CF3IHMe
1924CF2CF3IHEt
1925CF2CF3IHPr
1926CF2CF3IHiPr
1927CF2CF3IHcPr
1928CF2CF3IHBu
1929CF2CF3IHcBu
1930CF2CF3IHtBu
1931CF2CF3IMeMe
1932CF2CF3IEtEt
1933CF2CF3IHCH2—cPr
1934CF2CF3IHCH2—C(CH3)3
1935CF2CF3IHCH2CH(CH3)2
1936CF2CF3IHCH2CH(CH2CH3)2
1937CF2CF3IHCH2CH2CH(CH3)2
1938CF2CF3IHCH2CH2C(CH3)3
1939CF2CF3IHCH2CH═CH2
1940CF2CF3IMeCH2CH═CH2
1941CF2CF3IHCH2—C(CH3)═CH2
1942CF2CF3IHCH2—CCH
1943CF2CF3IMeCH2—CCH
1944CF2CF3IHCH(CH3)CH2CH3
1945CF2CF3IHCH(CH3)cPr
1946CF2CF3IHCH(CH3)(CH2)2CH3
1947CF2CF3IHCH(CH3)(CH2)4CH3
1948CF2CF3IHCH(CH3)CH2CH(CH3)2
1949CF2CF3IHCH(CH3)C(CH3)3
1950CF2CF3IHCH(CH3)CH(CH3)2
1951CF2CF3IHCH(CH2CH3)2
1952CF2CF3IHCH2—CH(OMe)2
1953CF2CF3IHCH2—CH(OEt)2
1954CF2CF3IHHCH2CH2—OH
1955CF2CF3IHCH2CH2—OMe
1956CF2CF3IMeCH2CH2—OMe
1957CF2CF3IHCH(CH3)CH2—OMe
1958CF2CF3IHCH2CH2CH2—OMe
1959CF2CF3IHCH2—COOCH3
1960CF2CF3IMeCH2—COOCH3
1961CF2CF3IHCH(CH3)COOMe
1962CF2CF3IHCH(CH3)COOEt
1963CF2CF3IHCH2CH2—COOCH3
1964CF2CF2ClClHH
1965CF2CF2ClClHMe
1966CF2CF2ClClHEt
1967CF2CF2ClClHPr
1968CF2CF2ClClHiPr
1969CF2CF2ClClHcPr
1970CF2CF2ClClHBu
1971CF2CF2ClClHcBu
1972CF2CF2ClClHtBu
1973CF2CF2ClClMeMe
1974CF2CF2ClClEtEt
1975CF2CF2ClClHCH2—cPr
1976CF2CF2ClClHCH2—C(CH3)3
1977CF2CF2ClClHCH2CH(CH3)2
1978CF2CF2ClClHCH2CH(CH2CH3)2
1979CF2CF2ClClHCH2CH2CH(CH3)2
1980CF2CF2ClClHCH2CH2C(CH3)3
1981CF2CF2ClClHCH2CH═CH2
1982CF2CF2ClClMeCH2CH═CH2
1983CF2CF2ClClHCH2—C(CH3)═CH2
1984CF2CF2ClClHCH2—CCH
1985CF2CF2ClClMeCH2—CCH
1986CF2CF2ClClHCH(CH3)CH2CH3
1987CF2CF2ClClHCH(CH3)cPr
1988CF2CF2ClClHCH(CH3)(CH2)2CH3
1989CF2CF2ClClHCH(CH3)(CH2)4CH3
1990CF2CF2ClClHCH(CH3)CH2CH(CH3)2
1991CF2CF2ClClHCH(CH3)C(CH3)3
1992CF2CF2ClClHCH(CH3)CH(CH3)2
1993CF2CF2ClClHCH(CH2CH3)2
1994CF2CF2ClClHCH2—CH(OMe)2
1995CF2CF2ClClHCH2—CH(OEt)2
1996CF2CF2ClClHCH2CH2—OH
1997CF2CF2ClClHCH2CH2—OMe
1998CF2CF2ClClMeCH2CH2—OMe
1999CF2CF2ClClHCH(CH3)CH2—OMe
2000CF2CF2ClClHCH2CH2CH2—OMe
2001CF2CF2ClClHCH2—COOCH3
2002CF2CF2ClClMeCH2—COOCH3
2003CF2CF2ClClHCH(CH3)COOMe
2004CF2CF2ClClHCH(CH3)COOEt
2005CF2CF2ClClHCH2CH2—COOCH3
2006CF2CF2ClBrHH
2007CF2CF2ClBrHMe
2008CF2CF2ClBrHEt
2009CF2CF2ClBrHPr
2010CF2CF2ClBrHiPr
2011CF2CF2ClBrHcPr
2012CF2CF2ClBrHBu
2013CF2CF2ClBrHcBu
2014CF2CF2ClBrHtBu
2015CF2CF2ClBrMeMe
2016CF2CF2ClBrEtEt
2017CF2CF2ClBrHCH2—cPr
2018CF2CF2ClBrHCH2—C(CH3)3
2019CF2CF2ClBrHCH2CH(CH3)2
2020CF2CF2ClBrHCH2CH(CH2CH3)2
2021CF2CF2ClBrHCH2CH2CH(CH3)2
2022CF2CF2ClBrHCH2CH2C(CH3)3
2023CF2CF2ClBrHCH2CH═CH2
2024CF2CF2ClBrMeCH2CH═CH2
2025CF2CF2ClBrHCH2—C(CH3)═CH2
2026CF2CF2ClBrHCH2—CCH
2027CF2CF2ClBrMeCH2—CCH
2028CF2CF2ClBrHCH(CH3)CH2CH3
2029CF2CF2ClBrHCH(CH3)cPr
2030CF2CF2ClBrHCH(CH3)(CH2)2CH3
2031CF2CF2ClBrHCH(CH3)(CH2)4CH3
2032CF2CF2ClBrHCH(CH3)CH2CH(CH3)2
2033CF2CF2ClBrHCH(CH3)C(CH3)3
2034CF2CF2ClBrHCH(CH3)CH(CH3)2
2035CF2CF2ClBrHCH(CH2CH3)2
2036CF2CF2ClBrHCH2—CH(OMe)2
2037CF2CF2ClBrHCH2—CH(OEt)2
2038CF2CF2ClBrHCH2CH2—OH
2039CF2CF2ClBrHCH2CH2—OMe
2040CF2CF2ClBrMeCH2CH2—OMe
2041CF2CF2ClBrHCH(CH3)CH2—OMe
2042CF2CF2ClBrHCH2CH2CH2—OMe
2043CF2CF2ClBrHCH2—COOCH3
2044CF2CF2ClBrMeCH2—COOCH3
2045CF2CF2ClBrHCH(CH3)COOMe
2046CF2CF2ClBrHCH(CH3)COOEt
2047CF2CF2ClBrHCH2CH2—COOCH3
2048CF2CF2ClIHH
2049CF2CF2ClIHMe
2050CF2CF2ClIHEt
2051CF2CF2ClIHPr
2052CF2CF2ClIHiPr
2053CF2CF2ClIHcPr
2054CF2CF2ClIHBu
2055CF2CF2ClIHcBu
2056CF2CF2ClIHtBu
2057CF2CF2ClIMeMe
2058CF2CF2ClIEtEt
2059CF2CF2ClIHCH2—cPr
2060CF2CF2ClIHCH2—C(CH3)3
2061CF2CF2ClIHCH2CH(CH3)2
2062CF2CF2ClIHCH2CH(CH2CH3)2
2063CF2CF2ClIHCH2CH2CH(CH3)2
2064CF2CF2ClIHCH2CH2C(CH3)3
2065CF2CF2ClIHCH2CH═CH2
2066CF2CF2ClIMeCH2CH═CH2
2067CF2CF2ClIHCH2—C(CH3)═CH2
2068CF2CF2ClIHCH2—CCH
2069CF2CF2ClIMeCH2—CCH
2070CF2CF2ClIHCH(CH3)CH2CH3
2071CF2CF2ClIHCH(CH3)cPr
2072CF2CF2ClIHCH(CH3)(CH2)2CH3
2073CF2CF2ClIHCH(CH3)(CH2)4CH3
2074CF2CF2ClIHCH(CH3)CH2CH(CH3)2
2075CF2CF2ClIHCH(CH3)C(CH3)3
2077CF2CF2ClIHCH(CH3)CH(CH3)2
2078CF2CF2ClIHCH(CH2CH3)2
2079CF2CF2ClIHCH2—CH(OMe)2
2080CF2CF2ClIHCH2—CH(OEt)2
2081CF2CF2ClIHCH2CH2—OH
2082CF2CF2ClIMeCH2CH2—OMe
2083CF2CF2ClIHCH2CH2—OMe
2084CF2CF2ClIHCH(CH3)CH2—OMe
2085CF2CF2ClIHCH2CH2CH2—OMe
2086CF2CF2ClIMeCH2—COOCH3
2087CF2CF2ClIHCH2—COOCH3
2088CF2CF2ClIHCH(CH3)COOMe
2089CF2CF2ClIHCH(CH3)COOEt
2090CFClCF3HHCH2CH2—COOCH3
2091CFClCF3HHH
2092CFClCF3HHMe
2093CFClCF3HHEt
2094CFClCF3HHPr
2095CFClCF3HHiPr
2096CFClCF3HHcPr
2097CFClCF3HHBu
2098CFClCF3HHtBu
2099CFClCF3HMeMe
2100CFClCF3HEtEt
2101CFClCF3HHCH2—cPr
2102CFClCF3HHCH2—C(CH3)3
2103CFClCF3HHCH2CH(CH3)2
2104CFClCF3HHCH2CH(CH2CH3)2
2105CFClCF3HHCH2CH2CH(CH3)2
2106CFClCF3HHCH2CH2C(CH3)3
2107CFClCF3HHCH2CH═CH2
2108CFClCF3HMeCH2CH═CH2
2109CFClCF3HHCH2—C(CH3)═CH2
2110CFClCF3HHCH2—CCH
2111CFClCF3HMeCH2—CCH
2112CFClCF3HHCH(CH3)CH2CH3
2113CFClCF3HHCH(CH3)cPr
2114CFClCF3HHCH(CH3)(CH2)2CH3
2115CFClCF3HHCH(CH3)(CH2)4CH3
2116CFClCF3HHCH(CH3)CH2CH(CH3)2
2117CFClCF3HHCH(CH3)C(CH3)3
2118CFClCF3HHCH(CH3)CH(CH3)2
2119CFClCF3HHCH(CH2CH3)2
2120CFClCF3HHCH—CH(OMe)2
2121CFClCF3HHCH—CH(OEt)2
2122CFClCF3HHCH2CH2—OH
2123CFClCF3HHCH2CH2—OMe
2124CFClCF3HMeCH2CH2—OMe
2125CFClCF3HHCH(CH3)CH2—OMe
2126CFClCF3HHCH2CH2CH2—OMe
2127CFClCF3HHCH2—COOCH3
2128CFClCF3HMeCH2—COOCH3
2129CFClCF3HHCH(CH3)COOMe
2130CFClCF3HHCH(CH3)COOEt
2131CFClCF3HHCH2CH2—COOCH3
2132CFClCF3BrHH
2133CFClCF3BrHMe
2134CFClCF3BrHEt
2135CFClCF3BrHPr
2136CFClCF3BrHiPr
2137CFClCF3BrHcPr
2138CFClCF3BrHBu
2139CFClCF3BrHcBu
2140CFClCF3BrHtBu
2141CFClCF3BrMeMe
2142CFClCF3BrEtEt
2143CFClCF3BrHCH2—cPr
2144CFClCF3BrHCH2—C(CH3)3
2145CFClCF3BrHCH2CH(CH3)2
2146CFClCF3BrHCH2CH(CH2CH3)2
2147CFClCF3BrHCH2CH2CH(CH3)2
2148CFClCF3BrHCH2CH2C(CH3)3
2149CFClCF3BrHCH2CH═CH2
2150CFClCF3BrMeCH2CH═CH2
2151CFClCF3BrHCH2—C(CH3)═CH2
2152CFClCF3BrHCH2—C≡CH
2153CFClCF3BrMeCH2—C≡CH
2154CFClCF3BrHCH(CH3)CH2CH3
2155CFClCF3BrHCH(CH3)cPr
2156CFClCF3BrHCH(CH3)(CH2)2CH3
2157CFClCF3BrHCH(CH3)(CH2)4CH3
2158CFClCF3BrHCH(CH3)CH2CH(CH3)2
2159CFClCF3BrHCH(CH3)C(CH3)3
2160CFClCF3BrHCH(CH3)CH(CH3)2
2161CFClCF3BrHCH(CH2CH3)2
2162CFClCF3BrHCH2—CH(OMe)2
2163CFClCF3BrHCH2—CH(OEt)2
2164CFClCF3BrHCH2CH2—OH
2165CFClCF3BrHCH2CH2—OMe
2166CFClCF3BrMeCH2CH2—OMe
2167CFClCF3BrHCH(CH3)CH2—OMe
2168CFClCF3BrHCH2CH2CH2—OMe
2169CFClCF3BrHCH2—COOCH3
2170CFClCF3BrMeCH2—COOCH3
2171CFClCF3BrHCH(CH3)COOMe
2172CFClCF3BrHCH(CH3)COOEt
2173CFClCF3BrHCH2CH2—COOCH3

[0000]

NMR data of compounds from Table 1
Ex. No.1H-NMR data
1[CDCl3] 3.03 (d, 3H); 6.88 (d, 1H); 8.65 (d, 1H); 9.22 (br, 1H)
2[CDCl3] 1.25 (t, 3H); 3.5 (m, 2H); 6.92 (d, 1H); 8.72 (d, 1H), 9.33 (br, 1H), 13.4 (br, 1H)
3[CDCl3] 1.02 (t, 3H); 1.62 (m, 2H); 3.42 (m, 2H); 6.90 (d, 1H); 8.70 (d, 1H); 9.35 (br, 1H);
13.3 (br, 1H)
4[CDCl3] 1.25 (d, 6H); 4.22 (m, 1H); 6.90 (d, 1H); 8.68 (d, 1H); 9.22 (d, br, 1H)
5[CDCl3] 0.61 (m, 2H); 0.89 (m, 2H); 3.00 (m, 1H); 6.90 (d, 1H); 8.68 (d, 1H), 9.31 (br, 1H)
6[CDCl3] 0.96 (t, 3H); 1.41 (m, 2H); 1.61 (m, 2H); 3.48 (q, 2H); 6.90 (d, 1H); 8.70 (d, 1H);
9.31 (br, 1H); 13.3 (br, 1H)
7[CDCl3] 1.80 (m, 2H); 2.00 (m, 2H); 2.42 (m, 2H); 4.55 (m, 1H); 6.88 (d, 1H); 8.65 (d, 1H);
9.50 (br, 1H)
8[CDCl3] 1.44 (s, 9H); 6.90 (d, 1H); 8.62 (d, 1H); 9.32 (br, 1H); 13.4 (br, 1H)
9[CDCl3] 3.05 (s, 6H); 7.10 (d, 1H); 7.77 (d, 1H)
10[CDCl3] 1.22 (t, 3H); 3.02 (s, 3H); 3.46 (m, 2H); 7.08 (d, 1H); 7.77 (d, 1H)
11[CDCl3] 0.90 (t, 3H); 1.30 (br, 2H); 1.60 (m, 2H); 3.03 (s, 3H); 3.42 (br, 2H); 7.10 (d, 1H);
7.74 (d, 1H)
13[CDCl3] 1.20 (d, 6H); 2.90 (s, 3H); 4.05 (m, br, 1H); 7.03 (d, 1H); 8.68 (d, 1H); 11.2 (br)
14[CDCl3] 1.20 (t, 6H); 3.40 (m, 4H); 7.05 (d, 1H); 8.70 (d, 1H); 11.1 (br)
16[CDCl3] 1.21 (m, 9H); 3.39 (q, 2H); 4.0 (br, 1H); 7.04 (d, 1H); 7.68 (d, 1H); 10.6 (br, 1H)
18[CDCl3] 1.5-1.8 (m, 8H); 4.40 (m, 1H); 6.90 (d, 1H); 8.68 (d, 1H); 9.40 (d, br, 1H); 13.5 (br)
19[CDCl3] 1.2-1.5 (m, 6H); 1.76 (m, 2H); 2.00 (m, 2H); 4.00 (m, 1H); 6.90 (d, 1H); 8.68 (d, 1H);
9.30 (d, br, 1H); 13.4 (br, 1H)
20[CDCl3] 0.90 (t, 3H); 1.38 (m, 4H); 1.61 (m, 2H); 3.41 (m, 2H); 6.86 (d, 1H); 8.63 (d, 1H);
9.20 (t, 1H)
22[CDCl3] 0.30 (m, 2H); 0.60 (m, 2H); 1.05 (m, 1H); 3.30 (m, 2H); 6.90 (d, 1H), 8.70 (d, 1H);
9.38 (br, 1H)
24[CDCl3] 1.00 (s, 9H); 3.28 (d, 2H); 6.90 (d, 1H); 8,73 (d, 1H); 9.4 (br, 1H); 13.2 (br, 1H)
25[CDCl3] 4.18 (dt, 2H); 6.92 (d, 1H); 8.72 (d, 1H); 9.8 (t, br, 1H)
26[CDCl3] 4.11 (m, 2H); 6.90 (d, 1H); 8.70 (d, 1H); 9.80 (br, 1H); 12.16 (br, 1H)
27[CDCl3] 4.22 (dt; 2H); 6.93 (d, 1H); 8.72 (d, 1H); 9.80 (t, br, 1H)
30[CDCl3] 1.00 (d, 6H); 1.87 (m, 1H); 3.29 (t, 2H); 6.88 (d, 1H); 8.64 (d, 1H); 9.32 (br, 1H);
12.5 (br, 1H)
32[CDCl3] 0.95 (d, 6H); 1.48 (m, 2H); 1.70 (m, 1H); 3.48 (m, 2H); 6.88 (d, 1H); 8.65 (d, 1H);
9.22 (br, 1H), 12.6 (br)
34[CDCl3] 4.10 (t, 2H); 5.22 (dd, 2H); 5.95 (m, 1H); 6.90 (d, 1H); 8.70 (d, 1H); 9.40 (br, 1H);
12.7 (br, 1H)
36[CDCl3] 4.0 (m, 4H); 5.21 (d, 4H); 5.80 (m, 2H); 7.04 (d, 1H); 7.78 (d, 1H); 11.0 (br)
38[CDCl3] 1.80 (s, 3H); 4.02 (d, 2H); 4.93 (d, 2H); 6.89 (d 1H); 8.70 (d, 1H); 9.43 (br, 1H);
13.2 (br, 1H)
39[CDCl3] 2.24 (t, 1H); 4.22 (m, 2H); 6.88 (d, 1H); 8.68 (d, 1H); 9.50 (br, 1H)
40[CDCl3] 2.30 (s, 1H); 3.12 (s, 3H); 4.22 (br, 2H); 7.04 (d, 1H); 7.84 (d, 1H); 10.9 (br)
41[CDCl3] 0.95 (t, 3H); 1.22 (d, 3H); 1.58 (m, 2H); 4.10 (m, 1H); 6.88 (d, 1H); 8.66 (d, 1H);
9.20 (br, 1H); 13.0 (br, 1H)
43[DMSO] 0.93 (t, 3H); 1.16 (d, 3H); 1.30 (m, 2H); 1.48 (m, 2H); 4.00 (m, 1H); 7.35 (br, 1H);
7.39 (d, 1H); 8.40 (d, 1H); 13.40 (br)
44[DMSO] 0.87 (t, 3H); 1.15 (d, 3H); 1.27 (m, 6H); 1.48 (m, 2H); 4.00 (m, 1H); 7.33 (d, 1H);
8.40 (d, 1H); 8.80 (br, 1H), 13.4 (br, 1H)
47[CDCl3] 0.93 (d, 6H); 1.22 (d, 3H); 1.35 (m, 1H), 1.50 (m, 1H); 1.65 (m, 1H); 4.23 (m, 1H);
6.90 (d, 1H); 8.64 (d, 1H); 9.20 (d, br, 1H); 13.3 (br, 1H)
48[CDCl3] 0.96 (s, 9H); 1.18 (d, 3H); 4.10 (m, 1H); 6.90 (d, 1H); 8.74 (d, 1H); 9.37 (d, br, 1H),
13.6 (br, 1H)
49[CDCl3] 0.95 (dt, 6H); 1.20 (d, 3H); 1.80 (m, 1H); 4.07 (m, 1H); 6.90 (d, 1H); 8.70 (d, 1H);
9.30 (d, br, 1H); 13.6 (br)
51[DMSO] 0.85 (t, 6H); 1.45 (m, 2H); 1.55 (m, 2H); 3.80 (m, 1H); 7.33 (d, br, 1H); 8.38 (d, 1H);
8.65 (br, 1H); 13.5 (br, 1H)
54[CDCl3] 3.40 (s, 6H); 3.62 (t, 2H); 4.50 (t, 1H); 6.89 (d, 1H); 8.65 (d, 1H); 9.30 (br, 1H);
12.4 (br, 1H)
55[CDCl3] 1.21 (t, 6H); 3.60 (m, 4H); 3.72 (m, 2H); 4.61 (t, 1H); 6.88 (d, 1H); 8.61 (d, 1H);
9.28 (br, 1H), 12.0 (br)
56[DMSO] 3.40 (m, 2H); 3.53 (m, 2H); 7.32 (d, br, 1H); 8.45 (d, 1H); 9.05 (br, 1H); 13.6 (br,
1H)
57[CDCl3] 3.40 (s, 3H); 3.56 (t, 2H); 3.64 (m, 2H); 6.90 (d, 1H), 8.65 (d, 1H); 9.35 (br, 1H)
64[CDCl3] 1.25 (d, 3H); 3.40 (s, 3H); 3.43 (d, 2H); 4.37 (m, 1H); 6.89 (d, 1H); 8.64 (d, 1H);
9.30 (d, br, 1H); 13.0 (br, 1H)
66[CDCl3] 1.90 (m, 2H); 3.34 (s, 3H); 3.46 (t, 2H); 3.55 (q, 2H); 6.90 (d, 1H); 8.60 (d, 1H);
9.23 (br, 1H); 12.5 (br)
71[CDCl3] 3.80 (s, 3H); 4.22 (d, 2H); 6.88 (d, 1H); 8.64 (d, 1H); 9.62 (t, 1H),
72[CDCl3] 3.10 (s, 3H); 3.75 (s, 3H); 4.25 (s, 2H); 7.18 (d, 1H); 7.80 (d, 1H)
75[CDCl3] 2.64 (t, 2H); 3.69 (s, 3H); 3.73 (m, 2H); 6.88 (d, 1H); 8.61 (d, 1H); 9.41 (t, br, 1H);
12.2 (br, 1H)
76[CDCl3] 3.83 (s, 6H); 5.42 (d, 1H); 6.90 (d, 1H); 8.63 (d, 1H), 10.2 (br, 1H),
77[CDCl3] 0.99 (t, 6H); 1.25 (t, 3H)1.75 (m, 3H); 4.20 (m, 2H); 4.72 (m, 1H); 6.90 (d, 1H);
8.64 (d, 1H); 9.60 (d, br, 1H)
78[CDCl3] 1.05 (t, 6H); 2.30 (m, 1H); 3.78 (s, 3H); 4.72 (m, 1H); 6.90 (d, 1H); 8.70 (d, 1H);
9.76 (d, br, 1H), 13.6 (br, 1H)
79[CDCl3] 1.35 (t, 3H); 4.10 (q, 2H); 6.91 (d, 1H); 8.71 (d, 1H); 11.46 (s, 1H)
80[CDCl3] 3.41 (s, 3H); 3.68 (s, 3H); 7.18 (d, 1H); 8.32 (d, 1H)
81[CDCl3] 4.50 (d, 2H); 5.3 (m, 2H); 6.0 (m, 1H); 6.90 (d, 1H); 8.70 (d, 1H); 11.43 (s, 1H)
82[CDCl3] 1.36 (s, 9H); 6.92 (d, 1H); 8.72 (d, 1H); 11.22 (s, 1H); 13.0 (br, 1H)
92[CDCl3] 4.62 (d, 2H), 6.84 (d, 1H); 7.3 (m, 5H); 8.70 (d, 1H); 9.65 (br, 1H), 13.0 (br, 1H)
93[CDCl3] 2.95 (s, 3H); 4.65 (br, 2H); 7.05 (d, 1H); 7.3 (m, 5H), 7.82 (d, 1H); 11.7 (br)
94[DMSO] 4.55 (d, 2H); 7.33 (d, 1H); 7.37 (dd, 1H); 7.75 (dt, 1H); 8.40 (d, 1H); 8.48 (dd, 1H);
8.58 (s, 1H); 9.45 (br, 1H); 13.4 (br, 1H)
95[DMSO] 4.55 (d, 2H); 7.30 (d, br, 1H); 7.50 (d, 1H); 7.80 (dd, 1H); 8.37 (m, 2H); 9.55 (br,
1H); 13.4 (br, 1H)
96[CDCl3] 1.59 (d, 3H); 5.25 (m, 1H); 6.88 (d, 1H); 7.2-7.4 (m, 5H); 8.68 (d, 1H); 9.75 (d, br,
1H); 13.5 (br, 1H)
97[CDCl3] 2.94 (t, 2H); 3.70 (m, 2H); 6.85 (d, 1H); 7.2-7.4 (m, 5H); 8.62 (d, 1H); 9.24 (br, 1H)
98[CDCl3] 4.81 (d, 2H); 6.85 (d, 1H); 7.40 (t, 1H); 7.52 (t, 1H); 7.61 (d, 1H); 7.67 (d, 1H);
8.68 (d, 1H); 9.68 (t, br, 1H)
99[DMSO] 2.28 (q, 2H); 3.20 (q, 2H); 4.03 (t, 1H); 7.1-7.4 (m, 11H); 8.35 (d, 1H); 9.0 (br),
13.4 (br, 1H)
100[CDCl3] 3.45-3.55 (br, 4H); 3.75 (m, 4H); 7.03 (d, 1H); 7.80 (d, 1H); 11.3 (br, 1H)
101[CDCl3] 1.65 (m, 6H); 3.52 (m, 4H); 7.10 (d, 1H); 7.72 (d, 1H)
102[CDCl3] 3.06 (t, 2H); 3.90 (m, 2H); 4.65 (m, 2H); 7.08 (d, 1H); 7.90 (d, 1H); 11.0 (br)
103[CDCl3] 2.00 (m, 4H); 3.67 (m, 4H); 7.20 (d, 1H); 7.97 (d, 1H), 11.7 (br, 1H)
104[CDCl3] 1.30 (m, 3H); 1.65 (m, 1H); 1.85 (m, 1H); 2.00 (m, 1H); 2.19 (m, 1H); 3.62 (m, 2H);
4.30 (m, 1H); 7.10 (d, 1H); 7.89 (d, 1H)
105[CDCl3] 3.25 (s, 3H); 3.35 (3.3H); 7.25 (d, 1H); 8.58 (d, 1H); 8.76 (s, 1H)
112[CDCl3] 1.95 (m, 1H); 2.65 (m, 1H); 2.90 (m, 1H); 3.05 (m, 1H); 5.60 (m, 1H); 6.85 (d, 1H);
7.2-7.4 (m, 4H); 8.68 (d, 1H); 9.52 (d, br, 1H)
113[CDCl3] 1.60 (m, 1H), 1.90 (m, 2H), 2.01 (m, 1H); 3.42 (m, 1H), 3.65-3.82 (m, 2H), 3.90 (m,
1H), 4.09 (m, 1H); 6.88 (d, 1H); 8.63 (d, 1H); 9.37 (br, 1H)
114[DMSO] 7.35 (d, 1H); 8.10 (br, 1H); 8.40 (d, 1H); 8.41 (br, 1H); 13.6 (br, 1H)
115[CDCl3] 3.01 (d, 3H); 6.81 (d, 1H); 8.63 (d, 1H); 9.22 (br, 1H); 11.7 (br, 1H)
116[CDCl3] 1.25 (t, 3H); 3.5 (m, 2H); 6.85 (d, 1H); 8.66 (d, 1H), 9.33 (br, 1H), 13.0 (br, 1H)
117[CDCl3] 1.01 (t, 3H); 1.62 (m, 2H); 3.42 (m, 2H); 6.86 (d, 1H); 8.66 (d, 1H); 9.35 (br, 1H);
12.6 (br, 1H)
118[CDCl3] 1.27 (d, 6H); 4.25 (m, 1H); 6.85 (d, 1H); 8.64 (d, 1H); 9.27 (br, 1H); 13.1 (br, 1H)
119[CDCl3] 0.62 (m, 2H); 0.85 (m, 2H); 3.02 (m, 1H); 6.84 (d, 1H); 8.78 (d, 1H), 9.33 (br, 1H)
120[CDCl3] 0.98 (t, 3H); 1.41 (m, 2H); 1.61 (m, 2H); 3.45 (q, 2H); 6.83 (d, 1H); 8.65 (d, 1H);
9.33 (br, 1H); 12.9 (br, 1H)
121[CDCl3] 1.80 (m, 2H); 2.05 (m, 2H); 2.44 (m, 2H); 4.58 (m, 1H); 6.84 (d, 1H); 8.63 (d, 1H);
9.60 (br, 1H); 13.1 (br)
122[CDCl3] 1.46 (s, 9H); 6.86 (d, 1H); 8.62 (d, 1H); 9.34 (br, 1H); 13.4 (br, 1H)
123[CDCl3] 3.08 (s, 6H); 7.06 (d, 1H); 7.79 (d, 1H)
124[CDCl3] 1.23 (t, 3H); 3.04 (s, 3H); 3.46 (m, 2H); 7.02 (d, 1H); 7.72 (d, 1H)
125[CDCl3] 0.92 (t, 3H); 1.30 (br, 2H); 1.60 (m, 2H); 3.04 (s, 3H); 3.41 (br, 2H); 7.04 (d, 1H);
7.71 (d, 1H)
127[CDCl3] 1.20 (d, 6H); 2.90 (s, 3H); 4.05 (m, br, 1H); 7.00 (d, 1H); 7.68 (d, 1H)
128[CDCl3] 1.20 (t, 6H); 3.41 (m, 4H); 6.98 (d, 1H); 7.66 d, 1H); 11.0 (br)
130[CDCl3] 1.20 (m, 9H); 3.40 (q, 2H); 4.06 (m, br, 1H); 6.98 (d, 1H); 8.64 (d, 1H); 10.2 (br)
132[CDCl3] 1.5-1.8 (m, 8H); 4.40 (m, 1H); 6.85 (d, 1H); 8.65 (d, 1H); 9.40 (d, br, 1H); 13.1 (br,
1H)
133[CDCl3] 1.2-1.7 (m, 6H); 1.80 (m, 2H); 2.00 (m, 2H); 3.98 (m, 1H); 6.85 (d, 1H); 8.64 (d, 1H);
9.30 (d, br, 1H); 13.0 (br)
134[CDCl3] 0.90 (t, 3H); 1.40 (m, 4H); 1.62 (m, 2H); 3.44 (m, 2H); 6.84 (d, 1H); 8.64 (d, 1H);
9.30 (br, 1H)
136[CDCl3] 0.30 (m, 2H); 0.59 (m, 2H); 1.05 (m, 1H); 3.32 (m, 2H); 6.86 (d, 1H), 8.65 (d, 1H);
9.40 (br)
138[CDCl3] 1.00 (s, 9H); 3.26 (d, 2H); 6.86 (d, 1H); 8.70 (d, 1H); 9.42 (br, 1H); 12.5 (br, 1H)
139[DMSO] 4.25 (dt, 2H); 7.25 (d, 1H); 8.40 (d, 1H); 9.35 (br, 1H); 13.5 (br, 1H)
140[CDCl3] 4.15 (m, 2H); 6.88 (d, 1H); 8.70 (d, 1H); 9.80 (br, 1H)
141[CDCl3] 4.20 (dt; 2H); 6.90 (d, 1H); 8.70 (d, 1H); 9.83 (t, br, 1H); 12.80 (br)
144[CDCl3] 1.00 (d, 6H); 1.90 (m, 1H); 3.30 (t, 2H); 6.83 (d, 1H); 8.65 (d, 1H); 9.35 (br, 1H);
12.2 (br)
146[CDCl3] 0.96 (d, 6H); 1.50 (m, 2H); 1.70 (m, 1H); 3.48 (m, 2H); 6.83 (d, 1H); 8.67 (d, 1H);
9.30 (br, 1H), 12.9 (br, 1H)
148[CDCl3] 4.62 (d, 2H); 5.36 (dd, 2H); 5.95 (m, 1H); 7.80 (d, 1H); 8.65 (d, 1H)
150[CDCl3] 4.0 (m, 4H); 5.22 (d, 4H); 5.80 (m, 2H); 6.93 (d, 1H); 7.72 (d, 1H)
152[CDCl3] 1.80 (s, 3H); 4.02 (d, 2H); 4.90 (d, 2H); 6.85 (d 1H); 8.68 (d, 1H); 9.48 (br, 1H);
12.8 (br, 1H)
153[CDCl3] 2.26 (t, 1H); 4.23 (m, 2H); 6.84 (d, 1H); 8.64 (d, 1H); 9.58 (br, 1H); 12.4 (br)
154[CDCl3] 2.30 (s, 1H); 3.12 (s, 3H); 4.24 (br, 2H); 7.01 (d, 1H); 7.82 (d, 1H); 10.9 (br)
155[CDCl3] 0.98 (t, 3H); 1.22 (d, 3H); 1.59 (m, 2H); 4.10 (m, 1H); 6.85 (d, 1H); 8.65 (d, 1H);
9.26 (d, br, 1H); 13.4 (br, 1H)
157[CDCl3] 0.92 (t, 3H); 1.22 (d, 3H); 1.40 (m, 2H); 1.55 (m, 2H); 4.20 (m, 1H); 6.85 (d, 1H);
8.68 (d, 1H); 9.30 (d, br, 1H)
158[CDCl3] 0.87 (t, 3H); 1.12 (d, 3H); 1.30 (m, 4H); 1.58 (m, 4H); 4.15 (m, 1H); 6.84 (d, 1H);
8.65 (d, 1H); 9.24 (br, 1H), 13.1 (br)
161[CDCl3] 0.90 (d, 6H); 1.22 (d, 3H), 1.30 (m, 1H); 1.55 (m, 2H); 4.23 (m, 1H); 6.86 (d, 1H);
8.64 (d, 1H); 9.20 (d, br, 1H); 13.0 (br, 1H)
162[CDCl3] 0.98 (s, 9H); 1.20 (d, 3H); 4.10 (m, 1H); 6.87 (d, 1H); 8.70 (d, 1H); 9.38 (d, br, 1H),
13.2 (br, 1H)
163[CDCl3] 0.95 (dt, 6H); 1.20 (d, 3H); 1.82 (m, 1H); 4.05 (m, 1H); 6.84 (d, 1H); 8.68 (d, 1H);
9.30 (d, br, 1H); 13.1 (br)
165[CDCl3] 0.96 (t, 6H); 1.50 (m, 2H); 1.65 (m, 2H); 4.00 (m, 1H); 6.85 (d, 1H); 8.68 (d, 1H);
9.22 (d, br, 1H); 13.5 (br, 1H)
166[CDCl3] 0.90 (t, 3H); 1.41 (s; 6H); 1.85 (q, 2H); 6.82 (d, 1H); 8.61 (d, 1H); 9.20 (br, 1H);
13.1 (br)
168[CDCl3] 3.40 (s, 6H); 3.63 (t, 2H); 4.50 (t, 1H); 6.85 (d, 1H); 8.65 (d, 1H); 9.40 (br, 1H);
12.4 (br, 1H)
169[CDCl3] 1.21 (t, 6H); 3.60 (m, 4H); 3.74 (m, 1H); 4.62 (t, 1H); 6.84 (d, 1H); 8.60 (d, 1H);
9.35 (br, 1H), 11.5 (br)
171[CDCl3] 3.40 (s, 3H); 3.58 (m, 2H); 3.67 (m, 2H); 6.84 (d, 1H), 8.62 (d, 1H); 9.40 (br, 1H)
178[CDCl3] 1.24 (d, 3H); 3.40 (s, 3H); 3.42 (d, 2H); 4.40 (m, 1H); 6.86 (d, 1H); 8.64 (d, 1H);
9.35 (br, 1H); 13.0 (br)
180[DMSO] 1.75 (m, 2H); 3.22 (s, 3H); 3.36 (m, 4H); 7.3 (br, 1H); 8.4 (d, 1H); 9.0 (br); 13.4 (br,
1H)
185[DMSO] 3.65 (s, 3H); 4.12 (d, 2H); 7.28 (d, br, 1H); 8.42 (d, 1H); 9.25 (t, br, 1H), 13.6 (br,
1H)
189[CDCl3] 2.66 (t, 2H); 3.70 (s, 3H); 3.76 (m, 2H); 6.83 (d, 1H); 8.61 (d, 1H); 9.51 (t, br, 1H);
12.4 (br, 1H)
193[CDCl3] 1.37 (t, 3H); 4.08 (q, 2H); 6.88 (d, 1H); 8.69 (d, 1H); 11.48 (s, 1H)
194[CDCl3] 3.88 (s, 3H); 6.88 (d, 1H); 8.65 (d, 1H); 11.5 (s, 1H)
195[CDCl3] 4.50 (d, 2H); 5.34 (m, 2H); 6.05 (m, 1H); 6.88 (d, 1H); 8.70 (d, 1H); 11.44 (s, 1H)
196[CDCl3] 1.39 (s, 9H); 6.88 (d, 1H); 8.70 (d, 1H); 11.22 (s, 1H)
206[CDCl3] 4.62 (d, 2H), 6.82 (d, 1H); 7.2-7.3 (m, 5H); 8.68 (d, 1H); 9.65 (t, br, 1H), 12.8 (br,
1H)
207[CDCl3] 2.99 (s, 3H); 4.67 (br, 2H); 7.00 (d, 1H); 7.3-7.4 (m, 5H), 7.78 (d, 1H); 10.2 (br)
210[CDCl3] 1.60 (d, 3H); 5.30 (m, 1H); 6.85 (d, 1H); 7.2-7.4 (m, 5H); 8.65 (d, 1H); 9.78 (d, br,
1H); 13.2 (br, 1H)
211[CDCl3] 2.95 (t, 2H); 3.70 (m, 2H); 6.82 (d, 1H); 7.2-7.35 (m, 5H); 8.63 (d, 1H); 9.40 (t, br,
1H); 12.2 (br, 1H)
214[CDCl3] 3.45-3.55 (br, 4H); 3.75 (m, 4H); 6.96 (d, 1H); 7.78 (d, 1H)
215[CDCl3] 1.65 (m, 6H); 3.53 (m, 4H); 7.00 (d, 1H); 7.70 (d, 1H)
216[CDCl3] 3.05 (t, 2H); 3.92 (m, 2H); 4.66 (m, 2H); 7.04 (d, 1H); 7.86 (d, 1H); 10.4 (br)
217[CDCl3] 2.00 (m, 4H); 3.70 (m, 4H); 7.16 (d, 1H); 7.97 (d, 1H), 11.7 (br, 1H)
218[CDCl3] 1.30 (m, 3H); 1.65 (m, 1H); 1.85 (m, 1H); 2.04 (m, 1H); 2.20 (m, 1H); 3.63 (m, 2H);
4.33 (m, 1H); 7.12 (d, 1H); 7.89 (d, 1H), 11.5 (br, 1H)
227[CDCl3] 1.60 (m, 1H), 1.90 (m, 2H), 2.00 (m, 1H); 3.42 (m, 1H), 3.65-3.82 (m, 2H), 3.90 (m,
1H), 4.10 (m, 1H); 6.88 (d, 1H); 8.65 (d, 1H); 9.5 (br, 1H)
228[DMSO] 6.80 (br, 1H); 6.90 (t, 1H); 7.72 (br, 1H); 8.40 (d, 1H); 8.90 (br, 1H); 13.20 (br, 1H)
229[DMSO] 2.82 (d, 3H); 6.75 (d, br, 1H); 6.90 (t, 1H); 8.89 (d, 1H); 9.50 (br, 1H); 13.2 (br, 1H)
230[DMSO] 1.11 (t, 3H); 3.32 (m, 2H); 6.75 (d, br, 1H); 6.90 (t, 1H); 8.39 (d, 1H), 9.60 (br, 1H),
13.2 (br, 1H)
232[CDCl3] 1.25 (d, 6H); 4.22 (m, 1H); 6.55 (t, 1H); 6.69 (d, 1H); 8.64 (d, 1H); 9.42 (d, br, 1H);
13.0 (br, 1H)
233[DMSO] 0.51 (m, 2H); 0.74 (m, 2H); 2.84 (m, 1H); 6.79 (d, br, 1H); 6.90 (t, 1H); 8.37 (d, 1H);
9.65 (br, 1H); 13.1 (br, 1H)
250[DMSO] 0.23 (m, 2H); 0.46 (m, 2H); 1.02 (m, 1H); 3.20 (m, 2H); 6.75 (br, 1H), 6.92 (t, 1H);
8.40 (d, 1H); 9.70 (br, 1H); 13.1 (br, 1H)
252[DMSO] 0.91 (s, 9H); 3.15 (d, 2H); 6.80 (br, 1H); 6.91 (t, 1H); 8.40 (d, 1H); 9.85 (br, 1H);
13.2 (br, 1H)
258[DMSO] 0.90 (d, 6H); 1.80 (m, 1H); 3.15 (t, 2H); 6.80 (br, 1H); 6.91 (t, 1H); 8.40 (d, 1H);
9.73 (br, 1H); 13.1 (br, 1H)
262[DMSO] 3.96 (m, 2H); 5.15 (dd, 2H); 5.94 (m, 1H); 6.80 (br, 1H); 6.92 (t, 1H); 8.40 (d, 1H);
9.75 (br, 1H); 13.2 (br, 1H)
271[CDCl3] 0.92 (t, 3H); 1.25 (d, 3H); 1.42 (m, 2H); 1.55 (m, 2H); 4.19 (m, 1H); 6.60 (t, 1H);
6.73 (d, 1H); 8.66 (d, 1H); 9.50 (d, br, 1H)
272[CDCl3] 0.90 (t, 3H); 1.2-1.4 (m, 9H); 1.58 (m, 2H); 4.17 (m, 1H); 6.60 (t, 1H); 6.75 (d, 1H);
8.68 (d, 1H); 9.48 (d, br, 1H)
279[CDCl3] 0.85 (t, 6H); 1.45 (m, 2H); 1.55 (m, 2H); 3.80 (m, 1H); 6.80 (br, 1H); 6.91 (t, 1H);
8.40 (d, 1H); 9.51 (br, 1H); 13.1 (br, 1H)
280[DMSO] 0.86 (t, 3H); 1.12 (d, 3H); 1.50 (m, 2H); 3.90 (m, 1H); 6.75 (br, 1H); 6.91 (t, 1H);
8.39 (d, 1H); 9.57 (br, 1H); 13.1 (br, 1H)
285[DMSO] 3.29 (s, 3H); 3.46 (m, 4H); 6.76 (br, 1H), 6.91 (t, 1H); 8.50 (d, 1H); 9.73 (br, 1H),
13.1 (br, 1H)
291[DMSO] 1.14 (d, 3H); 3.27 (s, 3H); 3.35 (m, 2H); 4.15 (m, 1H); 6.80 (br, 1H); 6.91 (t, 1H);
8.40 (d, 1H); 9.70 (br, 1H); 13.1 (br, 1H))
293[DMSO] 1.72 (m, 2H); 3.22 (s, 3H); 3.37 (m, 4H); 6.75 (br, 1H); 6.90 (t, 1H); 8.40 (d, 1H);
9.70 (br, 1H)); 13.2 (br, 1H)
341[DMSO] 7.45 (d, 1H); 8.15 (br, 1H); 8.45 (br, 1H); 8.50 (d, 1H); 13.7 (br, 1H)
342[CDCl3] 3.01 (d, 3H); 6.90 (d, 1H); 8.72 (d, 1H); 9.34 (br, 1H)
343[DMSO] 1.11 (t, 3H); 3.31 (m, 2H); 7.41 (d, 1H); 8.42 (d, 1H); 8.85 (br, 1H), 13.4 (br, 1H)
344[CDCl3] 1.02 (t, 3H); 1.61 (m, 2H); 3.42 (q, 2H); 6.88 (d, 1H); 8.72 (d, 1H); 9.38 (br, 1H)
345[CDCl3] 1.25 (d, 6H); 4.25 (m, 1H); 6.90 (d, 1H); 8.72 (d, 1H); 9.30 (d, br, 1H); 13.8 (br, 1H)
346[CDCl3] 0.60 (m, 2H); 0.88 (m, 2H); 3.02 (m, 1H); 6.90 (d, 1H); 8.72 (d, 1H); 9.42 (br, 1H);
13.4 (br)
347[DMSO] 0.88 (t, 3H); 1.34 (m, 2H); 1.50 (m, 2H); 3.31 (q, 2H); 7.27 (d, 1H); 8.35 (d, 1H);
9.21 (br, 1H); 12.4 (br, 1H)
348[DMSO] 1.70 (m, 2H); 2.02 (m, 2H); 2.27 (m, 2H); 4.40 (m, 1H); 7.41 (d, 1H); 8.48 (d, 1H);
9.00 (br, 1H); 13.4 (br, 1H)
349[DMSO] 1.36 (s, 9H); 7.35 (d, br, 1H); 8.40 (d, 1H); 8.60 (br, 1H); 13.3 (br, 1H)
350[CDCl3] 3.08 (s, 6H); 7.08 (d, 1H); 7.81 (d, 1H)
355[CDCl3] 1.21 (t, 6H); 3.42 (m, 4H); 7.04 (d, 1H); 7.71 (d, 1H); 10.8 (br)
363[DMSO] 0.27 (m, 2H); 0.46 (m, 2H); 1.05 (m, 1H); 3.15 (m, 2H); 7.45 (d, br, 1H); 8.45 (d,
1H); 8.95 (br, 1H); 13.4 (br, 1H)
365[DMSO] 0.91 (s, 9H); 3.15 (d, 2H); 7.38 (d, br, 1H); 8.40 (d, 1H); 8.83 (br, 1H); 13.4 (br, 1H)
373[DMSO] 0.90 (d, 6H); 1.42 (m, 2H); 1.63 (m, 1H); 3.33 (m, 2H); 7.40 (d, br, 1H); 8.40 (d,
1H); 8.83 (br, 1H), 13.4 (br, 1H)
375[DMSO] 3.95 (m, 2H); 5.15 (dd, 2H); 5.90 (m, 1H); 7.40 (d, 1H); 8.41 (d, 1H); 8.98 (br, 1H);
13.4 (br, 1H)
379[DMSO] 1.73 (s, 3H); 3.88 (m, 2H); 4.75 (d, 2H); 7.40 (d, br, 1H); 8.41 (d, 1H); 8.97 (br, 1H);
13.4 (br, 1H)
380[DMSO] 3.15 (t, 1H); 4.21 (m, 2H); 7.40 (d, 1H); 8.40 (d, 1H); 9.12 (br, 1H); 13.3 (br, 1H)
382[CDCl3] 0.97 (t, 3H); 1.22 (d, 3H); 1.59 (m, 2H); 4.10 (m, 1H); 6.88 (d, 1H); 8.72 (d, 1H);
9.24 (d, br, 1H); 13.6 (br)
384[CDCl3] 0.92 (t, 3H); 1.21 (d, 3H); 1.40 (m, 2H); 1.50 (m, 2H); 4.20 (m, 1H); 6.88 (d, 1H);
8.72 (d, 1H); 9.28 (d, br, 1H)
385[DMSO] 0.85 (t, 3H); 1.1-1.35 (m, 9H); 1.50 (m, 2H); 4.00 (m, 1H); 7.41 (d, 1H); 8.40 (d,
1H); 8.65 (br, 1H); 13.4 (br, 1H)
388[DMSO] 0.88 (d, 6H); 1.15 (d, 3H), 1.28 (m, 1H); 1.48 (m, 1H); 1.62 (m, 1H); 4.11 (m, 1H);
7.40 (d, br, 1H); 8.40 (d, 1H); 8.52 (d, br, 1H); 13.4 (br, 1H)
389[DMSO] 0.90 (s, 9H); 1.10 (d, 3H); 3.90 (m, 1H); 7.38 (d, br, 1H); 8.40 (d, 1H); 8.70 (br, 1H),
13.4 (br, 1H)
390[DMSO] 0.79 (dt, 6H); 1.10 (d, 3H); 1.75 (m, 1H); 3.87 (m, 1H); 7.40 (d, br, 1H); 8.41 (d,
1H); 8.65 (d, br, 1H); 13.4 (br, 1H)
392[CDCl3] 0.95 (t, 6H); 1.50 (m, 2H); 1.65 (m, 2H); 4.00 (m, 1H); 6.90 (d, 1H); 8.75 (d, 1H);
9.20 (d, br, 1H); 13.7 (br, 1H)
395[DMSO] 3.30 (s, 6H); 3.42 (t, 2H); 4.50 (t, 1H); 7.40 (d, br, 1H); 8.45 (d, 1H); 8.90 (br, 1H);
13.4 (br, 1H)
397[DMSO] 3.38 (m, 2H); 3.52 (m, 2H); 4.80 (t, 1H); 7.40 (d, br, 1H); 8.43 (d, 1H); 8.95 (br,
1H); 13.4 (br, 1H)
398[CDCl3] 3.38 (s, 3H); 3.58 (m, 2H); 3.65 (m, 2H); 6.88 (d, 1H), 8.70 (d, 1H); 9.43 (br, 1H)
405[CDCl3] 1.25 (d, 3H); 3.38 (s, 3H); 3.42 (d, 2H); 4.40 (m, 1H); 6.88 (d, 1H); 8.70 (d, 1H);
9.38 (d, br, 1H)
407[CDCl3] 1.89 (m, 2H); 3.32 (s, 3H); 3.48 (t, 2H); 3.58 (m, 2H); 6.92 (d, 1H); 8.64 (d, 1H);
9.30 (br, 1H)
455[DMSO] 8.25 (br, 1H); 8.35 (br, 1H); 8.50 (s, 1H); 13.8 (br, 1H)
456[DMSO] 2.84 (d, 3H); 8.40 (s, 1H); 8.72 (d, br, 1H)
457[DMSO] 1.12 (t, 3H); 3.35 (q, 2H); 8.40 (s, 1H); 8.75 (t, br, 1H); 13.5 (br, 1H)
458[DMSO] 0.89 (t, 3H); 1.52 (m, 2H); 3.25 (m, 2H); 8.41 (s, 1H); 8.73 (t, br, 1H); 13.4 (br, 1H)
459[DMSO] 1.19 (d, 6H); 4.08 (m, 1H); 8.43 (s, 1H); 8.59 (d, br, 1H); 13.4 (br, 1H)
460[DMSO] 0.59 (m, 2H); 0.75 (m, 2H); 2.87 (m, 1H); 8.39 (s, 1H); 8.73 (d, br, 1H)
461[DMSO] 0.90 (t, 3H); 1.32 (m, 2H); 1.50 (m, 2H); 3.30 (m, 2H); 8.41 (s, 1H); 8.74 (t, br, 1H);
13.5 (br, 1H)
462[DMSO] 1.70 (m, 2H); 2.03 (m, 2H); 2.25 (m, 2H); 4.40 (m, 1H); 8.41 (s, 1H); 8.90 (d, br,
1H); 13.5 (br, 1H)
477[DMSO] 0.25 (m, 2H); 0.47 (m, 2H); 1.02 (m, 1H); 3.19 (t, 2H); 8.45 (s, 1H); 8.80 (t, br, 1H)
479[DMSO] 0.90 (s, 9H); 3.14 (d, 2H); 8.38 (s, 1H); 8.60 (t, br, 1H); 13.7 (br, 1H)
485[DMSO] 0.89 (d, 6H); 1.82 (m, 1H); 3.13 (t, 2H); 8.40 (s, 1H); 8.72 (t, br, 1H)
487[DMSO] 0.90 (d, 6H); 1.41 (q, 2H); 1.62 (m, 1H); 3.32 (m, 2H); 8.40 (s, 1H); 8.72 (t, br, 1H);
13.5 (br, 1H)
489[CDCl3] 4.10 (d, 2H); 5.25 (dd, 2H); 5.93 (m, 1H); 8.60 (s, 1H); 9.10 (br, 1H); 12.4 (br, 1H)
493[DMSO] 1.71 (s, 3H); 3.86 (d, 2H); 4.84 (d, 2H); 8.40 (s, 1H); 8.85 (t, br, 1H); 13.5 (br)
494[DMSO] 3.17 (m, 1H); 4.11 (m, 2H); 8.39 (s, 1H); 8.98 (t, br, 1H), 13.4 (br)
496[CDCl3] 0.95 (t, 3H); 1.25 (d, 3H); 1.60 (m, 2H); 4.12 (m, 1H); 8.48 (s, 1H); 8.52 (br, 1H)
498[CDCl3] 0.95 (t, 3H); 1.25 (d, 3H); 1.40 (m, 2H); 1.55 (m, 2H); 4.17 (m, 1H); 8.53 (s, 1H);
8.70 (br, 1H)
499[CDCl3] 0.87 (t, 3H); 1.21 (d, 3H); 1.32 (m, 6H); 1.53 (m, 2H); 4.15 (m, 1H); 8.62 (s, 1H);
8.99 (d, br, 1H); 13.0 (br)
502[CDCl3] 0.91 (d, 6H); 1.23 (d, 3H); 1.35 (m, 1H); 1.48 (m, 1H); 1.66 (m, 1H); 4.25 (m, 1H);
8.62 (s, 1H); 8.96 (d, br, 1H); 12.9 (br, 1H)
504[CDCl3] 0.95 (m, 6H); 1.18 (d, 3H); 1.81 (m, 1H); 4.07 (m, 1H); 8.61 (s, 1H); 8.97 (d, br,
1H); 12.9 (br, 1H)
506[CDCl3] 0.94 (t, 6H); 1.50 (m, 2H); 1.65 (m, 2H), 4.00 (m, 1H); 8.56 (s, 1H); 8.73 (d, br, 1H)
512[DMSO] 3.28 (s, 3H); 3.48 (m, 4H); 8.42 (s, 1H); 8.78 (br, 1H); 13.7 (br, 1H)
519[DMSO] 1.16 (d, 3H); 3.30 (s, 3H); 3.42 (m, 2H); 4.18 (m, 1H); 8.42 (s, 1H); 8.60 (d, br, 1H);
13.7 (br, 1H)
521[DMSO] 1.74 (m, 2H); 3.26 (s, 3H); 3.39 (m, 4H); 8.40 (s, 1H); 8.80 (t, br, 1H); 13.6 (br, 1H)
569[DMSO] 8.25 (br, 1H); 8.35 (br, 1H); 8.50 (s, 1H); 13.7 (br, 1H)
570[DMSO] 2.82 (d, 3H); 8.40 (s, 1H); 8.71 (br, 1H); 13.5 (br, 1H)
571[DMSO] 1.12 (t, 3H); 3.35 (q, 2H); 8.40 (s, 1H); 8.75 (t, br, 1H); 13.7 (br, 1H)
572[DMSO] 0.89 (t, 3H); 1.52 (m, 2H); 3.26 (m, 2H); 8.39 (s, 1H); 8.82 (br, 1H)
573[DMSO] 1.18 (d, 6H); 4.09 (m, 1H); 8.42 (s, 1H); 8.53 (d, br, 1H); 13.5 (br, 1H)
574[DMSO] 0.59 (m, 2H); 0.74 (m, 2H); 2.85 (m, 1H); 8.37 (s, 1H); 8.72 (d, br, 1H)
575[DMSO] 0.89 (t, 3H); 1.35 (m, 2H); 1.50 (m, 2H); 3.35 (m, 2H); 8.39 (s, 1H); 8.75 (br, 1H)
576[DMSO] 1.70 (m, 2H); 2.05 (m, 2H); 2.25 (m, 2H); 4.40 (m, 1H); 8.40 (s, 1H); 8.94 (br, 1H)
591[DMSO] 0.25 (m, 2H); 0.45 (m, 2H); 1.03 (m, 1H); 3.21 (t, 2H); 8.40 (s, 1H); 8.84 (br, 1H)
599[DMSO] 0.89 (d, 6H); 1.82 (m, 1H); 3.14 (m, 2H); 8.38 (s, 1H); 8.74 (br, 1H)
601[CDCl3] 0.96 (d, 6H); 1.51 (m, 2H); 1.70 (m, 1H); 3.49 (m, 2H); 8.59 (s, 1H); 9.02 (br, 1H);
12.2 (br)
603[DMSO] 3.95 (t, 2H); 5.18 (dd, 2H); 5.89 (m, 1H); 8.40 (s, 1H); 8.85 (t, br, 1H); 13.6 (br, 1H)
612[CDCl3] 0.91 (t, 3H); 1.24 (d, 3H); 1.40 (m, 2H); 1.54 (m, 2H); 4.18 (m, 1H); 8.57 (s, 1H);
8.90 (d, br, 1H); 12.2 (br, 1H)
620[CDCl3] 0.94 (t, 6H); 1.51 (m, 2H); 1.67 (m, 2H); 3.99 (m, 1H); 8.57 (s, 1H); 8.82 (d, br, 1H)
626[DMSO] 3.29 (s, 3H); 3.48 (m, 4H); 8.41 (s, 1H); 8.78 (br, 1H); 13.7 (br, 1H)
633[CDCl3] 1.28 (d, 3H); 3.40 (s, 3H); 3.45 (m, 2H); 4.37 (m, 1H); 8.48 (s, 1H); 8.78 (br, 1H)
635[DMSO] 1.75 (m, 2H); 3.25 (s, 3H); 3.39 (m, 4H); 8.40 (s, 1H); 8.81 (br, 1H); 13.6 (br, 1H)
797[DMSO] 8.27 (br, 1H); 8.38 (br, 1H); 8.52 (s, 1H); 13.7 (br, 1H)
798[DMSO] 2.82 (d, 3H); 8.40 (s, 1H); 8.75 (d, br, 1H); 13.6 (br, 1H)
799[DMSO] 1.12 (t, 3H); 3.33 (m, 2H); 8.41 (s, 1H); 8.78 (t, br, 1H); 13.6 (br, 1H)
800[DMSO] 0.89 (t, 3H); 1.52 (m, 2H); 3.27 (q, 2H); 8.41 (s, 1H); 8.76 (t, br, 1H); 13.5 (br, 1H)
801[DMSO] 1.18 (d, 6H); 4.09 (m, 1H); 8.42 (s, 1H); 8.60 (d, br, 1H)
802[DMSO] 0.55 (m, 2H); 0.75 (m, 2H); 2.85 (m, 1H); 8.31 (s, 1H); 9.24 (br, 1H); 13.4 (br, 1H)
803[DMSO] 0.89 (t, 3H); 1.33 (m, 2H); 1.51 (m, 2H); 3.30 (m, 2H); 8.40 (s, 1H); 8.75 (t, br, 1H),
13.4 (br)
804[DMSO] 1.70 (m, 2H); 2.04 (m, 2H); 2.25 (m, 2H); 4.39 (m, 1H); 8.43 (s, 1H); 8.95 (d, br,
1H); 13.4 (br, 1H)
806[DMSO] 2.82 (s, 3H); 2.98 (s, 3H); 8.06 (s, 1H); 12.6 (s, br, 1H)
811[CDCl3] 1.24 (t, 6H); 3.44 (m, 4H); 7.72 (s, 1H)
819[DMSO] 0.25 (m, 2H); 0.46 (m, 2H); 1.03 (m, 1H); 3.20 (t, 2H); 8.45 (s, 1H); 8.87 (t, br, 1H);
13.4 (br, 1H)
821[DMSO] 0.90 (s, 9H); 3.13 (d, 2H); 8.37 (s, 1H); 8.61 (t, br, 1H); 13.4 (br, 1H)
827[DMSO] 0.88 (d, 6H); 1.82 (m, 1H); 3.13 (t, 2H); 8.40 (s, 1H); 8.76 (t, br, 1H); 13.5 (br, 1H)
829[DMSO] 0.90 (d, 6H); 1.42 (m, 2H); 1.61 (m, 1H); 3.30 (m, 2H); 8.41 (s, 1H); 8.76 (t, br, 1H);
13.5 (br, 1H)
831[DMSO] 3.95 (t, 2H); 5.19 (dd, 2H); 5.89 (m, 1H); 8.41 (s, 1H); 8.88 (t, br, 1H); 13.5 (br, 1H)
835[DMSO] 1.72 (s, 3H); 3.87 (d, 2H); 4.86 (d, 2H); 8.39 (s, 1H); 8.90 (t, br, 1H); 13.4 (br, 1H)
836[DMSO] 3.18 (m, 1H); 4.10 (m, 2H); 8.36 (s, 1H); 9.01 (t, br, 1H); 13.4 (br, 1H)
838[DMSO] 0.88 (t, 3H); 1.14 (d, 3H); 1.51 (m, 2H); 3.91 (m, 1H); 8.41 (s, 1H); 8.54 (d, br, 1H);
13.5 (br, 1H)
840[DMSO] 0.88 (t, 3H); 1.14 (d, 3H); 1.33 (m, 2H); 1.47 (m, 2H); 4.01 (m, 1H); 8.42 (s, 1H);
853 (d, br, 1H); 13.5 (br, 1H)
841[DMSO] 0.85 (t, 3H); 1.14 (d, 3H); 1.28 (m, 6H); 1.49 (m, 2H); 3.98 (m, 1H); 8.41 (s, 1H);
8.60 (d, br, 1H); 13.5 (br, 1H)
844[DMSO] 0.87 (d, 6H); 1.14 (d, 3H); 1.27 (m, 1H); 1.48 (m, 1H); 1.62 (m, 1H); 4.09 (m, 1H);
8.41 (s, 1H); 8.52 (d, br, 1H); 13.5 (br, 1H)
845[DMSO] 0.90 (s, 9H); 1.08 (d, 3H); 3.90 (m, 1H); 8.35 (s, 1H); 8.38 (d, br, 1H); 13.4 (br)
846[DMSO] 0.89 (d, 6H); 1.12 (d, 3H); 1.75 (m, 1H); 3.87 (m, 1H); 8.40 (s, 1H); 8.50 (d, br, 1H);
13.5 (br)
848[DMSO] 0.87 (t, 6H); 1.44 (m, 2H); 1.55 (m, 2H); 3.79 (m, 1H); 8.40 (s, 1H); 8.42 (d, br,
1H); 13.4 (br, 1H)
851[CDCl3] 3.42 (s, 6H); 3.63 (t, 2H); 4.50 (t, 1H); 8.55 (s, 1H); 8.95 (t, br, 1H); 12.1 (br, 1H)
853[CDCl3] 3.65 (m, 2H); 3.86 (m, 2H); 8.47 (s, 1H); 8.98 (br, 1H)
854[CDCl3] 3.39 (s, 3H); 3.58 (m, 2H); 3.69 (m, 2H); 8.49 (s, 1H); 8.80 (br, 1H); 11.9 (br, 1H)
861[CDCl3] 1.28 (d, 3H); 3.38 (s, 3H); 3.45 (m, 2H); 4.39 (m, 1H); 8.51 (s, 1H); 8.85 (br, 1H);
12.4 (br, 1H)
863[CDCl3] 1.90 (m, 2H); 3.40 (s, 3H); 3.57 (m, 4H); 8.30 (s, 1H); 8.70 (br, 1H)
868[CDCl3] 3.80 (s, 3H); 4.25 (d, 2H); 8.52 (s, 1H); 9.16 (br, 1H)
909[DMSO] 8.22 (br, 1H); 8.32 (br, 1H); 8.61 (s, 1H); 13.8 (br, 1H)
910[DMSO] 2.83 (d, 3H); 8.51 (s, 1H); 8.74 (br, 1H); 13.7 (br, 1H)
911[DMSO] 1.12 (t, 3H); 3.32 (q, 2H); 8.54 (s, 1H); 8.75 (t, br, 1H); 13.7 (br, 1H)
912[DMSO] 0.89 (t, 3H); 1.52 (m, 2H); 3.25 (q, 2H); 8.54 (s, 1H); 8.75 (t, br, 1H); 13.6 (br, 1H)
913[CDCl3] 1.25 (d, 6H); 4.25 (m, 1H); 8.54 (br, 1H); 8.70 (s, 1H)
914[DMSO] 0.58 (m, 2H); 0.75. (m, 2H); 2.86 (m, 1H); 8.50 (s, 1H); 8.75 (d, 1H); 13.6 (br, 1H)
915[DMSO] 0.89 (t, 3H); 1.32 (m, 2H); 1.50 (m, 2H); 3.32 (m, 2H); 8.53 (s, 1H); 8.74 (t, br, 1H),
13.5 (br)
916[DMSO] 1.70 (m, 2H); 2.05 (m, 2H); 2.25 (m, 2H); 4.40 (m, 1H); 8.52 (s, 1H); 8.98 (d, br,
1H); 13.5 (br, 1H)
917[CDCl3] 1.50 (s, 9H); 8.65 (s, 1H); 8.80 (s, br, 1H); 12.3 (br, 1H)
918[DMSO] 2.82 (s, 3H); 2.99 (s, 3H); 8.14 (s, 1H); 12.6 (br, 1H)
923[DMSO] 1.02 (t, 3H); 1.12 (t, 3H); 3.10 (q, 2H); 3.40 (9, 2H); 8.15 (s, 1H); 12.5 (br, 1H)
931[DMSO] 0.24 (m, 2H); 0.46 (m, 2H); 1.04 (m, 1H); 3.18 (t, 2H); 8.55 (s, 1H); 8.82 (t, br, 1H)
933[DMSO] 0.90 (s, 9H); 3.13 (d, 2H); 8.50 (s, 1H); 8.61 (t, br, 1H)
939[DMSO] 0.88 (d, 6H); 1.83 (m, 1H); 3.14 (t, 2H); 8.52 (s, 1H); 8.72 (t, br, 1H); 13.6 (br, 1H)
941[DMSO] 0.90 (d, 6H); 1.43 (m, 2H); 1.62 (m, 1H); 3.35 (m, 2H); 8.52 (s, 1H); 8.72 (t, br, 1H);
13.5 (br, 1H)
943[DMSO] 3.94 (t, 2H); 5.18 (dd, 2H); 5.89 (m, 1H); 8.52 (s, 1H); 8.85 (t, br, 1H)
947[DMSO] 1.72 (s, 3H); 3.87 (d, 2H); 4.85 (d, 2H); 8.51 (s, 1H); 8.87 (t, br, 1H); 13.5 (br)
948[DMSO] 3.18 (m, 1H); 4.12 (m, 2H); 8.50 (s, 1H); 9.00 (t, br, 1H)
950[DMSO] 0.92 (t, 3H); 1.21 (d, 3H); 1.57 (m, 2H); 3.97 (m, 1H); 8.55 (d, br, 1H); 8.60 (s, 1H);
13.7 (br, 1H)
952[CDCl3] 0.90 (t, 3H); 1.24 (d, 3H); 1.40 (m, 2H); 1.55 (m, 2H); 4.18 (m, 1H); 8.72 (s, 1H);
8.90 (d, br, 1H)
953[DMSO] 0.77 (t, 3H); 1.15 (d, 3H); 1.27 (m, 6H); 1.49 (m, 2H); 3.99 (m, 1H); 8.50 (d, br, 1H);
8.55 (s, 1H); 13.6 (br)
956[DMSO] 0.88 (d, 6H); 1.15 (d, 3H); 1.27 (m, 1H); 1.48 (m, 1H); 1.62 (m, 1H); 4.10 (m, 1H);
8.50 (d, br, 1H); 8.55 (s, 1H); 13.6 (br, 1H)
957[DMSO] 0.91 (s, 9H); 1.09 (d, 3H); 3.80 (m, 1H); 8.39 (d, br, 1H); 8.49 (s, 1H); 13.6 (br, 1H)
958[DMSO] 0.89 (d, 6H); 1.11 (d, 3H); 1.75 (m, 1H); 3.86 (m, 1H); 8.48 (d, br, 1H); 8.52 (s, 1H);
13.6 (br)
960[CDCl3] 0.95 (t, 6H); 1.50 (m, 2H); 1.62 (m, 2H); 4.00 (m, 1H); 8.73 (s, 1H); 8.90 (d, br, 1H)
963[CDCl3] 3.43 (s, 6H); 3.65 (t, 2H); 4.50 (t, 1H); 8.62 (s, 1H); 8.78 (br, 1H)
965[DMSO] 3.40 (m, 2H); 3.52 (m, 2H); 8.57 (s, 1H); 8.78 (t, br, 1H); 13.6 (br, 1H)
966[DMSO] 3.29 (s, 3H); 3.48 (m, 4H); 8.54 (s, 1H); 8.78 (br, 1H); 13.6 (br, 1H)
973[CDCl3] 1.29 (d, 3H); 3.40 (s, 3H); 3.45 (m, 2H); 4.36 (m, 1H); 8.60 (s, 1H); 8.72 (br, 1H)
975[DMSO] 1.75 (m, 2H); 3.20 (s, 3H); 3.38 (m, 4H); 8.51 (s, 1H); 8.81 (t, br, 1H); 13.6 (br)
1023[DMSO] 8.22 (br, 1H); 8.35 (br, 1H); 8.61 (s, 1H); 13.8 (br, 1H)
1024[DMSO] 2.82 (d, 3H); 8.50 (s, 1H); 8.75 (br, 1H); 13.7 (br, 1H)
1025[DMSO] 1.13 (t, 3H); 3.35 (m, 2H); 8.52 (s, 1H); 8.75 (br, 1H); 13.5 (br, 1H)
1026[DMSO] 0.90 (t, 3H); 1.53 (m, 2H); 3.25 (m, 2H); 8.52 (s, 1H); 8.75 (t, br, 1H); 13.5 (br, 1H)
1027[DMSO] 1.18 (d, 6H); 4.08 (m, 1H); 8.54 (s, 1H); 8.56 (br, 1H)
1028[DMSO] 0.58 (m, 2H); 0.75 (m, 2H); 3.86 (m, 1H); 8.48 (s, 1H); 8.75 (br, 1H)
1029[DMSO] 0.89 (t, 3H); 1.34 (m, 2H); 1.50 (m, 2H); 3.26 (m, 2H); 8.51 (s, 1H); 8.81 (br, 1H);
13.6 (br, 1H)
1030[DMSO] 1.70 (m, 2H); 2.04 (m, 2H); 2.25 (m, 2H); 4.39 (m, 1H); 8.53 (s, 1H); 8.91 (d, br,
1H); 13.4 (br, 1H)
1031[CDCl3] 1.46 (s, 9H); 8.63 (s, 1H); 8.83 (br, 1H); 111.9 (br, 1H)
1032[DMSO] 2.82 (s, br, 3H); 2.96 (s, br, 3H); 8.11 (s, 1H); 12.5 (br, 1H)
1037[CDCl3] 1.23 (t, 6H); 3.42 (br, 4H); 7.88 (s, 1H)
1045[DMSO] 0.25 (m, 2H); 0.46 (m, 2H); 1.04 (m, 1H); 3.20 (t, 2H); 8.55 (s, 1H); 8.82 (t, br, 1H);
13.6 (br, 1H)
1047[DMSO] 0.90 (s, 9H); 3.13 (d, 2H); 8.48 (s, 1H); 8.61 (t, br, 1H)
1053[DMSO] 0.90 (d, 6H); 1.82 (m, 1H); 3.13 (m, 2H); 8.50 (s, 1H); 8.75 (br, 1H); 13.5 (br, 1H)
1055[DMSO] 0.89 (d, 6H); 1.41 (m, 2H); 1.61 (m, 1H); 3.31 (m, 2H); 8.49 (s, 1H); 8.90 (br, 1H);
13.5 (br, 1H)
1057[DMSO] 3.95 (t, 2H); 5.18 (dd, 2H); 5.90 (m, 1H); 8.50 (s, 1H); 8.85 (t, br, 1H)
1061[CDCl3] 1.80 (s, 3H); 4.03 (d, 2H); 4.93 (d, 2H); 8.76 (s, 1H); 9.22 (t, br, 1H);
1062[DMSO] 3.18 (m, 1H); 4.10 (m, 2H); 8.48 (s, 1H); 9.00 (br, 1H)
1064[DMSO] 0.88 (t, 3H); 1.16 (d, 3H); 1.51 (m, 2H); 3.93 (m, 1H); 8.50 (d, br, 1H); 8.55 (s, 1H);
13.6 (br, 1H)
1066[DMSO] 0.86 (t, 3H); 1.15 (d, 3H); 1.30 (m, 2H); 1.48 (m, 2H); 4.00 (m, 1H); 8.50 (d, br,
1H); 8.52 (s, 1H); 13.6 (br, 1H)
1067[CDCl3] 0.86 (t, 3H); 1.22 (d, 3H); 1.25 (m, 6H); 1.48 (m, 2H); 4.16 (m, 1H); 8.62 (s, 1H);
8.68 (br, 1H)
1070[CDCl3] 0.93 (d, 6H); 1.23 (d, 3H); 1.27 (m, 1H); 1.50 (m, 1H); 1.70 (m, 1H); 4.25 (m, 1H);
8.63 (br, 2H)
1071[CDCl3] 0.95 (s, 9H); 1.17 (d, 3H); 4.08 (m, 1H); 8.70 (s, 1H); 9.00 (d, br, 1H)
1072[CDCl3] 0.95 (m, 6H); 1.20 (d, 3H); 1.82 (m, 1H); 4.07 (m, 1H); 8.76 (s, 1H); 9.13 (br, 1H)
1074[CDCl3] 0.92 (t, 6H); 1.50 (m, 2H); 1.65 (m, 2H); 3.96 (m, 1H); 8.72 (s, 1H); 9.00 (d, br, 1H)
1077[CDCl3] 3.42 (s, 6H); 3.62 (t, 2H); 4.50 (t, 1H); 8.62 (s, 1H); 8.90 (br, 1H)
1079[CDCl3] 3.65 (m, 2H); 3.85 (m, 2H); 8.64 (s, 1H); 9.22 (br, 1H)
1080[DMSO] 3.30 (s, 3H); 3.46 (m, 4H); 8.52 (s, 1H); 8.75 (br, 1H)
1087[CDCl3] 1.29 (d, 3H); 3.39 (s, 3H); 3.45 (m, 2H); 4.37 (m, 1H); 8.66 (s, 1H); 8.98 (br, 1H);
12.50 (br, 1H)
1089[DMSO] 1.75 (m, 2H); 3.23 (s, 3H); 3.38 (m, 4H); 8.52 (s, 1H); 8.80 (t, br, 1H)
1094[CDCl3] 3.80 (s, 3H); 4.24 (d, 2H); 8.61 (s, 1H); 9.19 (br, 1H)
1138[DMSO] 2.83 (d, 3H); 7.07 (t, 1H); 8.40 (s, 1H); 8.94 (br, 1H); 13.4 (br, 1H)
1139[DMSO] 1.12 (t, 3H); 3.33 (m, 2H); 7.08 (t, 1H); 8.40 (s, 1H); 9.00 (br, 1H); 13.4 (br, 1H)
1171[DMSO] 3.90 (t, 2H); 5.15 (dd, 2H); 5.90 (m, 1H); 7.10 (t, 1H); 8.40 (s, 1H); 9.16 (br, 1H);
13.4 (br, 1H)
1178[CDCl3] 0.95 (t, 3H); 1.21 (d, 3H); 1.58 (m, 2H); 4.08 (m, 1H); 6.86 (t, 1H); 8.70 (s, 1H);
9.34 (d, br, 1H); 12.9 (br, 1H)
1180[CDCl3] 0.93 (t, 3H); 1.21 (d, 3H); 1.40 (m, 2H); 1.52 (m, 2H); 4.16 (m, 1H); 6.87 (t, 1H);
8.70 (s, 1H); 9.31 (d, br, 1H); 12.9 (br, 1H)
1188[CDCl3] 0.92 (t, 6H); 1.50 (m, 2H); 1.65 (m, 2H); 3.98 (m, 1H); 6.86 (t, 1H); 8.71 (s, 1H);
9.28 (d, br, 1H); 12.9 (br, 1H)
1201[CDCl3] 1.27 (d, 3H); 3.40 (s, 3H); 3.43 (m, 2H); 4.37 (m, 1H); 6.85 (t, 1H); 8.68 (s, 1H);
9.42 (d, br, 1H); 12.7 (br, 1H)
1251[DMSO] 8.26 (br, 1H), 8.42 (br, 1H); 8.62 (s, 1H)
1252[CDCl3] 3.00 (d, 3H); 8.66 (s, 1H); 8.82 (br, 1H)
1253[CDCl3] 1.24 (t, 3H); 3.50 (m, 2H); 8.68 (s, 1H); 8.86 (br, 1H)
1254[CDCl3] 1.00 (t, 3H); 1.62 (m, 2H); 3.42 (m, 2H); 8.67 (s, 1H); 8.90 (br, 1H)
1255[CDCl3] 1.25 (d, 6H); 4.25 (m, 1H); 8.70 (s, 1H); 8.84 (br, 1H)
1256[CDCl3] 0.60 (m, 2H); 0.89. (m, 2H); 3.00 (m, 1H); 8.70 (s, 1H); 9.00 (br, 1H)
1257[CDCl3] 0.96 (t, 3H); 1.42. (m, 2H); 1.60 (m, 2H); 3.45 (m, 2H); 8.70 (s, 1H); 8.88 (br, 1H);
12.1 (br, 1H)
1258[CDCl3] 1.77 (m, 2H); 1.98. (m, 2H); 2.43 (m, 2H); 4.55 (m, 1H); 8.68 (s, 1H); 9.13 (br, 1H);
12.5 (br, 1H)
1259[CDCl3] 1.45 (s, 9H); 8.67 (s, 1H); 8.78 (br, 1H); 12.4 (br, 1H)
1260[CDCl3] 3.11 (s, 6H); 7.95 (s, 1H)
1265[CDCl3] 1.25 (t, 6H); 3.45 (br, 4H); 7.89 (s, 1H)
1273[CDCl3] 0.27 (m, 2H); 0.56. (m, 2H); 1.04 (m, 1H); 3.32 (m, 2H); 8.67 (s, 1H); 8.92 (br, 1H);
12.3 (br, 1H)
1275[CDCl3] 0.97 (s, 9H); 3.29 (d, 2H); 8.73 (s, 1H); 9.00 (br, 1H); 11.9 (br, 1H)
1281[CDCl3] 0.98 (d, 6H); 1.89 (m, 1H); 3.29 (t, 2H); 8.70 (s, 1H); 8.98 (br, 1H); 12.1 (br, 1H)
1283[CDCl3] 0.95 (d, 6H); 1.50 (m, 2H); 1.68 (m 1H); 3.46 (m, 2H); 8.69 (s, 1H); 8.83 (br, 1H);
12.1 (br, 1H)
1285[CDCl3] 4.09 (t, 2H); 5.22 (dd, 2H); 5.91 (m, 1H); 8.70 (s, 1H); 9.01 (br, 1H); 12.2 (br, 1H)
1289[DMSO] 0.26 (m, 2H); 0.47 (m, 2H); 1.05 (m, 1H); 3.20 (m, 2H); 6.85 (tt, 1H); 7.25 (br, 1H);
8.45 (d, 1H); 9.15 (br, 1H), 13.4 (br, 1H)
1290[CDCl3] 2.25 (m, 1H); 4.23 (m, 2H); 8.72 (s, 1H); 9.20 (br, 1H), 12.0 (br, 1H)
1292[CDCl3] 0.95 (t, 3H); 1.21 (d, 3H); 1.55 (m 2H); 4.10 (m, 1H); 8.70 (s, 1H); 8.82 (br, 1H)
1294[CDCl3] 0.93 (t, 3H); 1.22 (d, 3H); 1.38 (m, 2H); 1.52 (m, 2H); 4.18 (m, 1H); 8.70 (s, 1H);
8.79 (br, 1H); 12.4 (br, 1H)
1295[CDCl3] 0.89 (t, 3H); 1.20 (d, 3H); 1.25-1.4 (m, 6H); 1.50 (m, 2H); 4.16 (m, 1H); 8.70 (s,
1H); 8.75 (br, 1H)
1298[CDCl3] 0.92 (t, 6H); 1.40 (d, 3H); 1.32 (m, 1H); 1.45 (m, 1H); 1.55 (m, 1H); 4.25 (m, 1H);
8.70 (s, 1H); 8.75 (br, 1H); 12.4 (br, 1H)
1299[CDCl3] 0.95 (s, 9H); 1.15 (d, 3H); 4.10 (m, 1H); 8.72 (s, 1H); 8.88 (br, 1H); 11.9 (br, 1H)
1300[CDCl3] 0.95 (m, 6H); 1.15 (d, 3H); 1.77 (m, 1H); 4.05 (m, 1H); 8.71 (s, 1H); 8.85 (br, 1H)
1302[CDCl3] 0.93 (t, 6H); 1.48 (m, 2H); 1.65 (m, 2H); 3.99 (m, 1H); 8.71 (s, 1H); 8.76 (br, 1H);
12.4 (br, 1H)
1305[CDCl3] 3.40 (s, 6H); 3.62 (t, 2H); 4.50 (t, 1H); 8.60 (s, 1H); 8.74 (br, 1H); 11.7 (br, 1H)
1307[CDCl3] 3.65 (m, 2H); 3.87 (m, 2H); 4.50 (t, 1H); 8.66 (s, 1H); 9.11 (br, 1H)
1308[CDCl3] 3.40 (s, 3H); 3.58 (m, 2H); 3.67 (m, 2H); 8.60 (s, 1H); 8.75 (br, 1H); 11.7 (br, 1H)
1315[CDCl3] 1.48 (d, 3H); 3.38 (s, 3H); 3.44 (m, 2H); 4.38 (m, 1H); 8.62 (s, 1H); 8.72 (br, 1H);
12.1 (br, 1H)
1317[CDCl3] 1.90 (m, 2H); 3.40 (s, 3H); 3.58 (m, 4H); 8.39 (s, 1H); 8.62 (br, 1H)
1322[CDCl3] 3.79 (s, 3H); 4.25 (d, 2H); 8.65 (s, 1H); 9.18 (br, 1H)
1365[DMSO] 8.24 (br, 1H), 8.42 (br, 1H); 8.81 (s, 1H); 13.6 (br, 1H)
1366[DMSO] 8.19 (br, 1H), 8.34 (br, 1H); 8.78 (s, 1H); 13.7 (br, 1H)
1368[DMSO] 2.83 (d, 3H); 6.81 (tt, 1H); 7.22 (br, 1H); 8.41 (d, 1H); 9.00 (br, 1H); 13.4 (br, 1H)
1369[DMSO] 1.12 (t, 3H); 3.35 (m, 2H); 6.85 (tt, 1H); 7.20 (br, 1H); 8.41 (d, 1H); 9.20 (br, 1H);
13.4 (br, 1H)
1370[DMSO] 0.89 (t, 3H); 1.52 (m, 2H); 3.27 (q, 2H); 6.82 (tt, 1H); 7.20 (br, 1H); 8.40 (d, 1H);
9.20 (br, 1H); 13.4 (br, 1H)
1371[DMSO] 1.18 (d, 6H); 4.09 (m, 1H); 6.82 (tt, 1H); 7.20 (br, 1H); 8.42 (d, 1H); 8.95 (br, 1H);
13.4 (br, 1H)
1372[DMSO] 0.56 (m, 2H); 0.75 (m, 2H); 2.85 (m, 1H); 6.83 (tt, 1H); 7.21 (br, 1H); 8.40 (d, 1H);
9.05 (br, 1H); 13.4 (br, 1H)
1373[DMSO] 0.89 (t, 3H); 1.32 (m, 2H); 1.50 (m, 2H); 3.30 (q, 2H); 6.84 (tt, 1H); 7.20 (br, 1H);
8.41 (d, 1H); 9.10 (br, 1H); 13.4 (br, 1H)
1389[DMSO] 0.26 (m, 2H); 0.47 (m, 2H); 1.05 (m, 1H); 3.20 (m, 2H); 6.85 (tt, 1H); 7.25 (br, 1H);
8.45 (d, 1H); 9.15 (br, 1H), 13.4 (br, 1H)
1391[DMSO] 0.91 (s, 9H); 3.16 (d, 2H); 6.82 (tt, 1H); 7.10 (br, 1H); 8.41 (d, 1H); 9.20 (br, 1H);
13.3 (br, 1H)
1397[DMSO] 0.90 (d, 6H); 1.82 (m, 1H); 3.15 (m, 2H); 6.82 (tt, 1H); 7.20 (br, 1H); 8.40 (d, 1H);
9.15 (br, 1H), 13.4 (br, 1H)
1401[DMSO] 3.95 (m, 2H); 5.18 (dd, 2H); 5.92 (m, 1H); 6.82 (tt, 1H); 7.20 (d, 1H); 8.42 (d, 1H);
9.20 (br, 1H); 13.3 (br, 1H)
1406[DMSO] 3.15 (t, 1H); 4.13 (m, 2H); 6.82 (tt, 1H); 7.18 (br, 1H); 8.41 (d, 1H); 9.35 (br, 1H);
13.3 (br, 1H)
1408[DMSO] 0.87 (t, 3H); 1.14 (d, 3H); 1.51 (m, 2H); 3.92 (m, 1H); 6.82 (tt, 1H); 7.20 (br, 1H);
8.41 (d, 1H); 8.90 (br, 1H), 13.4 (br, 1H)
1410[DMSO] 0.86 (t, 3H); 1.15 (d, 3H); 1.30 (m, 2H); 1.48 (m, 2H); 4.02 (m, 1H); 6.83 (tt, 1H);
7.20 (br, 1H); 8.42 (d, 1H); 8.90 (br, 1H), 13.4 (br, 1H)
1411[DMSO] 0.88 (t, 3H); 1.15 (d, 3H); 1.27 (m, 6H); 1.49 (m, 2H); 4.00 (m, 1H); 6.82 (tt, 1H);
7.20 (br, 1H); 8.42 (d, 1H); 8.92 (br, 1H), 13.4 (br, 1H)
1414[DMSO] 0.88 (d, 6H); 1.15 (d, 3H); 1.28 (m, 1H); 1.46 (m, 1H); 1.60 (m, 1H); 4.10 (m, 1H);
6.81 (tt, 1H); 7.20 (br, 1H); 8.42 (d, 1H); 8.90 (br, 1H), 13.4 (br, 1H)
1418[CDCl3] 0.93 (t, 6H); 1.50 (m, 2H); 1.65 (m, 2H); 4.00 (m, 1H); 6.83 (d, 1H); 8.69 (d, 1H);
9.21 (d, br, 1H); 13.0 (br, 1H)
1421[CDCl3] 3.41 (s, 6H); 3.52 (t, 2H); 4.50 (t, 1H); 6.12 (tt, 1H); 6.81 (d, 1H); 8.64 (d, 1H);
9.41 (br, 1H); 12.5 (br, 1H)
1424[CDCl3] 3.37 (s, 3H); 3.56 (m, 2H); 3.67 (m, 2H); 6.11 (tt, 1H); 6.84 (d, 1H); 8.65 (d, 1H);
9.46 (br, 1H), 12.2 (br, 1H)
1431[CDCl3] 1.28 (d, 3H); 3.39 (s, 3H); 3.45 (m, 2H); 4.40 (m, 1H); 6.10 (tt, 1H); 6.83 (d, 1H);
8.67 (d, 1H); 9.39 (d, br, 1H); 13.0 (br, 1H)
1433[DMSO] 1.75 (m, 2H); 3.24 (s, 3H); 3.38 (m, 4H); 6.83 (tt, 1H); 7.20 (br, 1H); 8.42 (d, 1H);
9.15 (br, 1H), 13.4 (br, 1H)
1481[DMSO] 7.42 (br, 1H); 8.10 (br, 1H); 8.40 (br, 1H); 8.46 (d, 1H), 13.6 (br, 1H)
1482[CDCl3] 3.01 (d, 3H); 6.88 (d, 1H); 8.67 (d, 1H); 9.34 (br, 1H); 12.5 (br, 1H)
1483[CDCl3] 1.27 (t, 3H); 3.50 (m, 2H); 6.88 (d, 1H); 8.68 (d, 1H); 9.32 (br, 1H); 12.6 (br, 1H)
1484[CDCl3] 1.00 (t, 3H); 1.63 (m, 2H); 3.41 (m, 2H); 6.88 (d, 1H); 8.70 (d, 1H); 9.38 (br, 1H);
12.9 (br, 1H)
1485[CDCl3] 1.25 (d, 6H); 4.27 (m, 1H); 6.88 (d, 1H); 8.70 (d, 1H); 9.30 (d, br, 1H); 13.4 (br, 1H)
1486[CDCl3] 0.62 (m, 2H); 0.86 (m, 2H); 3.01 (m, 1H); 6.88 (d, 1H); 8.70 (d, 1H); 9.41 (br, 1H);
12.6 (br, 1H)
1487[CDCl3] 0.95 (t, 3H); 1.44 (m, 2H); 1.61 (m, 2H); 3.45 (m, 2H); 6.88 (d, 1H); 8.70 (d, 1H);
9.35 (t, br, 1H); 12.7 (br, 1H)
1488[CDCl3] 1.78 (m, 2H); 2.00 (m, 2H); 2.42 (m, 2H); 4.58 (m, 1H); 6.88 (d, 1H); 8.68 (d, 1H);
9.60 (d, br, 1H); 13.3 (br, 1H)
1503[CDCl3] 0.26 (m, 2H); 0.55 (m, 2H); 1.06 (m, 1H); 3.33 (m, 2H); 6.88 (d, 1H); 8.70 (d, 1H);
9.45 (br, 1H); 12.9 (br, 1H)
1505[CDCl3] 0.98 (s, 9H); 3.30 (d, 2H); 6.88 (d, 1H); 8.72 (d, 1H); 9.43 (t, br, 1H); 12.5 (br, 1H)
1511[CDCl3] 0.98 (d, 6H); 1.90 (m, 1H); 3.30 (m, 2H); 6.88 (d, 1H); 8.70 (d, 1H); 9.42 (t, br, 1H)
1513[CDCl3] 0.85 (d, 6H); 1.51 (m, 2H); 1.70 (m, 1H); 3.47 (m, 2H); 6.88 (d, 1H); 8.70 (d, 1H);
9.32 (t, br, 1H); 12.7 (br, 1H)
1515[CDCl3] 4.10 (t, 2H); 5.25 (dd, 2H); 5.91 (m, 1H); 6.88 (d, 1H); 8.70 (d, 1H); 9.47 (br, 1H);
12.8 (br, 1H)
1519[DMSO] 1.71 (s, 3H); 3.88 (d, 2H); 4.84 (d, 2H); 7.35 (br, 1H); 8.41 (d, 1H); 9.02 (br, 1H);
13.4 (br, 1H)
1520[DMSO] 3.15 (m, 1H); 4.12 (m, 2H); 7.36 (d, br, 1H); 8.42 (d, 1H); 9.15 (br, 1H), 13.4 (br,
1H)
1522[CDCl3] 0.95 (t, 3H); 1.22 (d, 3H); 1.59 (m, 2H); 4.11 (m, 1H); 6.88 (d, 1H); 8.71 (d, 1H);
9.28 (d, br, 1H); 13.4 (br, 1H)
1524[CDCl3] 0.92 (t, 3H); 1.23 (d, 3H); 1.40 (m, 2H); 1.52 (m, 2H); 4.20 (m, 1H); 6.89 (d, 1H);
8.71 (d, 1H); 9.27 (d, br, 1H); 13.4 (br, 1H)
1525[CDCl3] 0.88 (t, 3H); 1.23 (d, 3H); 1.25-1.4 (m, 6H); 1.55 (m, 2H); 4.18 (m, 1H); 7.89 (d,
1H); 8.70 (d, 1H); 9.28 (br, 1H); 13.2 (br, 1H)
1528[CDCl3] 0.92 (d, 6H); 1.22 (d, 3H), 1.35 (m, 1H); 1.50 (m, 1H); 1.68 (m, 1H); 4.28 (m, 1H);
6.89 (d, 1H); 8.71 (d, 1H); 9.26 (d, br, 1H); 13.3 (br, 1H)
1529[CDCl3] 0.95 (s, 9H); 1.17 (d, 3H); 4.12 (m, 1H); 6.89 (d, 1H); 8.73 (d, 1H); 9.30 (d, br, 1H),
12.8 (br, 1H)
1530[CDCl3] 0.95 (dt, 6H); 1.17 (d, 3H); 1.82 (m, 1H); 4.08 (m, 1H); 6.89 (d, 1H); 8.72 (d, 1H);
9.31 (d, br, 1H); 13.2 (br, 1H)
1532[CDCl3] 0.95 (t, 6H); 1.50 (m, 2H); 1.66 (m, 2H); 4.00 (m, 1H); 6.89 (d, 1H); 8.72 (d, 1H);
9.21 (d, br, 1H); 13.3 (br, 1H)
1535[DMSO] 3.32 (s, 6H); 3.45 (t, 2H); 4.50 (t, 1H); 7.33 (d, br, 1H); 8.43 (d, 1H); 8.92 (br, 1H);
13.4 (br, 1H)
1537[DMSO] 3.38 (m, 2H); 3.52 (m, 2H); 4.80 (br, 1H); 7.37 (br, 1H); 8.45 (d, 1H); 8.96 (br, 1H);
13.4 (br, 1H)
1538[DMSO] 3.25 (s, 3H); 3.49 (m, 4H); 7.37 (d, br, 1H); 8.44 (d, 1H); 8.97 (br, 1H); 13.5 (br, 1H)
1545[DMSO] 1.15 (d, 3H); 3.27 (s, 3H); 3.40 (m, 2H); 4.19 (m, 1H); 7.35 (d, br, 1H); 8.43 (d, 1H);
8.82 (br, 1H); 13.4 (br, 1H)
1547[DMSO] 1.75 (m, 2H); 3.25 (s, 3H); 3.40 (m, 4H); 7.38 (br, 1H); 8.40 (d, 1H); 8.94 (br, 1H);
13.4 (br, 1H)
1595[DMSO] 7.45 (d, 1H); 8.15 (br, 1H); 8.40 (br, 1H); 8.50 (d, 1H); 13.7 (br, 1H)
1596[DMSO] 2.82 (d, 3H); 7.42 (d, 1H); 8.41 (d, 1H); 8.80 (br, 1H); 13.4 (br, 1H)
1597[DMSO] 1.12 (t, 3H); 3.31 (m, 2H); 7.41 (d, 1H); 8.41 (d, 1H); 8.85 (br, 1H); 13.45 (br, 1H)
1598[DMSO] 0.90 (t, 3H); 1.54 (m, 2H); 3.25 (q, 2H); 7.41 (d, 1H); 8.40 (d, 1H); 8.85 (br, 1H);
13.45 (br)
1599[DMSO] 1.17 (d, 6H); 4.10 (m, 1H); 7.40 (d, 1H); 8.41 (d, 1H); 8.67 (d, br, 1H); 13.4 (br, 1H)
1600[DMSO] 0.57 (m, 2H); 0.75 (m, 2H); 2.86 (m, 1H); 7.41 (d, 1H); 8.37 (d, 1H); 8.80 (br, 1H);
13.35 (br, 1H)
1601[CDCl3] 0.95 (t, 3H); 1.40 (m, 2H); 1.60 (m, 2H); 3.45 (q, 2H); 6.88 (d, 1H); 8.71 (d, 1H);
9.28 (br, 1H); 12.9 (br, 1H)
1602[CDCl3] 1.78 (m, 2H); 1.95 (m, 2H); 2.40 (m, 2H); 4.57 (m, 1H); 6.86 (d, 1H); 8.70 (d, 1H);
9.45 (d, br, 1H); 12.9 (br, 1H)
1603[CDCl3] 1.45 (s, 9H); 6.85 (d, 1H); 8.67 (d, 1H); 9.15 (br, 1H); 12.6 (br, 1H)
1604[CDCl3] 3.05 (s, 6H); 7.07 (d, 1H); 7.80 (d, 1H)
1609[CDCl3] 1.22 (t, 6H); 3.40 (m, 4H); 7.02 (d, 1H); 7.72 (d, 1H)
1617[DMSO] 0.25 (m, 2H), 0.46 (m, 2H); 1.05 (m, 1H); 3.22 (m, 2H); 7.45 (d, br, 1H); 8.45 (d,
1H); 8.95 (br, 1H); 13.4 (br, 1H)
1619[DMSO] 0.90 (s, 9H), 3.15 (d, 2H); 7.38 (d, br, 1H); 8.40 (d, 1H); 8.80 (br, 1H); 13.4 (br, 1H)
1625[DMSO] 0.90 (d, 6H); 1.82 (m, 1H); 3.14 (t, 2H); 7.39 (d, 1H); 8.40 (d, 1H); 8.91 (t, br, 1H)
1627[CDCl3] 0.92 (d, 6H); 1.49 (m, 2H); 1.68 (m, 1H); 3.46 (m, 2H); 6.87 (d, 1H); 8.70 (d, 1H);
9.22 (br, 1H); 12.8 (br, 1H)
1629[DMSO] 3.95 (m, 2H); 5.15 (dd, 2H); 5.90 (m, 1H); 7.40 (d, 1H); 8.40 (d, 1H); 8.95 (br, 1H);
13.4 (br, 1H)
1633[CDCl3] 1.78 (s, 3H); 4.02 (d, 2H); 4.88 (d, 2H); 6.87 (d 1H); 8.72 (d, 1H); 9.42 (br, 1H);
12.7 (br, 1H)
1634[CDCl3] 2.23 (m, 1H); 4.23 (m, 2H); 6.88 (d, 1H); 8.73 (d, 1H); 9.51 (br, 1H), 12.8 (br, 1H)
1636[DMSO] 0.89 (t, 3H); 1.14 (d, 3H); 1.51 (m, 2H); 3.95 (m, 1H); 7.41 (d, 1H); 8.40 (d, 1H);
8.60 (br, 1H); 13.6 (br, 1H)
1638[DMSO] 0.87 (t, 3H); 1.15 (d, 3H); 1.32 (m, 2H); 1.46 (m, 2H); 4.03 (m, 1H); 7.40 (d, 1H);
8.40 (d, 1H); 8.51 (br, 1H); 13.4 (br, 1H)
1639[CDCl3] 0.88 (t, 3H); 1.21 (d, 3H); 1.32 (m, 6H); 1.50 (m, 2H); 4.18 (m, 1H); 6.88 (d, 1H);
8.71 (d, 1H); 9.12 (d, br, 1H), 12.9 (br, 1H)
1642[CDCl3] 0.92 (t, 6H); 1.20 (d, 3H); 1.32 (m, 1H); 1.46 (m, 1H); 1.67 (m, 1H); 4.27 (m, 1H);
6.88 (d, 1H); 8.71 (d, 1H); 9.12 (d, br, 1H), 12.9 (br, 1H)
1643[CDCl3] 0.93 (s, 9H); 1.15 (d, 3H); 4.12 (m, 1H); 6.88 (d, 1H); 8.72 (d, 1H); 9.22 (d, br, 1H)
1644[CDCl3] 0.95 (m, 6H); 1.15 (d, 3H); 1.78 (m, 1H); 4.05 (m, 1H); 6.88 (d, 1H); 8.72 (d, 1H);
9.18 (d, br, 1H); 12.7 (br, 1H)
1646[DMSO] 0.87 (t, 6H); 1.45 (m, 2H); 1.55 (m, 2H); 3.81 (m, 1H); 7.40 (d, 1H); 8.40 (d, 1H);
8.52 (d, br, 1H); 13.4 (br, 1H)
1649[CDCl3] 3.40 (s, 6H); 3.61 (t, 2H); 4.50 (t, 1H); 6.87 (d, 1H); 8.69 (d, 1H); 9.32 (br, 1H);
12.3 (br, 1H)
1651[CDCl3] 3.63 (m, 2H); 3.84 (m, 2H); 6.88 (d, 1H); 8.68 (d, 1H); 9.60 (br, 1H)
1652[DMSO] 3.25 (s, 3H); 3.50 (m, 4H); 7.40 (d, br, 1H); 8.45 (d, 1H); 8.92 (br, 1H); 13.5 (br, 1H)
1659[DMSO] 1.15 (d, 3H); 3.25 (s, 3H); 3.38 (m, 2H); 4.17 (m, 1H); 7.40 (d, br, 1H); 8.43 (d, 1H);
8.75 (br, 1H); 13.5 (br, 1H)
1661[DMSO] 1.74 (m, 2H); 3.22 (s, 3H); 3.37 (m, 4H); 7.42 (d, br, 1H); 8.42 (d, 1H); 8.90 (br,
1H); 13.4 (br, 1H)
1666[CDCl3] 3.77 (s, 3H); 4.23 (d, 2H); 6.87 (d, 1H); 8.67 (d, 1H); 9.65 (br, 1H); 12.1 (br, 1H)
1711[DMSO] 2.83 (d, 3H); 8.39 (s, 1H); 8.72 (d, br, 1H); 13.5 (br)
1712[DMSO] 1.11 (t, 3H); 3.30 (m, 2H); 8.40 (s, 1H); 8.75 (t, br, 1H)
1713[CDCl3] 0.99 (t, 3H); 1.62 (m, 2H); 3.41 (q, 2H); 8.56 (s, 1H); 9.00 (br, 1H)
1714[CDCl3] 1.24 (d, 6H); 4.22 (m, 1H); 8.41 (s, 1H); 9.17 (br, 1H)
1715[CDCl3] 0.61 (m, 2H); 0.90 (m, 2H); 2.95 (m, 1H); 8.57 (s, 1H); 9.02 (br, 1H)
1716[CDCl3] 0.94 (t, 3H); 1.41 (m, 2H); 1.58 (m, 2H); 3.45 (m, 2H); 8.54 (s, 1H); 9.05 (br, 1H)
1717[CDCl3] 1.80 (m, 2H); 1.98 (m, 2H); 2.42 (m, 2H); 4.55 (m, 1H); 8.55 (s, 1H); 9.01 (br, 1H);
12.0 (br, 1H)
1719[DMSO] 2.83 (s, 3H); 2.97 (s, 3H); 8.04 (s, 1H); 12.6 (br, 1H)
1720[DMSO] 1.03 (t, 3H); 1.15 (t, 3H); 3.12 (q, 2H); 3.45 (q, 2H); 8.05 (s, 1H); 12.5 (br, 1H)
1721[CDCl3] 0.25 (m, 2H); 0.55 (m, 2H); 1.05 (m, 1H); 3.32 (m, 2H); 8.57 (s, 1H); 8.93 (br, 1H);
12.1 (br, 1H)
1722[CDCl3] 0.96 (s, 9H); 3.28 (d, 2H); 8.59 (s, 1H); 9.05 (br, 1H)
1723[CDCl3] 0.95 (d, 6H); 1.90 (m, 1H); 3.29 (t, 2H); 8.59 (s, 1H); 9.00 (br, 1H); 12.0 (br, 1H)
1725[CDCl3] 0.94 (d, 6H); 1.49 (q, 2H); 1.65 (m, 1H); 3.45 (m, 2H); 8.59 (s, 1H); 8.93 (br, 1H);
12.1 (br, 1H)
1727[CDCl3] 4.08 (m, 2H); 5.21 (dd, 2H); 5.90 (m, 1H); 8.60 (s, 1H); 9.05 (br, 1H); 12.1 (br, 1H)
1728[CDCl3] 1.78 (s, 3H); 4.01 (d, 2H); 4.90 (d, 2H); 8.61 (s, 1H); 9.09 (bt, 1H); 11.9 (br, 1H)
1729[CDCl3] 2.25 (m, 1H); 4.23 (m, 2H); 8.63 (s, 1H); 9.23 (br, 1H); 11.9 (br, 1H)
1731[CDCl3] 0.95 (t, 3H); 1.23 (d, 3H); 1.58 (m, 2H); 4.11 (m, 1H); 8.55 (s, 1H); 8.60 (br, 1H)
1733[CDCl3] 0.92 (t, 3H); 1.23 (d, 3H); 1.39 (m, 2H); 1.52 (m, 2H); 4.20 (m, 1H); 8.55 (s, 1H);
8.66 (br, 1H)
1734[CDCl3] 0.87 (t, 3H); 1.22 (d, 3H); 1.35 (m, 6H); 1.52 (m, 2H); 4.17 (m, 1H); 8.52 (s, 1H);
8.61 (br, 1H)
1735[CDCl3] 0.94 (m, 6H); 1.23 (d, 3H); 1.33 (m, 1H); 1.45 (m, 1H); 1.65 (m, 1H); 4.27 (m, 1H);
8.56 (s, 1H); 8.63 (br, 1H); 11.9 (br)
1736[CDCl3] 0.96 (s, 9H); 1.17 (d, 3H); 4.08 (m, 1H); 8.57 (s, 1H); 8.80 (d, br, 1H)
1737[CDCl3] 0.95 (m, 6H); 1.18 (d, 3H); 1.80 (m, 1H); 4.05 (m, 1H); 8.57 (s, 1H); 8.73 (d, br, 1H)
1738[DMSO] 0.87 (t, 6H), 1.45 (m, 2H), 1.55 (m, 2H); 3.80 (m, 1H); 8.40 (s, 1H); 8.42 (d, br, 1H);
13.4 (br, 1H)
1739[CDCl3] 3.42 (s, 6H); 3.63 (t, 2H); 4.50 (t, 1H); 8.49 (s, 1H); 8.74 (br, 1H); 11.4 (br, 1H)
1741[CDCl3] 3.65 (m, 2H); 3.85 (m, 2H); 8.55 (s, 1H); 9.16 (br, 1H)
1742[CDCl3] 3.40 (s, 3H); 3.57 (m, 2H); 3.67 (m, 2H); 8.47 (s, 1H); 8.75 (br, 1H); 11.5 (br, 1H)
1744[CDCl3] 1.27 (d, 3H); 3.39 (s, 3H); 3.45 (m, 2H); 4.37 (m, 1H); 8.45 (s, 1H); 8.57 (br, 1H);
11.6 (br, 1H)
1745[CDCl3] 1.90 (m, 2H); 3.40 (s, 3H); 3.56 (m, 4H); 8.27 (s, 1H); 8.65 (br, 1H); 11.8 (br, 1H)
1746[DMSO] 3.67 (s, 3H); 4.13 (d, 2H); 8.38 (s, 1H); 9.12 (br, 1H); 13.6 (br, 1H)
1751[DMSO] 8.24 (br, 1H); 8.38 (br, 1H); 8.61 (br, 1H); 13.7 (br, 1H)
1752[CDCl3] 3.00 (d, 3H); 8.71 (s, 1H); 8.91 (br, 1H); 12.2 (br, 1H)
1753[CDCl3] 1.23 (t, 3H); 3.49 (m, 2H); 8.71 (s, 1H); 8.89 (br, 1H); 12.1 (br, 1H)
1754[CDCl3] 0.98 (t, 3H); 1.62 (m, 2H); 3.40 (q, 2H); 8.70 (s, 1H); 8.90 (br, 1H)
1755[CDCl3] 1.25 (d, 6H); 4.25 (m, 1H); 8.68 (br, 2H); 12.0 (br, 1H)
1756[CDCl3] 0.61 (m, 2H); 0.89 (m, 2H); 2.95 (m, 1H); 8.70 (s, 1H); 8.97 (br, 1H)
1757[CDCl3] 0.94 (t, 3H); 1.40 (m, 2H); 1.58 (m, 2H); 3.45 (m, 2H); 8.69 (s, 1H); 8.88 (br, 1H);
12.0 (br, 1H)
1758[CDCl3] 1.80 (m, 2H); 1.98 (m, 2H); 2.41 (m, 2H); 4.55 (m, 1H); 8.67 (s, 1H); 8.98 (br, 1H);
12.1 (br, 1H)
1759[CDCl3] 1.32 (s, 9H); 8.50 (br, 1H); 8.60 (s, 1H)
1760[CDCl3] 3.12 (s, 6H); 7.99 (s, 1H)
1761[CDCl3] 1.24 (t, 6H); 3.43 (m, 4H); 7.89 (s, 1H)
1762[CDCl3] 0.28 (m, 2H); 0.55 (m, 2H); 1.03 (m, 1H); 3.31 (m, 2H); 8.67 (s, 1H); 8.85 (br, 1H);
11.9 (br, 1H)
1763[CDCl3] 0.96 (s, 9H); 3.27 (d, 2H); 8.71 (s, 1H); 9.00 (br, 1H)
1764[CDCl3] 0.95 (d, 6H); 1.89 (m, 1H); 3.28 (t, 2H); 8.70 (s, 1H); 8.97 (br, 1H)
1766[CDCl3] 0.95 (d, 6H); 1.48 (q, 2H); 1.65 (m, 1H); 3.45 (m, 2H); 8.69 (s, 1H); 8.85 (br, 1H);
12.0 (br, 1H)
1768[CDCl3] 4.08 (m, 2H); 5.21 (dd, 2H); 5.89 (m, 1H); 8.71 (s, 1H); 9.02 (br, 1H); 12.1 (br, 1H)
1769[CDCl3] 1.77 (s, 3H); 4.01 (d, 2H); 4.87 (d, 2H); 8.71 (s, 1H); 9.03 (br, 1H)
1770[CDCl3] 2.23 (m, 1H); 4.23 (m, 2H); 8.72 (s, 1H); 9.20 (br, 1H); 12.0 (br, 1H)
1772[CDCl3] 0.95 (t, 3H); 1.21 (d, 3H); 1.55 (m, 2H); 4.10 (m, 1H); 8.67 (br, 1H); 8.70 (s, 1H);
12.1 (br, 1H)
1774[CDCl3] 0.91 (t, 3H); 1.21 (d, 3H); 1.38 (m, 2H); 1.50 (m, 2H); 4.19 (m, 1H); 8.64 (br, 1H);
8.69 (s, 1H); 12.0 (br, 1H)
1775[CDCl3] 0.89 (t, 3H); 1.21 (d, 3H); 1.33 (m, 6H); 1.51 (m, 2H); 4.17 (m, 1H); 8.60 (br, 1H);
8.68 (s, 1H)
1776[CDCl3] 0.90 (m, 6H); 1.21 (d, 3H); 1.31 (m, 1H); 1.45 (m, 1H); 1.64 (m, 1H); 4.25 (m, 1H);
8.60 (br, 1H); 8.69 (s, 1H)
1777[CDCl3] 0.94 (s, 9H); 1.15 (d, 3H); 4.08 (m, 1H); 8.69 (s, 1H); 8.79 (br, 1H)
1778[CDCl3] 0.93 (m, 6H); 1.17 (d, 3H); 1.79 (m, 1H); 4.05 (m, 1H); 8.67 (s, 1H); 8.71 (br, 1H)
1780[CDCl3] 0.92 (t, 6H); 1.48 (m, 2H); 1.62 (m, 2H); 3.96 (m, 1H); 8.61 (s, 1H); 9.16 (d, br, 1H)
1781[CDCl3] 3.40 (s, 6H); 3.61 (t, 2H); 4.50 (t, 1H); 8.63 (s, 1H); 8.76 (br, 1H)
1783[CDCl3] 3.64 (m, 2H); 3.86 (m, 2H); 8.68 (s, 1H); 9.17 (br, 1H)
1784[CDCl3] 3.49 (s, 3H); 3.55 (m, 2H); 3.66 (m, 2H); 8.62 (s, 1H); 8.77 (br, 1H)
1785[CDCl3] 1.27 (d, 3H); 3.39 (s, 3H); 3.44 (m, 2H); 4.37 (m, 1H); 8.56 (br, 1H); 8.60 (s, 1H);
11.9 (br, 1H)
1786[CDCl3] 1.90 (m, 2H); 3.40 (s, 3H); 3.58 (m, 4H); 8.40 (s, 1H); 8.65 (br, 1H)
1787[CDCl3] 3.78 (s, 3H); 4.24 (d, 2H); 8.69 (s, 1H); 9.25 (br, 1H); 11.5 (br, 1H)
1792[DMSO] 8.22 (br, 1H); 8.37 (br, 1H); 8.81 (br, 1H); 13.7 (br, 1H)
1793[CDCl3] 3.00 (d, 3H); 8.80 (s, br, 2H); 12.0 (br, 1H)
1794[CDCl3] 1.24 (t, 3H); 3.49 (m, 2H); 8.40 (s, br, 2H); 12.0 (br, 1H)
1795[DMSO] 0.89 (t, 3H); 1.53 (m, 2H); 3.26 (q, 2H); 8.72 (s, 1H); 8.78 (t, br, 1H); 13.4 (br, 1H)
1796[DMSO] 1.18 (d, 6H); 4.08 (m, 1H); 8.60 (d, br, 2H); 13.4 (br, 1H)
1797[DMSO] 0.60 (m, 2H); 0.75 (m, 2H); 2.88 (m, 1H); 8.68 (s, 1H); 8.77 (d, br, 1H); 13.3 (br,
1H)
1798[CDCl3] 0.94 (t, 3H); 1.40 (m, 2H); 1.59 (m, 2H); 3.44 (m, 2H); 8.79 (s, br, 2H)
1799[DMSO] 1.70 (m, 2H); 2.05 (m, 2H); 2.27 (m, 2H); 4.39 (m, 1H); 8.71 (s, 1H); 8.95 (d, br,
1H); 13.4 (br, 1H)
1800[CDCl3] 1.43 (s, 9H); 8.70 (br, 1H); 8.85 (s, 1H); 11.5 (br)
1801[CDCl3] 3.10 (s, 6H); 8.20 (s, 1H)
1802[CDCl3] 1.23 (t, 6H); 3.43 (m, br, 4H); 8.12 (s, 1H)
1803[DMSO] 0.26 (m, 2H); 0.50 (m, 2H); 1.05 (m, 1H); 3.19 (t, 2H); 8.76 (s, 1H); 8.87 (br, 1H);
13.5 (br, 1H)
1804[DMSO] 0.91 (s, 9H); 3.13 (d, 2H); 8.61 (t, br, 1H); 8.68 (s, 1H); 13.4 (br, 1H)
1805[DMSO] 0.89 (d, 6H); 1.84 (m, 1H); 3.14 (t, 2H); 8.70 (s, 1H); 8.75 (t, br, 1H); 13.4 (br, 1H)
1807[DMSO] 0.89 (d, 6H); 1.40 (q, 2H); 1.62 (m, 1H); 3.30 (m, 2H); 8.71 (s, 1H); 8.73 (t, br, 1H);
13.4 (br, 1H)
1809[DMSO] 3.93 (m, 2H); 5.18 (dd, 2H); 5.90 (m, 1H); 8.71 (s, 1H); 8.89 (t, br, 1H); 13.4 (br,
1H)
1810[DMSO] 1.72 (s, 3H); 3.87 (d, 2H); 4.85 (d, 2H); 8.71 (s, 1H); 8.87 (t, br, 1H); 13.3 (br, 1H)
1811[DMSO] 3.18 (m, 1H); 4.10 (m, 2H); 8.69 (s, 1H); 9.01 (t, br, 1H); 13.4 (br, 1H)
1813[DMSO] 0.87 (t, 3H); 1.14 (d, 3H); 1.50 (m, 2H); 3.90 (m, 1H); 8.52 (d, br, 1H); 8.72 (s, 1H);
13.4 (br, 1H)
1815[DMSO] 0.89 (t, 3H); 1.15 (d, 3H); 1.30 (m, 2H); 1.47 (m, 2H); 4.00 (m, 1H); 8.54 (br, 1H);
8.72 (s, 1H); 13.4 (br, 1H)
1816[CDCl3] 0.89 (t, 3H); 1.20 (d, 3H); 1.27-1.37 (m, 6H); 1.51 (m, 2H); 4.16 (m, 1H); 8.75 (br,
1H); 8.90 (s, 1H); 12.1 (br, 1H)
1817[CDCl3] 0.91 (m, 6H); 1.20 (d, 3H); 1.32 (m, 1H); 1.45 (m, 1H); 1.65 (m, 1H); 4.25 (m, 1H);
8.66 (br, 1H); 8.90 (s, 1H); 11.9 (br, 1H)
1818[CDCl3] 0.94 (s, 9H); 1.14 (d, 3H); 4.07 (m, 1H); 8.85 (br, 1H); 8.90 (s, 1H)
1819[CDCl3] 0.95 (m, 6H); 1.18 (d, 3H); 1.79 (m, 1H); 4.04 (m, 1H); 8.75 (br, 1H); 8.89 (s, 1H)
1820[CDCl3] 0.93 (t, 6H); 1.48 (m, 2H); 1.64 (m, 2H); 3.98 (m, 1H); 8.63 (br, 1H); 8.90 (s, 1H);
11.6 (br, 1H)
1821[CDCl3] 3.40 (s, 6H); 3.60 (t, 2H); 4.49 (t, 1H); 8.85 (s, br, 2H); 11.4 (br, 1H)
1823[CDCl3] 3.63 (m, 2H); 3.83 (m, 2H); 8.86 (s, 1H); 9.17 (br, 1H)
1824[CDCl3] 3.38 (s, 3H); 3.55 (m, 2H); 3.65 (m, 2H); 8.82 (s, 1H); 8.84 (br, 1H); 11.4 (br, 1H)
1826[CDCl3] 1.25 (d, 3H); 3.39 (s, 3H); 3.43 (m, 2H); 4.38 (m, 1H); 8.67 (br, 1H); 8.82 (s, 1H);
11.5 (br, 1H)
1827[CDCl3] 1.89 (m, 2H); 3.40 (s, 3H); 3.55 (m, 4H); 8.67 (s, 1H); 8.74 (br, 1H); 11.8 (br, 1H)
1828[CDCl3] 3.78 (s, 3H); 4.24 (d, 2H); 8.89 (s, 1H); 9.30 (br, 1H)
1833[DMSO] 2.85 (d, 3H); 8.69 (s, 1H); 8.71 (br, 1H); 13.5 (br, 1H)
1834[DMSO] 1.12 (t, 3H); 3.30 (m, 2H); 8.70 (s, 1H); 8.75 (t, br, 1H); 13.5 (br, 1H)
1835[DMSO] 0.89 (t, 3H); 1.52 (m, 2H); 3.25 (q, 2H); 8.70 (s, 1H); 8.75 (t, br, 1H); 13.5 (br, 1H)
1837[DMSO] 0.59 (m, 2H); 0.76 (m, 2H); 2.86 (m, 1H); 8.66 (s, 1H); 8.76 (br, 1H); 13.3 (br)
1838[CDCl3] 0.95 (t, 3H); 1.42 (m, 2H); 1.60 (m, 2H); 3.45 (m, 2H); 8.86 (s, 1H); 8.95 (br, 1H)
1839[CDCl3] 1.81 (m, 2H); 2.00 (m, 2H); 2.42 (m, 2H); 4.54 (m, 1H); 8.84 (s, 1H); 9.17 (d, br,
1H); 12.2 (br, 1H)
1845[CDCl3] 0.29 (m, 2H); 0.57 (m, 2H); 1.05 (m, 1H); 3.32 (t, 2H); 8.87 (s, 1H); 9.05 (br, 1H);
12.3 (br, 1H)
1847[CDCl3] 1.00 (d, 6H); 1.90 (m, 1H); 3.30 (t, 2H); 8.85 (s, 1H); 9.00 (br, 1H)
1849[CDCl3] 0.95 (d, 6H); 1.51 (q, 2H); 1.68 (m, 1H); 3.46 (m, 2H); 8.85 (s, 1H); 8.91 (br, 1H)
1851[DMSO] 3.94 (m, 2H); 5.16 (dd, 2H); 5.90 (m, 1H); 8.70 (s, 1H); 8.85 (t, br, 1H); 13.4 (br,
1H)
1852[CDCl3] 1.79 (s, 3H); 4.02 (m, 2H); 4.92 (m, 2H); 8.88 (s, 1H); 9.10 (t, br, 1H)
1853[CDCl3] 2.26 (m, 1H); 4.22 (m, 2H); 8.86 (s, 1H); 9.25 (br, 1H)
1854[DMSO] 0.87 (t, 3H); 1.13 (d, 3H); 1.50 (m, 2H); 3.91 (m, 1H); 8.55 (d, br, 1H); 8.70 (br,
1H); 13.5 (br, 1H)
1856[DMSO] 0.89 (t, 3H); 1.15 (d, 3H); 1.30 (m, 2H); 1.49 (m, 2H); 4.01 (m, 1H); 8.51 (d, br, 1H);
8.71 (s, 1H); 13.6 (br, 1H)
1857[CDCl3] 0.87 (t, 3H); 1.22 (8, 3H); 1.25-1.35 (m, 6H); 1.53 (m, 2H); 4.14 (m, 1H); 8.81 (d,
br, 1H); 8.88 (s, 1H)
1858[CDCl3] 0.92 (m, 6H); 1.22 (d, 3H); 1.33 (m, 1H); 1.48 (m, 1H); 1.65 (m, 1H); 4.25 (m, 1H);
8.84 (br, 1H); 8.88 (s, 1H); 12.3 (br, 1H)
1860[CDCl3] 0.95 (m, 6H); 1.18 (d, 3H); 1.81 (m, 1H); 4.05 (m, 1H); 8.90 (s, 1H); 9.01 (d, br, 1H)
1861[DMSO] 0.88 (t, 6H); 1.45 (m, 2H); 1.55 (m, 2H); 3.79 (m, 1H); 8.40 (d, br, 1H); 8.70 (s, 1H);
13.5 (br, 1H)
1867[DMSO] 3.29 (s, 3H); 3.47 (m, 4H); 8.73 (s, 1H); 8.79 (br, 1H); 13.6 (br, 1H)
1869[CDCl3] 1.28 (d, 3H); 3.39 (s, 3H); 3.45 (m, 2H); 4.35 (m, 1H); 8.81 (s, 1H); 8.86 (br, 1H);
12.0 (br, 1H)
1870[CDCl3] 1.90 (m, 2H); 3.41 (s, 3H); 3.56 (m, 4H); 8.62 (s, 1H); 8.76 (br, 1H); 11.9 (br, 1H)
1876[DMSO] 8.18 (br, 1H); 8.35 (br, 1H); 8.79 (s, 1H); 13.7 (br, 1H)
1877[DMSO] 2.83 (d, 3H); 8.70 (br, 2H); 13.5 (br, 1H)
1878[DMSO] 1.12 (t, 3H); 3.32 (m, 2H); 8.71 (s, 1H); 8.76 (t, br, 1H); 13.4 (br, 1H)
1879[DMSO] 0.90 (t, 3H); 1.51 (m, 2H); 3.25 (q, 2H); 8.70 (s, 1H); 8.78 (t, br, 1H); 13.5 (br, 1H)
1880[DMSO] 1.18 (d, 6H); 4.07 (m, 2H); 8.57 (d, br, 1H); 8.72 (s, 1H); 13.4 (br, 1H)
1881[DMSO] 0.58 (m, 2H); 0.74 (m, 2H); 2.85 (m, 1H); 8.66 (s, 1H); 8.74 (br, 1H); 13.4 (br, 1H)
1882[DMSO] 0.89 (t, 3H); 1.31 (m, 2H); 1.50 (m, 2H); 3.30 (m, 2H); 8.70 (s, 1H); 8.75 (br, 1H)
1883[DMSO] 1.69 (m, 2H); 2.02 (m, 2H); 2.25 (m, 2H); 4.39 (m, 1H); 8.70 (s, 1H); 8.95 (br, 1H)
1884[CDCl3] 1.47 (s, 9H); 8.87 (s, 1H); 9.02 (br, 1H); 12.2 (br, 1H)
1885[CDCl3] 3.12 (s, 6H); 8.16 (s, 1H)
1886[DMSO] 0.23 (m, 2H); 0.45 (m, 2H); 1.02 (m, 1H); 3.19 (t, 2H); 8.72 (s, 1H); 8.83 (br, 1H);
13.4 (br, 1H)
1887[DMSO] 0.90 (s, 9H); 3.14 (d, 2H); 8.72 (br, 1H); 8.67 (s, 1H); 13.4 (br, 1H)
1888[DMSO] 0.90 (d, 6H); 1.84 (m, 1H); 3.12 (t, 2H); 8.68 (s, 1H); 8.73 (t, br, 1H); 13.4 (br, 1H)
1890[DMSO] 0.90 (d, 6H); 1.41 (m, 2H); 1.60 (m, 1H); 3.30 (m, 2H); 8.69 (s, 1H); 8.72 (t, br, 1H);
13.5 (br, 1H)
1892[DMSO] 3.94 (m, 2H); 5.15 (dd, 2H); 5.89 (m, 1H); 8.70 (s, 1H); 8.85 (t, br, 1H)
1894[DMSO] 1.70 (s, 3H); 3.86 (d, 2H); 4.84 (d, 2H); 8.68 (s, 1H); 8.95 (br, 1H); 13.4 (br, 1H)
1895[DMSO] 3.10 (t, 1H); 4.05 (m, 2H); 8.25 (br, 1H); 8.30 (s, 1H); 11.5 (br, 1H)
1897[CDCl3] 0.95 (t, 3H); 1.24 (d, 3H); 1.60 (m, 2H); 4.10 (m, 1H); 8.87 (br, 2H)
1899[CDCl3] 0.92 (t, 3H); 1.23 (d, 3H); 1.40 (m, 2H); 1.52 (m, 2H); 4.17 (m, 1H); 8.88 (s, 1H);
8.91 (br, 1H)
1900[DMSO] 0.86 (t, 3H); 1.15 (d, 3H); 1.25 (m, 6H); 1.48 (m, 2H); 4.00 (m, 1H); 8.53 (d, br, 1H);
8.71 (s, 1H); 13.4 (br, 1H)
1903[DMSO] 0.89 (d, 6H); 1.13 (d, 3H); 1.27 (m, 1H); 1.48 (m, 1H); 1.62 (m, 1H); 4.09 (m, 1H);
8.50 (d, br, 1H); 8.71 (s, 1H); 13.5 (br, 1H)
1904[DMSO] 0.81 (s, 9H); 1.07 (d, 3H); 3.90 (m, 1H); 8.43 (d, br, 1H); 8.67 (s, 1H); 13.4 (br, 1H)
1905[DMSO] 0.88 (d, 6H); 1.10 (d, 3H); 1.75 (m, 1H); 1.48 (m, 1H); 3.85 (m, 1H); 8.49 (d, br,
1H); 8.70 (s, 1H); 13.5 (br, 1H)
1907[DMSO] 0.87 (t, 6H); 1.43 (m, 2H); 1.55 (m, 2H); 3.78 (m, 1H); 8.55 (br, 1H); 8.67 (s, 1H);
13.5 (br, 1H)
1910[CDCl3] 3.41 (s, 6H); 3.62 (t, 2H); 4.50 (t, 1H); 8.82 (s, 1H); 8.95 (br, 1H); 11.2 (br, 1H)
1912[DMSO] 3.39 (m, 2H); 3.52 (m, 2H); 4.83 (br, 1H); 8.76 (s, 1H); 8.80 (t, br, 1H); 13.6 (br, 1H)
1913[DMSO] 3.26 (s, 3H); 3.47 (m, 4H); 8.71 (s, 1H); 8.79 (br, 1H)
1916[CDCl3] 1.27 (d, 3H); 3.39 (s, 3H); 3.44 (m, 2H); 4.38 (m, 1H); 8.83 (s, 1H); 8.95 (br, 1H);
12.1 (br, 1H)
1917[DMSO] 1.75 (m, 2H); 3.24 (s, 3H); 3.39 (m, 4H); 8.70 (s, 1H); 8.81 (br, 1H); 13.4 (br, 1H)
1918[DMSO] 3.66 (s, 3H); 4.12 (d, 2H); 8.71 (s, 1H); 9.02 (t, br, 1H), 13.5 (br, 1H)
1923[DMSO] 2.81 (d, 3H); 8.72 (s, 1H); 8.77 (br, 1H); 13.4 (br)
1924[DMSO] 1.14 (t, 3H); 3.35 (m, 2H); 8.74 (s, 1H); 8.82 (t, br, 1H); 13.4 (br)
1925[DMSO] 0.89 (t, 3H); 1.53 (m, 2H); 3.28 (q, 2H); 8.73 (s, 1H); 8.80 (t, br, 1H)
1926[DMSO] 1.18 (d, 6H); 4.10 (m, 1H); 8.63 (d, br, 1H); 8.75 (s, 1H); 13.4 (br, 1H)
1927[DMSO] 0.60 (m, 2H); 0.75 (m, 2H); 2.87 (m, 1H); 8.69 (s, 1H); 8.80 (br, 1H)
1928[DMSO] 0.89 (t, 3H); 1.34 (m, 2H); 1.51 (m, 2H); 3.30 (m, 2H); 8.72 (s, 1H); 8.79 (br, 1H)
1929[DMSO] 1.72 (m, 2H); 2.05 (m, 2H); 2.27 (m, 2H); 4.38 (m, 1H); 8.73 (s, 1H); 9.00 (d, br,
1H); 13.3 (br)
1930[DMSO] 1.37 (s, 9H); 8.30 (br, 1H); 8.66 (s, 1H); 13.4 (br)
1931[DMSO] 2.80 (s, 3H); 2.96 (s, 3H); 8.27 (s, 1H); 12.4 (br, 1H)
1932[DMSO] 1.01 (t, 3H); 1.11 (t, 3H); 3.10 (q, 2H); 3.42 (q, 2H); 8.25 (s, 1H); 12.3 (br, 1H)
1933[DMSO] 0.26 (m, 2H); 0.47 (m, 2H); 1.04 (m, 1H); 3.20 (m, 2H); 8.77 (s, 1H); 8.87 (t, br,
1H); 13.5 (br, 1H)
1934[DMSO] 0.90 (s, 9H); 3.13 (d, 2H); 8.62 (t, br, 1H); 8.70 (s, 1H); 13.3 (br, 1H)
1935[DMSO] 0.90 (d, 6H); 1.85 (m, 1H); 3.13 (m, 2H); 8.71 (s, 1H); 8.75 (t, br, 1H); 13.4 (br, 1H)
1937[CDCl3] 0.94 (d, 6H); 1.49 (q, 2H); 1.66 (m, 1H); 3.46 (m, 2H); 8.75 (br, 1H); 8.85 (s, 1H);
11.5 (br)
1939[DMSO] 3.93 (m, 2H); 5.19 (dd, 2H); 5.89 (m, 1H); 8.72 (s, 1H); 8.90 (t, br, 1H); 13.3 (br,
1H)
1941[DMSO] 1.72 (s, 3H); 3.87 (d, 2H); 4.87 (d, 2H); 8.73 (s, 1H); 8.89 (t, br, 1H); 13.3 (br)
1942[DMSO] 3.18 (m, 1H); 4.10 (m, 2H); 8.70 (s, 1H); 9.04 (t, br, 1H); 13.3 (br, 1H)
1944[DMSO] 0.89 (t, 3H); 1.14 (d, 3H); 1.51 (m, 2H); 3.91 (m, 1H); 8.55 (d, br, 1H); 8.75 (s, 1H);
13.4 (br, 1H)
1946[DMSO] 0.89 (t, 3H); 1.15 (d, 3H); 1.31 (m, 2H); 1.47 (m, 2H); 4.01 (m, 1H); 8.56 (br, 1H);
8.74 (s, 1H); 13.4 (br, 1H)
1947[DMSO] 0.85 (t, 3H); 1.15 (d, 3H); 1.20-1.35 (m, 6H); 1.49 (m, 2H); 4.00 (m, 1H); 8.58 (d,
br, 1H); 8.74 (s, 1H); 13.4 (br, 1H)
1948[DMSO] 0.88 (d, 6H); 1.15 (d, 3H); 1.27 (m, 1H); 1.48 (m, 1H); 1.61 (m, 1H); 4.10 (m, 1H);
8.56 (d, br, 1H); 8.74 (s, 1H); 13.5 (br, 1H)
1949[CDCl3] 0.94 (s, 1H); 1.15 (d, 3H); 4.09 (m, 1H); 8.89 (br, 1H); 8.91 (s, 1H)
1950[CDCl3] 0.94 (m, 6H); 1.17 (d, 3H); 1.80 (m, 1H); 4.05 (m, 1H); 8.88 (br, 1H); 8.92 (s, 1H)
1951[CDCl3] 0.92 (t, 6H); 1.49 (m, 2H); 1.65 (m, 2H); 3.99 (m, 1H); 8.78 (br, 1H); 8.92 (s, 1H)
1952[CDCl3] 3.41 (s, 6H); 3.61 (t, 2H); 4.50 (t, 1H); 8.84 (s, br, 2H); 11.4 (br, 1H)
1954[DMSO] 3.39 (m, 2H); 3.52 (m, 2H); 4.80 (br, 1H); 8.79 (s, 1H); 8.82 (t, br, 1H); 13.5 (br, 1H)
1955[CDCl3] 3.38 (s, 3H); 3.55 (m, 2H); 3.66 (m, 2H); 8.78 (s, br, 1H); 8.82 (s, 1H); 11.5 (br)
1957[CDCl3] 1.27 (d, 3H); 3.38 (s, 3H); 3.42 (m, 2H); 4.38 (m, 1H); 8.75 (br, 1H); 8.84 (s, 1H);
12.3 (br, 1H)
1958[CDCl3] 1.89 (m, 2H); 3.41 (s, 3H); 3.56 (m, 4H); 8.61 (s, 1H); 8.68 (br, 1H); 11.8 (br, 1H)
1959[DMSO] 3.67 (s, 3H); 4.12 (d, 2H); 8.73 (s, 1H); 9.04 (t, br, 1H); 13.5 (br, 1H)
1964[DMSO] 8.25 (br, 1H); 8.37 (br, 1H); 8.47 (s, 1H); 13.7 (br, 1H)
1965[DMSO] 2.82 (d, 3H); 8.37 (s, 1H); 8.72 (d, br, 1H); 13.5 (br, 1H)
1966[DMSO] 1.13 (t, 3H); 3.34 (m, 2H); 8.39 (s, 1H); 8.76 (t, br, 1H); 13.5 (br, 1H)
1967[DMSO] 0.90 (t, 3H); 1.53 (m, 2H); 3.26 (q, 2H); 8.39 (s, 1H); 8.75 (t, br, 1H); 13.5 (br, 1H)
1968[DMSO] 1.18 (d, 6H); 4.09 (m, 1H); 8.41 (s, 1H); 8.58 (d, br, 1H); 13.5 (br, 1H)
1969[DMSO] 0.59 (m, 2H); 0.75 (m, 2H); 2.86 (m, 1H); 8.34 (s, 1H); 8.73 (d, br, 1H); 13.4 (br,
1H)
1970[DMSO] 0.89 (t, 3H); 1.33 (m, 2H); 1.51 (m, 2H); 3.31 (m, 2H); 8.39 (s, 1H); 8.73 (t, br, 1H);
13.5 (br, 1H)
1971[DMSO] 1.70 (m, 2H); 2.04 (m, 2H); 2.25 (m, 2H); 4.38 (m, 1H); 8.39 (s, 1H); 8.92 (d, br,
1H); 13.4 (br, 1H)
2006[DMSO] 8.25 (br, 1H); 8.35 (br, 1H); 8.61 (s, 1H); 13.7 (br, 1H)
2007[DMSO] 2.82 (d, 3H); 8.51 (s, 1H); 8.74 (d, br, 1H); 13.5 (br, 1H)
2008[DMSO] 1.13 (t, 3H); 3.33 (m, 2H); 8.53 (s, 1H); 8.78 (t, br, 1H); 13.5 (br, 1H)
2009[DMSO] 0.89 (t, 3H); 1.53 (m, 2H); 3.26 (q, 2H); 8.51 (s, 1H); 8.76 (t, br, 1H); 13.5 (br, 1H)
2010[DMSO] 1.18 (d, 6H); 4.07 (m, 1H); 8.53 (s, 1H); 8.61 (d, br, 1H); 13.5 (br, 1H)
2011[DMSO] 0.58 (m, 2H); 0.74 (m, 2H); 2.86 (m, 1H); 8.48 (s, 1H); 8.77 (d, br, 1H); 13.4 (br,
1H)
2012[DMSO] 0.90 (t, 3H); 1.33 (m, 2H); 1.51 (m, 2H); 3.30 (m, 2H); 8.52 (s, 1H); 8.77 (t, br, 1H);
13.5 (br, 1H)
2013[DMSO] 1.72 (m, 2H); 2.05 (m, 2H); 2.25 (m, 2H); 4.39 (m, 1H); 8.51 (s, 1H); 8.95 (d, br,
1H); 13.4 (br, 1H)
2014[DMSO] 1.37 (s, 9H); 8.31 (br, 1H); 8.45 (s, 1H); 13.4 (br, 1H)
2015[DMSO] 2.82 (s, 3H); 2.95 (s, 3H); 8.12 (s, 1H); 12.5 (br, 1H)
2017[DMSO] 0.26 (m, 2H); 0.47 (m, 2H); 1.04 (m, 1H); 3.30 (m, 2H); 8.56 (s, 1H); 8.86 (t, br,
1H); 13.5 (br, 1H)
2018[DMSO] 0.91 (s, 9H); 3.13 (d, 2H); 8.47 (s, 1H); 8.63 (t, br, 1H); 13.5 (br, 1H)
2019[DMSO] 0.90 (d, 6H); 1.83 (m, 1H); 3.13 (m, 2H); 8.50 (s, 1H); 8.73 (t, br, 1H); 13.4 (br, 1H)
2021[DMSO] 0.89 (d, 6H); 1.42 (q, 2H); 1.62 (m, 1H); 3.31 (m, 2H); 8.51 (s, 1H); 8.75 (t, br, 1H);
13.5 (br, 1H)
2023[DMSO] 3.94 (m, 2H); 5.18 (dd, 2H); 5.89 (m, 1H); 8.52 (s, 1H); 8.88 (t, br, 1H); 13.4 (br,
1H)
2025[DMSO] 1.72 (s, 3H); 3.86 (d, 2H); 4.85 (d, 2H); 8.50 (s, 1H); 8.87 (t, br, 1H); 13.4 (br, 1H)
2026[DMSO] 3.18 (m, 1H); 4.10 (m, 2H); 8.48 (s, 1H); 9.02 (t, br, 1H); 13.3 (br, 1H)
2030[CDCl3] 0.93 (t, 3H); 1.23 (d, 3H); 1.40 (m, 2H); 1.52 (m, 2H); 4.21 (m, 1H); 8.74 (s, 1H);
8.97 (d, br, 1H); 12.9 (br, 1H)
2031[DMSO] 0.85 (t, 3H); 1.15 (d, 3H); 1.20-1.35 (m, 6H); 1.48 (m, 2H); 3.99 (m, 1H); 8.52 (s,
1H); 8.54 (d, br, 1H); 13.5 (br, 1H)
2032[DMSO] 0.88 (d, 6H); 1.14 (d, 3H); 1.27 (m, 1H); 1.48 (m, 1H); 1.62 (m, 1H); 4.10 (m, 1H);
8.51 (s, 1H); 8.53 (d, br, 1H); 13.5 (br, 1H)
2035[DMSO] 0.86 (t, 6H); 1.45 (m, 2H); 1.55 (m, 2H); 3.78 (m, 1H); 8.82 (d, br, 1H); 8.51 (s, 1H);
13.5 (br, 1H)
2036[CDCl3] 3.41 (s, 6H); 3.61 (t, 2H); 4.50 (t, 1H); 8.67 (s, 1H); 9.00 (br, 1H); 11.7 (br, 1H)
2038[DMSO] 3.35 (m, 2H); 3.53 (m, 2H); 4.81 (br, 1H); 8.56 (s, 1H); 8.80 (t, br, 1H); 13.6 (br, 1H)
2039[CDCl3] 3.38 (s, 3H); 3.56 (m, 2H); 3.65 (m, 2H); 8.65 (s, 1H); 9.01 (s, 1H); 11.8 (br, 1H)
2041[DMSO] 1.15 (d, 3H); 3.30 (s, 3H); 3.40 (m, 2H); 4.18 (m, 1H); 8.52 (s, 1H); 8.64 (d, br, 1H);
13.4 (br, 1H)
2048[DMSO] 8.20 (br, 1H); 8.37 (br, 1H); 8.81 (s, 1H); 13.7 (br, 1H)
2090[DMSO] 7.45 (d, 1H); 8.14 (br, 1H); 8.42 (br, 1H); 8.48 (d, 1H); 13.7 (br, 1H)
2091[DMSO] 2.84 (d, 3H); 7.42 (d, 1H); 8.41 (d, 1H); 8.79 (br, 1H); 13.4 (br, 1H)
2092[DMSO] 1.12 (t, 3H); 3.32 (m, 2H); 7.42 (d, 1H); 8.42 (d, 1H); 8.83 (br, 1H); 13.4 (br, 1H)
2093[DMSO] 0.89 (t, 3H); 1.54 (m, 2H); 3.27 (q, 2H); 7.42 (d, 1H); 8.41 (d, 1H); 8.82 (br, 1H);
13.4 (br, 1H)
2094[DMSO] 1.18 (d, 6H); 4.11 (m, 1H); 7.41 (d, 1H); 8.41 (d, 1H); 8.63 (br, 1H); 13.4 (br, 1H)
2095[CDCl3] 0.61 (m, 2H); 0.88 (m, 2H); 3.00 (m, 1H); 6.89 (d, 1H); 8.68 (d, 1H); 9.35 (br, 1H);
12.5 (br, 1H)
2096[DMSO] 0.89 (t, 3H); 1.33 (m, 2H); 1.52 (m, 2H); 3.32 (m, 2H); 7.42 (d, 1H); 8.41 (d, 1H);
8.81 (br, 1H); 13.3 (br, 1H)
2097[DMSO] 1.72 (m, 2H); 2.05 (m, 2H); 2.46 (m, 2H); 4.41 (m, 1H); 7.43 (d, 1H); 8.39 (d, 1H);
8.96 (br, 1H); 13.3 (br, 1H)
2101[DMSO] 0.26 (m, 2H), 0.47 (m, 2H); 1.06 (m, 1H); 3.22 (m, 2H); 7.45 (d, 1H); 8.45 (d, 1H);
8.91 (br, 1H); 13.4 (br, 1H)
2102[DMSO] 0.92 (s, 9H); 3.15 (d, 2H); 7.40 (d, 1H); 8.41 (d, 1H); 8.75 (br, 1H); 13.3 (br, 1H)
2103[DMSO] 0.90 (d, 6H); 1.83 (m, 1H); 3.14 (t, 2H); 7.40 (d, 1H); 8.40 (d, 1H); 8.81 (t, br, 1H);
13.3 (br, 1H)
2105[DMSO] 0.90 (d, 6H); 1.42 (m, 2H); 1.62 (m, 1H); 3.33 (m, 2H); 7.41 (d, 1H); 8.40 (d, 1H);
8.80 (br, 1H); 13.3 (br, 1H)
2107[DMSO] 3.95 (t, 2H); 5.17 (dd, 2H); 5.90 (m, 1H); 7.41 (d, 1H); 8.41 (d, 1H); 8.93 (br, 1H);
13.3 (br, 1H)
2109[DMSO] 1.72 (s, 3H); 3.88 (d, 2H); 4.85 (d, 2H); 7.42 (d 1H); 8.42 (d, 1H); 8.94 (br, 1H);
13.3 (br, 1H)
2110[DMSO] 3.17 (m, 1H); 4.11 (m, 2H); 7.41 (d, 1H); 8.40 (d, 1H); 9.06 (br, 1H), 13.3 (br, 1H)
2112[DMSO] 0.89 (t, 3H); 1.15 (d, 3H); 1.53 (m, 2H); 3.95 (m, 1H); 7.42 (d, 1H); 8.42 (d, 1H);
8.60 (br, 1H); 13.4 (br, 1H)
2114[DMSO] 0.88 (t, 3H); 1.15 (d, 3H); 1.32 (m, 2H); 1.48 (m, 2H); 4.04 (m, 1H); 7.42 (d, 1H);
8.41 (d, 1H); 8.59 (br, 1H); 13.4 (br, 1H)
2115[DMSO] 0.85 (t, 3H); 1.16 (d, 3H); 1.20-1.35 (m, 6H); 1.50 (m, 2H); 4.02 (m, 1H); 7.42 (d,
1H); 8.44 (d, 1H); 8.62 (d, br, 1H), 13.4 (br, 1H)
2116[DMSO] 0.88 (d, 6H); 1.14 (d, 3H); 1.25 (m, 1H); 1.48 (m, 1H); 1.63 (m, 1H); 4.21 (m, 1H);
6.92 (d, 1H); 8.42 (d, 1H); 8.59 (d, br, 1H), 13.4 (br, 1H)
2122[DMSO] 3.40 (m, 2H); 3.52 (m, 2H); 4.82 (br, 1H); 7.44 (d, 1H); 8.46 (d, 1H); 8.88 (br, 1H);
13.4 (br, 1H)
2133[DMSO] 2.83 (d, 3H); 8.58 (s, 1H); 8.82 (d, br, 1H); 13.4 (br, 1H)
2134[DMSO] 1.14 (t, 3H); 3.34 (m, 2H); 8.60 (s, 1H); 8.86 (t, br, 1H); 13.5 (br, 1H)
2135[DMSO] 0.89 (t, 3H); 1.54 (m, 2H); 3.26 (q, 2H); 8.59 (s, 1H); 8.85 (t, br, 1H); 13.5 (br, 1H)
2137[DMSO] 0.60 (m, 2H); 0.75 (m, 2H); 2.88 (m, 1H); 8.55 (s, 1H); 8.85 (d, br, 1H); 13.4 (br,
1H)
2138[DMSO] 0.90 (t, 3H); 1.33 (m, 2H); 1.51 (m, 2H); 3.31 (m, 2H); 8.59 (s, 1H); 8.84 (t, br, 1H);
13.4 (br, 1H)
2139[DMSO] 1.71 (m, 2H); 2.05 (m, 2H); 2.25 (m, 2H); 4.40 (m, 1H); 8.62 (s, 1H); 9.04 (d, br,
1H); 13.4 (br, 1H)
2143[DMSO] 0.26 (m, 2H); 0.47 (m, 2H); 1.05 (m, 1H); 3.20 (m, 2H); 8.63 (s, 1H); 8.94 (t, br,
1H); 13.4 (br, 1H)
2144[DMSO] 0.91 (s, 9H); 3.15 (d, 2H); 8.55 (s, 1H); 8.66 (t, br, 1H); 13.3 (br, 1H)

3. Biological Examples

3.1 Scoring of the Damage

[0590]

The damage to the plants is scored visually using a scale of 0-100%, in comparison to control plants:

[0591]

0%=no noticeable effect compared to the untreated plant

[0592]

100%=the treated plants dies.

3.2 Post-Emergence Herbicide Action and Safener Action

[0593]

Seeds or rhizome pieces of monocotyledonous and dicotyledonous harmful plants and crop plants are placed in sandy loam soil in plastic pots, covered with soil and cultivated in the greenhouse under good growth conditions. Alternatively, harmful plants encountered in paddy rice cultivation are cultivated in pots in which the surface of the soil is covered by up to 2 cm of water. Three weeks after sowing, the test plants are treated at the three-leaf stage. The herbicide/safener active compound combinations according to the invention, formulated as emulsion concentrates, and in parallel tests the individual active compounds formulated in a corresponding manner, are sprayed at various dosages at a water application rate of 3001 l/ha (converted) onto the green parts of the plants, and, after the test plants were left to stand in the greenhouse for about 2 to 3 weeks under optimum growth conditions, the effect of the preparations is scored visually in comparison to untreated controls. In the case of rice or harmful plants encountered in the cultivation of rice, the active compounds are also added directly to the irrigation water (application analogously to the so-called granule application) or sprayed onto the plants and into the irrigation water.

[0594]

The tests show that the safeners according to the invention in combination with herbicides, in a herbicides:safener ratio of from 2:1 to 1:20, considerably reduce the damage caused by the herbicide to crop plants such as corn, rice, wheat or barley or other cereals or dicotyledonous crop plants such as soybeans or oilseed rape compared to the application of the individual herbicides without safener, such that from 30% up to 100% less damage to the crop plant is observed. At the same time, the action of the herbicide against economically important harmful plants is not, or not essentially, adversely affected, so that good herbicidal post-emergence action against a broad spectrum of weed grasses and broad-leaved weeds can be achieved.

[0595]

In barley, for example, a good safener action for the herbicide mesosulfuron-methyl could be achieved using the compounds Nos. 1, 2, 3, 5, 7, 9, 10, 13, 14, 22, 25, 26, 30, 34, 36, 40, 57, 64, 66, 79, 100, 101, 102, 105, 114, 115, 116, 117, 119, 123, 124, 128, 130, 134, 136, 138, 140, 146, 148, 153, 154, 155, 157, 163, 165, 168, 169, 171, 178, 193, 194, 214, 341, 342, 344, 345, 346, 382, 384, 392, 398, 405, 407, 455, 457, 489, 496, 498, 571, 909, 910, 911, 913, 943, 950, 960, 1023, 1026, 1029, 1030, 1201, 1481, 1487, 1598, 1599, 1600, 1636, 1907.

[0596]

In corn, for example, a good safener action for the herbicide tembotrione could be achieved using the following compounds from Table 1: 4, 6, 9, 10, 14, 24, 32, 34, 36, 43, 64, 66, 71, 75, 79, 105, 114, 118, 140, 146, 148, 153, 169, 178, 210, 214, 345, 51, 95, 341, 456, 457, 489, 496, 498, 909, 911, 913, 943, 960, 1026, 1139, 1368, 1371, 1485, 1488, 1596, 1597, 1598, 1599, 1600, 1604, 1619, 1625, 1629, 1636, 1638, 1646, 1758.

[0597]

In rice, for example, the following compounds from Table 1 achieved good safener action for fenoxaprop-P-ethyl and thiencarbazone or thiencarbazone-methyl:

[0598]

1, 2, 3, 4, 9, 16, 20, 22, 34, 41, 47, 54, 57, 75, 76, 79, 80, 81, 101, 103, 105, 114, 115, 117, 118, 120, 127, 128, 130, 153, 154, 157, 162, 165, 169, 171, 178, 218, 271, 341, 342, 344, 345, 346, 350, 355, 392, 398, 405, 407, 456, 973, 1482, 1596, 1597, 1598, 1600, 1603, 1609, 1625, 1638, 1646, 1659.

3.3 Pre-Emergence Herbicide Action and Safener Action

[0599]

Seeds or rhizome pieces of monocotyledonous and dicotyledonous weed plants and crop plants were placed in sandy loam soil in plastic pots and covered with soil. The herbicide/safener active compound combinations according to the invention, formulated as suspension emulsion concentrates, and in parallel tests the individual active compounds formulated in a corresponding manner, were then, at various dosages at a water application rate of 600 to 800 l/ha (converted), applied to the surface of the covering soil.

[0600]

After the treatment, the pots were placed in the greenhouse and kept under good growth conditions for the weeds and the crop plants. Visual scoring of the plant damage or emergence damage was carried out after the test plants had emerged after a test period of 3 to 4 weeks, in comparison to untreated controls. The test results showed that the compounds according to the invention prevented or reduced herbicide damage to the crop plants without reducing, or reducing substantially, the herbicide action against the harmful plants.

[0601]

For example, example Nos. 2, 19, 39, 72, 104, 122, 155, 193, 194, 217, 232, 271, 341, 380, 392, 1368, 1597, 1625, 1636 of Table 1 showed in the test in combination with the herbicide isoxaflutol a good safener action in corn. The herbicidal action of the herbicidally active compounds used was not adversely affected.

[0602]

Accordingly, in many cases, the safeners, combined with herbicides, are suitable for the selective control of hermful plants in the pre-emergence treatment of crops of useful plants.

3.4 Seed Treatment

[0603]

Seeds of crop plants were mixed in bottles with the safeners according to the invention, formulated as suspension or emulsion concentrates, and water, and the mixture was shaken well so that the seeds were coated evenly with the formulation of the safener in question. The seeds or the emerged plants were then tested with herbicides in the pre- or post-emergence method according to the tests of examples 3.3 and 3.2, respectively.

[0604]

In the treatment of seed, too, the safeners showed good activity. The herbicidal action of the herbicidally active compounds used was not adversely affected.

[0605]

Having thus described in detail various embodiments of the present invention, it is to be understood that the invention defined by the above paragraphs is not to be limited to particular details set forth in the above description as many apparent variations thereof are possible without departing from the spirit or scope of the present invention.



Compounds of the formula (I), or salts thereof, in which R1 to R4 are as defined in formula (I) of claim 1 are suitable as useful-plant-protecting agents for reducing or preventing harmful effects of agrochemicals on the useful plants and their method of preparation are described.



1. A compound of the formula (I) or a salt thereof,

in which:

R1is a (C1-C6)-haloalkyl radical; and

R2is hydrogen or halogen;

wherein:

R3is:

hydrogen, (C1-C16)-alkyl, (C2-C16)-alkenyl, or (C2-C16)-alkynyl;

where each of the 3 last mentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]—carbonyl; or

(C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring;

where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted; and

R4is:

hydrogen, (C1-C16)-alkyl, (C2-C16)-alkenyl, or (C2-C16)-alkynyl;

where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl; or

(C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring;

where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted; or

wherein:

R3is (C1-C4)-alkoxy, (C2-C4)-alkenyloxy, (C2-C6-alkynyloxy, or (C2-C4)-haloalkoxy; and

R4is hydrogen or (C1-C4)-alkyl; or

wherein R3and R4together with the directly attached nitrogen atom ate a four- to eight-membered heterocyclic ring which, in addition to the nitrogen atom, may also comprise further hetero ring atoms, and which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, cyano, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, and (C1-C4)-alkylthio; or

wherein R3and R4together with the directly attached nitrogen atom are the group —N═CR5—NR6R7in which:

R5is hydrogen or (C1-C6)-alkyl, and

R6, R7independently of one another are hydrogen or (C1-C4)-alkyl, or

R6and R7together with the directly attached nitrogen atom form a five- to seven-membered heterocyclic ring; or

in which:

R1is a (C1-C6)-haloalkyl radical;

R2is halogen;

R3is hydrogen; and

R4is hydrogen; or

in which:

R1is a radical of the formula CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CFHCF3, CF(CF3)2, CH(CF3)2, CF2CF2CF3, or C(CH3)2F;

R2is hydrogen;

R3is hydrogen; and

R4is hydrogen.

2. A process for preparing compounds of the general formula (I) or salts thereof as defined in claim 1, which comprises:

(a) reacting a carboxylic acid of the general formula (II) with an amine of the formula (III) or a salt thereof to give the compound of the formula (I);

wherein the general formula (II) is:

where R1and R2are as defined for the compound of the formula (I) to be prepared;

wherein the formula (III) is:

where R3and R4are as defined for the compound of the formula (I) to be prepared; or

(b) reacting a carboxylic ester of the general formula (IlV) with an amine of the formula (III) or a salt thereof to give the compound of the formula (I);

wherein the general formula (IV) is:

where R1and R2are as defined for the compound of the formula (I) to be prepared and “Alkyl” is an alkyl radical;

wherein the formula (III) is:

where R1and R4are as defined for the compound of the formula (I) to be prepared; or

(c) reacting a carbonyl halide or a carboxylic anhydride of the general formula (V) with an amine of the formula (III) or a salt thereof to give the compound of the formula (I);

wherein the general formula (V) is:

where R1and R2are as defined for the compound of the formula (I) to be prepared and Hal is a halogen atom or an acyloxy radical;

wherein the formula (III) is:

where R3and R4are as defined for the compound of the formula (I) to be prepared; or

(d) if R3and R4in the compound of the formula (I) to be prepared are each hydrogen, reacting a compound of the formula (VI) with malonamide to give the compound of the formula (I);

wherein the formula (VI) is:

where R1is as defined for the compound of the formula (I) to be prepared, and “Alkyl” is an alkyl radical.

3. A crop protection composition comprising:

one or more compounds of the formula (I) or salts thereof as defined in claim 1; and formulation auxiliaries.

4. A crop protection composition comprising:

one or more compounds of the formula (I) or salts thereof as defined in claim 1; and one or more agrochemicals and, optionally, formulation auxiliaries.

5. The compound as claimed in claim 1;

wherein R3is:

hydrogen, (C1-C10)-alkyl, (C2-C10)-alkenyl, or (C2-C10)-alkynyl;

where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl; or

(C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring;

where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of:

halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl;

(C3-C3)-cycloalkyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl;

phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio; and

heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo; and

wherein R4is:

(C1-C10)-alkyl, (C1-C10)-alkenyl, or (C2-C10)-alkynyl;

where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl; or

(C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring;

where each of the 4 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of:

halogen, hydroxyl, cyano, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl;

(C3-C6)-cycloalkyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl and (C1-C4)-haloalkyl;

phenyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio; and

heterocyclyl, which is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio and oxo.

6. The compound as claimed in claim 1;

wherein R3is:

hydrogen, (C1-C10)alkyl, (C2-C10)-alkenyl, or (C2-C10)-alkynyl;

where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4) alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl; or

(C3-C6)-cycloalkyl or (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring;

where each of the 2 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkyl; and

wherein R4is:

(C1-C10)-alkyl, (C2-C10)-alkenyl, or (C2-C10)-alkynyl;

where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, hydroxyl, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, and [(C1-C4)-haloalkoxy]-carbonyl; or

(C3-C6)-cycloalkyl or (C3-C6)-cycloalkyl which is condensed at one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring;

where each of the 2 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkyl.

7. The compound as claimed in claim 1;

wherein R3is hydrogen, (C1-C10)-alkyl, (C2-C10)-alkenyl, or (C2-C10)-alkynyl;

where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, and [(C1-C4)-alkoxy]-carbonyl; and

wherein R4is (C1-C10)-alkyl, (C2-C10)-alkenyl, or (C2-C10)-alkynyl;

where each of the 3 lastmentioned radicals is unsubstituted or substituted by one or more radicals selected from the group consisting of (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, and [(C1-C4)-alkoxy]-carbonyl.

8. The compound as claimed in claim 1;

wherein R1is CF3, CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CF2CF2CF3, or C(CH3)2F; and

wherein R2is hydrogen or halogen.

9. The compound as claimed in claim 1;

wherein R1is a (C1-C6)-haloalkyl radical;

wherein R2is halogen;

wherein R3is hydrogen; and

wherein R4is hydrogen.

10. The compound as claimed in claim 1;

wherein R1is a radical of the formula CF2Cl, CF2H, CF2CF3, CF2CF2H, CF2CF2Cl, CFClCF3, CFHCF3, CF(CF3)2, CH(CF3), CF2CF2CF3, or C(CH3)2F;

wherein R2is hydrogen;

wherein R3is hydrogen; and

wherein R4is hydrogen.

11. A method for protecting useful plants against phytotoxic side effects of agrochemicals, the method comprising:

applying an effective amount of one or more compounds as defined in claim 1 before, after, or simultaneously with the agrochemicals to the plants, parts of the plants, the plant seeds, or seed of the plants.

12. The method as claimed in claim 11;

wherein one or more compounds of the formula (I) or salts thereof are used together with one or more agrochemicals which, applied on their own, cause damage to the useful plants, optionally in the presence of formulation auxiliaries.

13. The method as claimed in claim 11;

wherein the application is by the post-emergence method.

14. The method as claimed in claim 11;

wherein the application of the compound of the formula (I) or a salt thereof is by treating the plant seeds or seed of the plants.

15. The method as claimed in claim 11;

wherein the application is by the pre-emergence method.

16. A method for the selective control of harmful plants in crops of useful plants, the method comprising:

applying an effective amount of one or more compounds of the formula (I) or salts thereof as defined in claim 1 before, after, or simultaneously with one or more herbicides to the plants, parts of plants, plant seeds, or seed of the plants.

17. The method as claimed in claim 16, further comprising:

treating the seed of the plants with one or more compounds of the formula (I) or salts thereof and applying the herbicide after sowing by the pre-emergence method or by the post-emergence method.